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English abstract 
 
In this study, we decided to throw light on some aspects of 
donkeys’ helminths infestation and treatment, and to provide baseline 
data pertaining to some blood constituents of normal healthy donkeys 
which is, according to our knowledge, non existent or too meagre. 
In a field survey 1200 donkeys from Khartoum State were 
examined parasitically for the presence of helminth parasites by 
assessment of faecal eggs for a complete year (one hundred animals per 
month). Generally, 70.1% of the examined animals harboured a 
parasitical infection. Six nematodes genera were encountered in donkeys, 
among them Dictyocaulus arnfieldi (70.5%) reported for the first time in 
Sudanese donkeys. Strongylus spp. (35.8%), Cyathostomes (36.7%), 
Parascris equorum (10.7%), Trichostrongylus axei (12%), and 
Strongyloides westeri (3.4%). The incidence of infection with single 
species (53.2%) was found higher than that of mixed infection (46.7%). 
The order of degree of infection was, 58.6% animals showed mild 
infection, while 21.9% and 19.5% of them showed moderate and severe 
infection, respectively. In the current study, cold season encouraged 
higher incidence of gastrointestinal nematodes (34.48 %), more so than 
hot (32.94 %) and rainy (32.58 %) seasons. Other results obtained, 
showed that hot season revealed higher mean EPG count (1198.7 ± 
558.3) ranging from (100 to 17700), followed by the rainy season with 
mean EPG (961.2 ± 120.3) ranging from (100 to 13500), and cold season 
with mean EPG (888.6 ± 297.5) ranging from (100 to 13300). 
Twenty donkeys (10 male and 10 female) were used to study the 
seasonal variation in blood biochemical constituents and to obtain normal 
values and reference range of the donkey’s blood. They were kept for a 
whole year in the premises of the Department of Radioisotopes, Soba. 
Blood samples were collected bimonthly from the donkeys. 
Haematological parameters studied include packed cell volume 
(PCV), haemoglobin concentration (Hb), total white blood cell count 
(WBC), and Mean corpuscular haemoglobin concentration (MCHC). 
Serum biochemical constituents measured include: total serum protein, 
albumin, total globulin, total bilirubin, urea, creatinine, uric acid, glucose, 
cholesterol, triglycerides, phospholipids, sphingolipids, Aspartate 
aminotransferase (AST), Alanine aminotransferase (ALT), inorganic 
phosphorus, calcium, copper, zinc, sodium and potassium. Hormonal 
parameters studied were: thyroxine (T4), triiodothyronine (T3), and 
thyroid stimulating hormone (TSH). In this study for the first time we did 
the fractionation of the phospholipids using high performance liquid 
chromatography technique.   
Serum thyroxine (T4), triiodothyronine (T3), and thyroid 
stimulating hormone (TSH) concentrations were assayed in normal male 
and female donkeys by radioimmunoassay (RIA) and immuno-
radiometric assay (IRMA), respectively. Male donkeys had low serum 
concentrations of T3 (0.50 ± 0.21 ng/ml) as compared with the values in 
female donkeys (0.53 ± 0.21 ng/ml). Females had lower T4 values (6.28 ± 
5.21 ng/ml) as compared with the values in male donkeys (11.01 ± 7.94 
ng/ml). There is no difference in TSH concentration in male and female 
donkeys (0.86 ± 0 .14 and 0.86 ± 0 .14 mIU/ml respectively). 
A total of 50 male and female donkeys, 4-10 years of age and 
naturally infected with gastrointestinal nematodes were utilized in a 
controlled experiment to evaluate the therapeutic efficacy of Doramectin 
1% Injectable formulation at the dosage rate of 200 µg Doramectin per kg 
of live body weight applied intramuscularly and subcutaneously, and 
Ivermectin 1% commercial Injectable formulation at 200 µg Ivermectin 
per kg body weight applied intramuscularly. Animals were allocated to 
three treatment groups each of 16 donkeys based on pre-treatment eggs 
per gram (EPG) counts and treatments were randomized among the 
groups. Faecal egg counts were performed for the first week after 
treatment and then every week for 4 consecutive weeks. Doramectin 
administered subcutaneously reduced (EPG) count from 1839.3 ± 1209.9 
on day zero (before treatment) to 57.1 ± 150.5 on day 7. Both Doramectin 
and Ivermectin preparations administered intramuscularly reduced initial 
EPG from a mean of 1553.6 ± 968.2 and 1545.0 ± 1589.6 to 0 on Days 6 
and 7 and at the end of the trial on Day 28, respectively. Efficacy 
percentages of Doramectin and Ivermectin against immature and adult 
nematodes were as follows: Trichostrongylus axei, Parascaris equorum, 
Strongylus spp., Triodontophorus spp., Cyathostomes spp., Oxyuris equi, 
and Strongyloides westeri 100% for both products. Gasterophilus spp. 
was not found in donkeys from either treated group, while two of control 
donkeys had infections with this parasite. Doramectin when injected 
subcutaneously showed greater efficacy (96.5%) than Ivermectin (69.2%) 
against Strongylus vulgaris larvae found in the mesenteric artery 
aneurisms. No significant differences were noted between Doramectin 
and Ivermectin. Efficacy against the gastrointestinal nematode species 
found in this study was very evident for the efficacy of both products. No 
adverse reactions were observed during the experimental period.  
A study was conducted to evaluate the effect of medication with 
Doramectin Injectable formulation in donkeys naturally infected with 
gastrointestinal nematodes. Twenty male and female donkeys naturally 
infected with gastrointestinal nematodes received single injection of 
Doramectin either intramuscularly or subcutaneously. Before treatment at 
day zero and then every four days post treatment for 28 days, blood 
samples were collected from the animals and subjected to serum-
biochemical analysis. Results obtained although showed some significant 
changes in some parameters, but they were within the normal range 
suggested by other researchers. At the end of the experiment all the 
parameters measured were at the normal level. 
Another study was conducted to evaluate the sub acute toxicity of 
Doramectin Injectable formulation in healthy donkeys. This experiment 
involved four groups of animals, each of five. Three treatment groups 
received Doramectin injection intramuscularly at 100, 200 and 300 µg/kg 
body weight for seven continuous days, and blood samples were collected 
daily for the first week and then every week for 4 additional weeks. 
Results obtained from the treatment groups were compared with those of 
the control group. Only urea level showed significant increase (P<0.05) 
both in the treated and control groups at the end of the experiment. The 
change encountered here occurred both in treated and non treated animals 
and the only significant difference is reduction in urea level in the 
animals that received 100 µg/kg of Doramectin when compared to that of 
control group. 
In the same study the effect of Doramectin on T3, T4 and TSH 
hormones was also investigated, the fluctuation that occurred in the three 
hormones did not differ significantly (P>0.05) from that of the control 
animals, so it is concluded that Doramectin Injectable formulation 
injected at a dose rate of 100, 200 and 300 µg/kg body weight in donkeys 
for a whole week did not have any toxic or adverse effects. 
 
 
 ﺑﺴﻢ اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﻴﻢ
 اﻟﺨﻼﺻﺔ
ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ، ﻗﺮرﻧﺎ اﻟﻘﺎء اﻟﻀﻮء ﻋﻠﻲ ﺑﻌﺾ اﻟﺠﻮاﻧﺐ اﻟﺘﻲ ﺗﺘﻌﻠﻖ 
ﺑﺎﻻﺻﺎﺑﺔ ﺑﺎﻟﺪﻳﺪان  و ﻋﻼﺟﻬﺎ ﻓﻲ اﻟﺤٌﻤﺮ اﻷهﻠﻴﺔ، و أﻳﻀًﺎ اﻟﻌﻤﻞ ﻋﻠﻲ ﺗﻮﻓﻴﺮ ﻗﺎﻋﺪة 
ﺑﻴﺎﻧﺎت اﺳﺎﺳﻴﺔ ﺗﺘﻌﻠﻖ ﺑﺒﻌﺾ ﻣﻜﻮﻧﺎت اﻟﺪم ﻓﻲ اﻟﺤﻤﻴﺮ، و اﻟﺘﻲ ﻋﻠﻲ ﺣﺴﺐ اﻋﺘﻘﺎدﻧﺎ، 
 .ﺷﺤﻴﺤﺔ ﻗﺒﻞ اﻟﺸﺮوع ﻓﻲ هﺬا اﻟﺒﺤﺚﻏﻴﺮ ﻣﺘﻮﻓﺮة أو 
 رأس ﻣﻦ اﻟﺤﻤﻴﺮ ﻓﻲ وﻻﻳﺔ اﻟﺨﺮﻃﻮم ﺗﻢ اﻟﺘﻘﺼﻲ 0021ﻓﻲ ﻣﺴﺢ ﺣﻘﻠﻲ ﺷﻤﻞ 
ﻋﻦ وﺟﻮد اﻟﺪﻳﺪان اﻻﺳﻄﻮاﻧﻴﺔ اﻟﻤﺘﻄﻔﻠﺔ ﻋﻠﻲ اﻟﻘﻨﺎة اﻟﻬﻀﻤﻴﺔ و ذﻟﻚ ﻣﻦ ﺧﻼل ﻓﺤﺺ 
 ﻋﻤﻮﻣًﺎ .( ﺣﻴﻮان آﻞ ﺷﻬﺮ001)ﺑﻴﻮض اﻟﺪﻳﺪان ﻓﻲ اﻟﺒﺮاز و ذﻟﻚ ﻟﻤﺪة ﻋﺎم آﺎﻣﻞ 
ﺳﺘﺔ اﺟﻨﺎس ﻣﻦ اﻟﺪﻳﺪان . ﻟﺘﻲ ﺗﻢ ﻓﺤﺼﻬﺎ آﺎﻧﺖ ﻣﺼﺎﺑﺔ ﺑﺎﻟﺪﻳﺪانﻣﻦ اﻟﺤﻴﻮاﻧﺎت ا% 1.07
 idleifnra suluacoytciDﺗﻢ اﻟﺘﻌﺮف ﻋﻠﻴﻬﺎ، ﺗﺄﺗﻲ ﻓﻲ اﻟﻤﺮﺗﺒﺔ اﻻوﻟﻲ دﻳﺪان       
، و )%7.63( semotsohtayC، و ﺟﻨﺲ )%8.53( .pps sulygnortS، و ﺟﻨﺲ )%5.07(
،                          )%21( iexa sulygnortsohcirT، و )%7.01( murouqe siracsaraP
وﺟﺪ %( 2.35)، اﻻﺻﺎﺑﺔ ﺑﺠﻨﺲ واﺣﺪ ﻣﻦ اﻟﺪﻳﺪان )%4.3( iretsew sediolygnortSو 
درﺟﺔ اﻻﺻﺎﺑﺔ ﻓﻲ اﻟﺤﻴﻮاﻧﺎت اﻇﻬﺮت أن %(. 7.64)أﻋﻠﻲ ﻣﻦ اﻻﺻﺎﺑﺔ ﺑﻌﺪة اﺟﻨﺎس 
ﻣﻦ % 5.91و % 9.12ﻣﻦ اﻟﺤﻴﻮاﻧﺎت آﺎﻧﺖ درﺟﺔ اﻻﺻﺎﺑﺔ ﻓﻴﻬﺎ ﺧﻔﻴﻔﺔ، ﺑﻴﻨﻤﺎ % 6.85
ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ اﻟﻔﺼﻞ .  اﻇﻬﺮت اﺻﺎﺑﺔ ﻣﺘﻮﺳﻄﺔ اﻟﻲ ﺷﺪﻳﺪة، ﻋﻠﻲ اﻟﺘﻮاﻟﻲاﻟﺤﻴﻮاﻧﺎت
و %( 49.23)اآﺒﺮ ﻣﻦ اﻟﻔﺼﻞ اﻟﺤﺮ %( 84.43)اﻟﺒﺎرد أﻇﻬﺮ درﺟﺔ اﺻﺎﺑﺔ ﻋﺎﻟﻴﺔ 
اﻟﻨﺘﺎﺋﺞ اﻻﺧﺮي اﻟﺘﻲ ﺗﻢ اﻟﺤﺼﻮل ﻋﻠﻴﻬﺎ اﻇﻬﺮت ﻋﺪد اآﺒﺮ %(. 85.23)ﻓﺼﻞ اﻻﻣﻄﺎر 
 اﻟﻤﺪي ﻳﺘﺮاوح ﺑﻴﻦ ﻓﻲ ﻓﺼﻞ اﻟﺼﻴﻒ و آﺎن ( 7.8911±3.855)ﻣﻦ ﺑﻴﻮض اﻟﺪﻳﺪان 
و ( 2.169±3.021)، ﻳﻠﻲ ذﻟﻚ ﻓﺼﻞ اﻻﻣﻄﺎر ﺑﻤﺘﻮﺳﻂ ﻓﻲ ﻋﺪد اﻟﺒﻴﻮض (001-00771)
و ﻣﺪي ( 6.888±5.792)، و اﻟﻔﺼﻞ اﻟﺒﺎرد ﺑﻤﺘﻮﺳﻂ ﻋﺪد ﺑﻴﻮض (001-00531)ﻣﺪي 
 (.001-00331)
ﻟﺪراﺳﺔ (  ﻣﻦ اﻟﺬآﻮر و ﻣﺜﻠﻬﺎ ﻣﻦ اﻻﻧﺎث01)ﺗﻢ اﺳﺘﺨﺪام ﻋﺸﺮﻳﻦ ﺣﻤﺎرًا 
ﺣﻴﻮاﻧﺎت اﻻﺧﺘﺒﺎر ﺗﻢ ﺣﻔﻈﻬﺎ . ﻣﻜﻮﻧﺎت اﻟﺪم اﻟﻜﻴﻤﻮﺣﻴﻮﻳﺔاﻻﺧﺘﻼف اﻟﻔﺼﻠﻲ ﻓﻲ ﺑﻌﺾ 
ﺗﻢ ﺗﺠﻤﻴﻊ ﻋﻴﻨﺎت اﻟﺪم ﻣﺮﺗﻴﻦ آﻞ . ﺑﺤﻈﺎﺋﺮ ﻗﺴﻢ اﻟﻨﻈﺎﺋﺮ اﻟﻤﺸﻌﺔ، ﺳﻮﺑﺎ ﻟﻤﺪة ﻋﺎم آﺎﻣﻞ
 .ﺷﻬﺮ ﻣﻦ اﻟﺤﻤﻴﺮ
ﺗﺮآﻴﺰ ( VCP)ﺧﺼﺎﺋﺺ ﻣﺒﺤﺚ اﻟﺪم اﻟﺘﻲ ﺷﻤﻠﺘﻬﺎ اﻟﺪراﺳﺔ ﺿﻤﺖ ﻣﻜﺪاس اﻟﺪم 
، و ﺗﻢ ﺣﺴﺎب اﻟﺘﺮآﻴﺰ )CBW(و اﻟﻌﺪ اﻟﻜﻠﻲ ﻟﻜﺮﻳﺎت اﻟﺪم اﻟﺒﻴﻀﺎء ( bH)اﻟﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ 
أﻳﻀًﺎ ﺗﻢ ﺗﺠﻤﻴﻊ ﻋﻴﻨﺎت ﻣﺼﻞ اﻟﺪم ( . CHCM)اﻟﻤﺌﻮي ﻟﻠﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ ﻓﻲ اﻟﻜﺮﻳﺎت 
، اﻟﻘﻠﻮﺑﻴﻮﻟﻴﻦ، اﻟﻴﻮرﻳﺎ، اﻟﻜﺮﻳﺎﺗﻴﻨﻴﻦ، (اﻟﺰﻻل)ﻟﺪراﺳﺔ آﻤﻴﺔ اﻟﺒﺮوﺗﻴﻦ اﻟﻜﻠﻲ، اﻻح 
ﺣﻤﺾ اﻟﻴﻮرﻳﻚ، اﻟﺠﻠﻮآﻮز، اﻟﻜﻮﻟﺴﺘﺮول، اﻟﺠﻠﺴﺮﻳﺪات اﻟﺜﻼﺛﻴﺔ، اﻟﺪهﻮن اﻟﻔﻮﺳﻔﺎﺗﻴﺔ و 
، اﻟﻔﻮﺳﻔﻮر ﻏﻴﺮ اﻟﻌﻀﻮي، اﻟﻜﺎﻟﺴﻴﻮم، )TLA(، إﻧﺰﻳﻢ )TSA(اﻹﺳﻔﻨﺠﻴﺔ، إﻧﺰﻳﻢ اﻟﺪهﻮن 
 .اﻟﻨﺤﺎس، اﻟﺰﻧﻚ، اﻟﺼﻮدﻳﻮم و اﻟﺒﻮﺗﺎﺳﻴﻮم
 أﻳﻀًﺎ ﺗﻤﺖ دراﺳﺔ ﻣﺴﺘﻮي هﺮﻣﻮﻧﺎت اﻟﻐﺪة اﻟﺪرﻗﻴﺔ و اﻟﻔﺺ اﻷﻣﺎﻣﻲ ﻟﻠﻐﺪة 
 ﻓﻲ ﻣﺼﻞ اﻟﺪم HST،و هﺮﻣﻮن اﻟﻐﺪة اﻟﻨﺨﺎﻣﻴﺔ 4T و3Tﺣﻴﺚ ﺗﻢ ﻗﻴﺎس ﺗﺮآﻴﺰ . اﻟﻨﺨﺎﻣﻴﺔ
 ذآﻮر اﻟﺤﻴﻮاﻧﺎت اﻟﺼﺤﻴﺤﺔ و ذﻟﻚ ﺑﺎﺳﺘﺨﺪام ﺗﻘﻨﻴﺔ اﻟﻤﻘﺎﻳﺴﺔ اﻟﻤﻨﺎﻋﻴﺔ ﻓﻲ إﻧﺎث و
 و اﻟﺘﻲ أﻇﻬﺮت أن اﻟﺬآﻮر ﺗﺤﺘﻮي ﻋﻠﻲ ﻣﺴﺘﻮي أﻗﻞ ﻣﻦ اﻹﻧﺎث )AIR(اﻟﺸﻌﺎﻋﻴﺔ 
ﺑﺎﻟﻨﺴﺒﺔ ﻟﻬﺮﻣﻮن اﻟﺜﺎﻳﺮوﻧﻴﻦ ﺛﻼﺛﻲ اﻟﻴﻮد ﺑﻴﻨﻤﺎ اﻹﻧﺎث ﻟﺪﻳﻬﺎ ﻣﺴﺘﻮي اﻗﻞ ﻣﻦ هﺮﻣﻮن 
ف ﺑﻴﻦ اﻟﺠﻨﺴﻴﻦ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﻬﺮﻣﻮن ﺑﻴﺪ أﻧﻪ ﻻ ﻳﻮﺟﺪ  اﺧﺘﻼ. اﻟﺜﺎﻳﺮوآﺴﻴﻦ ﻣﻘﺎرﻧﺔ ﺑﺎﻟﺬآﻮر
 .اﻟﻤﻨﺸﻂ ﻟﻠﺪرﻗﻴﺔ
 ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ ﺗﻢ ﻻول ﻣﺮة اﻟﺘﻌﺮف ﻋﻠﻲ اﺟﺰاء اﻟﺪهﻮن اﻟﻔﻮﺳﻔﺎﺗﻴﺔ و ذﻟﻚ 
  .)CLPH(ﺑﺎﺳﺘﺨﺪام ﺗﻘﻨﻴﺔ اﻟﻜﺮوﻣﺎﺗﻮﻏﺮاﻓﻴﺎ اﻟﺴﺎﺋﻠﺔ ذات اﻻداء اﻟﻌﺎﻟﻲ 
 -4 ﺗﻢ اﺳﺘﺨﺪام ﻋﺪد ﺧﻤﺴﻴﻦ ﻣﻦ إﻧﺎث و ذآﻮر اﻟﺤﻤﻴﺮ أﻋﻤﺎرهﺎ ﺗﺘﺮاوح ﺑﻴﻦ  
ﻣﺼﺎﺑﺔ ﻃﺒﻴﻌﻴًﺎ ﺑﺪﻳﺪان ﻃﻔﻴﻠﻴﺔ اﺳﻄﻮاﻧﻴﺔ ﺗﺘﻮاﺟﺪ ﻓﻲ اﻟﻤﻌﺪة و اﻷﻣﻌﺎء و ذﻟﻚ  ﻋﺎم 01
 ﻣﻴﻜﺮوﺟﺮام 002اﻟﻤﻌﺪ ﻟﻠﺤﻘﻦ ﺑﺠﺮﻋﺔ ﻣﻘﺪارهﺎ % 1ﻻﺧﺘﺒﺎر ﻓﻌﺎﻟﻴﺔ ﻋﻘﺎر اﻟﺪوراﻣﻜﺘﻴﻦ 
ﻟﻜﻞ آﻴﻠﻮﺟﺮام وزن ﺣﻲ و ﻗﺪ ﺗﻢ ﺣﻘﻦ اﻟﻌﻘﺎر ﻣﺮة ﺗﺤﺖ اﻟﺠﻠﺪ و ﻣﺮة ﻓﻲ اﻟﻌﻀﻞ، و 
 ﻣﻴﻜﺮوﺟﺮام ﻟﻜﻞ 002ﺑﺠﺮﻋﺔ ( ﺗﺮآﻴﺐ اﻳﻀًﺎ ﻣﻌﺪ ﻟﻠﺤﻘﻦ% )1ﻋﻘﺎر اﻻﻳﻔﺮﻣﻜﺘﻴﻦ 
اﻟﺤﻴﻮاﻧﺎت ﺗﻢ ﺗﻘﺴﻴﻤﻬﺎ إﻟﻰ ﺛﻼث ﻣﺠﻤﻮﻋﺎت . آﻴﻠﻮﺟﺮام و ﻗﺪ ﺗﻢ اﻋﻄﺎؤﻩ ﻓﻲ اﻟﻌﻀﻞ
 ﺣﻴﻮان و ﻗﺪ ﺗﻢ 61اﻋﺘﻤﺎدًا ﻋﻠﻲ ﻋﺪد ﺑﻴﻮض اﻟﺪﻳﺪان ﻗﺒﻞ اﻟﻌﻼج، آﻞ ﻣﺠﻤﻮﻋﺔ ﺿﻤﺖ 
ﻟﺒﻴﻮض ﻳﻮﻣﻴًﺎ ﻟﻤﺪة ﺑﻌﺪ اﻟﻌﻼج ﺗﻢ إﺟﺮاء ﻋﺪ ا. إﺟﺮاء اﻟﻌﻼج ﻋﺸﻮاﺋﻴًﺎ ﻋﻠﻲ اﻟﻤﺠﻤﻮﻋﺎت
آﻞ ﻣﻦ اﻟﺪوراﻣﻜﺘﻴﻦ و اﻻﻳﻔﺮﻣﻜﺘﻴﻦ اﻟﻠﺬﻳﻦ .  أﺳﺎﺑﻴﻊ4أﺳﺒﻮع و ﻣﻦ ﺛﻢ آﻞ أﺳﺒﻮع ﻟﻤﺪة 
و ( 6.3551±2.869)ﺗﻢ إﻋﻄﺎؤهﻤﺎ ﻋﻦ ﻃﺮﻳﻖ اﻟﻌﻀﻞ اﺧﺘﺰﻻ ﻋﺪد اﻟﺒﻴﻮض ﻣﻦ ﻣﺘﻮﺳﻂ 
 أﻳﺎم و ﺣﺘﻰ ﻧﻬﺎﻳﺔ اﻟﺘﺠﺮﺑﺔ 7 و 6ﻗﺒﻞ إﻋﻄﺎء اﻟﺪواء إﻟﻰ ﺻﻔﺮ ﺧﻼل ( 5451±6.9851)
ﻧﺴﺒﺔ ﻓﻌﺎﻟﻴﺔ ﻋﻘﺎر اﻟﺪوراﻣﻜﺘﻴﻦ و اﻻﻳﻔﺮﻣﻜﺘﻴﻦ ﻋﻠﻲ اﻷﻃﻮار . اﻟﺘﻮاﻟﻲ ﻋﻠﻲ 82ﻓﻲ اﻟﻴﻮم 
 siracsaraP ,iexa sulygnortsohcirT -:اﻟﺒﺎﻟﻐﺔ و ﻏﻴﺮ اﻟﺒﺎﻟﻐﺔ ﻟﻠﺪﻳﺪان آﺎﻧﺖ آﻤﺎ ﻳﻠﻲ
 siruyxO ,.pps semotsohtayC  ,.pps surohpotnodoirT  ,.pps sulygnortS ,murouqe
  ﻟﻢ .pps sulihportsaGﻳﺮﻗﺎت . ﻜﻼ اﻟﻌﻘﺎرﻳﻦﻟ% 001  iretsew sediolygnortS  ,iuqe
ﻳﺘﻢ اﻟﻌﺜﻮر ﻋﻠﻴﻬﺎ ﻓﻲ اﻟﺤﻴﻮاﻧﺎت اﻟﺘﻲ ﺗﻢ ﻋﻼﺟﻬﺎ ﻋﻦ ﻃﺮﻳﻖ اﻟﻌﻀﻞ ﺑﻴﻨﻤﺎ ﻋﺜﺮ ﻋﻠﻴﻬﺎ 
ﻋﻘﺎر . ﻓﻲ اﺛﻨﻴﻦ ﻣﻦ ﺣﻴﻮاﻧﺎت اﻟﺘﺤﻜﻢ و اﻟﺤﻴﻮاﻧﺎت اﻟﺘﻲ ﺗﻢ ﺣﻘﻨﻬﺎ ﺗﺤﺖ اﻟﺠﻠﺪ
 اآﺒﺮ% 6.59اﻟﺪوراﻣﻜﺘﻴﻦ ﻋﻨﺪﻣﺎ ﺗﻢ اﻋﻄﺎؤﻩ ﻋﻦ ﻃﺮﻳﻖ اﻟﻌﻀﻞ اﻋﻄﻲ ﻓﻌﺎﻟﻴﺔ ﻋﺎﻟﻴﺔ 
 اﻟﻤﻮﺟﻮدة  siragluv sulygnortSﻋﻠﻲ اﻻﻃﻮار اﻟﻴﺮﻗﻴﺔ ﻟﺪﻳﺪان % 2.96ﻣﻦ اﻻﻳﻔﺮﻣﻜﺘﻴﻦ 
ﻟﻢ ﺗﻮﺟﺪ ﻓﺮوق ﻣﻌﻨﻮﻳﺔ ﺑﻴﻦ ﻓﻌﺎﻟﻴﺔ آﻞ ﻣﻦ اﻟﻌﻘﺎرﻳﻦ . اﻟﻘﺤﻔﻲ اﻟﻤﺴﺎرﻳﻘﻲ اﻟﺸﺮﻳﺎن ﻓﻲ
ﻟﻢ ﺗﻼﺣﻆ أي اﺛﺎر ﺳﺎﻟﺒﺔ أو ﻏﻴﺮ ﻣﺮﻏﻮﺑﺔ ﻧﺘﻴﺠﺔ ﻻﺳﺘﺨﺪام اﻟﺪوراﻣﻜﺘﻴﻦ . ﻣﺤﻞ اﻻﺧﺘﺒﺎر
 .ﺘﺒﺎرﻓﻲ اﻟﺤﻤﻴﺮ ﺧﻼل ﻓﺘﺮة اﻻﺧ
ﺗﻢ اﺟﺮاء دراﺳﺔ ﻟﺘﻘﻮﻳﻢ ﺗﺄﺛﻴﺮ اﻟﻌﻼج ﺑﻌﻘﺎر اﻟﺪوراﻣﻜﺘﻴﻦ اﻟﻤﺤﻘﻮن ﻓﻲ اﻟﺤﻤﻴﺮ 
ﻋﺸﺮﻳﻦ ﻣﻦ ذآﻮر و اﻧﺎث اﻟﺤﻤﻴﺮ ﻣﺼﺎﺑﺔ . اﻟﻤﺼﺎﺑﺔ ﻃﺒﻴﻌﻴًﺎ ﺑﺪﻳﺪان اﺳﻄﻮاﻧﻴﺔ ﻃﻔﻴﻠﻴﺔ
ﻃﺒﻴﻌﻴًﺎ ﺑﺎﻟﺪﻳﺪان اﻻﺳﻄﻮاﻧﻴﺔ اﻟﻤﻌﻮﻳﺔ ﺗﻢ ﺣﻘﻨﻬﺎ ﺑﺠﺮﻋﺔ ﻋﻼﺟﻴﺔ ﻣﻔﺮدﻩ ﻣﻦ اﻟﺪوراﻣﻜﺘﻴﻦ 
 اﻳﺎم ﻟﻤﺪة 4ﺛﻢ آﻞ ( ﻓﻲ اﻟﻴﻮم ﺻﻔﺮ) ﻗﺒﻞ اﻟﻌﻼج .ﻟﺠﻠﺪاﻣﺎ ﻋﻦ ﻃﺮﻳﻖ اﻟﻌﻀﻞ أو ﺗﺤﺖ ا
 ﻳﻮم ﺗﻢ ﺗﺠﻤﻴﻊ ﻋﻴﻨﺎت ﻣﺼﻞ اﻟﺪم ﻣﻦ ﺣﻴﻮاﻧﺎت اﻻﺧﺘﺒﺎر و ﻣﻦ ﺛﻢ اﺧﻀﺎﻋﻬﺎ ﻟﻠﺘﺤﻠﻴﻞ 82
اﻟﻨﺘﺎﺋﺞ اﻟﺘﻲ ﺗﻢ اﻟﺤﺼﻮل ﻋﻠﻴﻬﺎ اﻇﻬﺮت ﻓﺮوﻗًﺎ ﻣﻌﻨﻮﻳﺔ ﻓﻲ ﺑﻌﺾ ﻋﻨﺎﺻﺮ . اﻟﻜﻴﻤﻮﺣﻴﻮي
 اﻟﻌﺪﻳﺪ ﻣﻦ اﻟﺒﺎﺣﺜﻴﻦ اﻻﺧﺘﺒﺎرات و ﻟﻜﻨﻬﺎ آﺎﻧﺖ ﻓﻲ ﻧﻄﺎق اﻟﻤﺪي اﻟﻄﺒﻴﻌﻲ اﻟﺬي اﻗﺘﺮﺣﻪ
ﻓﻲ ﻧﻬﺎﻳﺔ ﻓﺘﺮة اﻻﺧﺘﺒﺎر آﻞ ﻋﻨﺎﺻﺮ اﻻﺧﺘﺒﺎر اﻟﺘﻲ ﺗﻢ ﻗﻴﺎﺳﻬﺎ آﺎﻧﺖ ﻓﻲ اﻟﻤﺪي . ﻣﻦ ﻗﺒﻞ
 .اﻟﻄﺒﻴﻌﻲ
ﺗﻢ اﺟﺮاء اﺧﺘﺒﺎر ﺁﺧﺮ ﻟﺘﻘﻮﻳﻢ اﻟﺘﺴﻤﻢ دون اﻟﺤﺎد ﻟﻠﺪوراﻣﻜﺘﻴﻦ اﻟﻤﺤﻘﻮن ﻓﻲ 
اﻟﺘﺠﺮﺑﺔ ﺷﻤﻠﺖ أرﺑﻌﺔ ﻣﺠﻤﻮﻋﺎت ﻣﻦ (. ﻏﻴﺮ اﻟﻤﺮﻳﻀﺔ)اﻟﺤﻴﻮاﻧﺎت اﻟﺼﺤﻴﺤﺔ 
ﺛﻼث ﻣﺠﻤﻮﻋﺎت ﺗﻢ ﺣﻘﻨﻬﺎ ﺑﻌﻘﺎر . ﺔ ﺿﻤﺖ ﺧﻤﺴﺔ ﺣﻤﻴﺮاﻟﺤﻴﻮاﻧﺎت، آﻞ ﻣﺠﻤﻮﻋ
 ﻣﻴﻜﺮوﺟﺮام ﻟﻜﻞ 003 و 002، 001: اﻟﺪوراﻣﻜﺘﻴﻦ ﻓﻲ اﻟﻌﻀﻞ ﺑﺠﺮﻋﺎت ﻣﻘﺪارهﺎ
آﻴﻠﻮﺟﺮام وزن ﺣﻲ ﻟﻤﺪة ﺳﺒﻌﺔ اﻳﺎم، ﺗﻢ ﺗﺠﻤﻴﻊ ﻋﻴﻨﺎت اﻟﺪم ﻳﻮﻣﻴًﺎ ﻓﻲ اﻻﺳﺒﻮع اﻻول ﺛﻢ 
 اﻟﻤﺠﻤﻮﻋﺎت اﻟﻨﺘﺎﺋﺞ اﻟﺘﻲ ﺗﻢ اﻟﺤﺼﻮل ﻋﻠﻴﻬﺎ ﻣﻦ. آﻞ اﺳﺒﻮع ﻟﻤﺪة ارﺑﻌﺔ اﺳﺎﺑﻴﻊ اﺿﺎﻓﻴﺔ
ﻓﻘﻂ ﺗﺮآﻴﺰ اﻟﻴﻮرﻳﺎ ﻓﻲ اﻟﺪم اﻇﻬﺮ زﻳﺎدة . اﻟﻤﻌﺎﻟﺠﺔ ﺗﻤﺖ ﻣﻘﺎرﻧﺘﻬﺎ ﺑﻤﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ
. ﻣﻌﻨﻮﻳﺔ ﻓﻲ آﻞ ﻣﻦ اﻟﻤﺠﻤﻮﻋﺎت اﻟﻤﻌﺎﻟﺠﺔ و ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ ﻓﻲ ﻧﻬﺎﻳﺔ ﻓﺘﺮة اﻻﺧﺘﺒﺎر
 .اﻟﺘﻐﻴﺮ اﻟﺬي ﺣﺪث هﻨﺎ ﺗﻤﺖ ﻣﻼﺣﻈﺘﻪ ﻓﻲ آﻞ اﻟﻤﺠﻤﻮﻋﺎت اﻻرﺑﻌﺔ
ﻟﺪوراﻣﻜﺘﻴﻦ ﻋﻠﻲ هﺮﻣﻮﻧﺎت ﻓﻲ ﻧﻔﺲ اﻟﺪراﺳﺔ ﺗﻢ اﺳﺘﻘﺼﺎء ﺗﺄﺛﻴﺮ ﻋﻘﺎر ا
اﻟﺘﺄرﺟﺢ اﻟﺬي ﺣﺪث . اﻟﺜﺎﻳﺮوآﺴﻴﻦ، اﻟﺜﺎﻳﺮوﻧﻴﻦ ﺛﻼﺛﻲ اﻟﻴﻮد و اﻟﻬﺮﻣﻮن اﻟﻤﻨﺸﻂ ﻟﻠﺪرﻗﻴﺔ
ﻓﻲ ﻣﺴﺘﻮي اﻟﻬﺮﻣﻮﻧﺎت، ﻓﻲ اﻟﻤﺠﻤﻮﻋﺎت اﻟﺘﻲ ﺗﻢ ﻋﻼﺟﻬﺎ، ﻟﻢ ﻳﻈﻬﺮ ﻓﺮوﻗًﺎ ﻣﻌﻨﻮﻳﺔ ﺑﻴﻨﻪ 
و ﻋﻠﻴﻪ ﻳﻤﻜﻦ اﻟﻘﻮل ﺑﺄن ﻋﻘﺎر . و ﺑﻴﻦ ﻣﺴﺘﻮي اﻟﻬﺮﻣﻮﻧﺎت ﻓﻲ ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ
 ﻣﻴﻜﺮوﺟﺮام ﻟﻜﻞ آﻴﻠﻮﺟﺮام 003 و 002، 001 ﻋﻨﺪ ﺣﻘﻨﻪ ﺑﺠﺮﻋﺎت ﻣﻘﺪارهﺎ اﻟﺪوراﻣﻜﺘﻴﻦ
 .وزن ﺣﻲ ﻟﻤﺪة اﺳﺒﻮع آﺎﻣﻞ ﻟﻴﺲ ﻟﻪ أي ﺳﻤﻴﺔ أو ﺁﺛﺎر ﺟﺎﻧﺒﻴﺔ ﺳﻴﺌﺔ ﻋﻠﻲ ﻓﺼﻴﻠﺔ اﻟﺤﻤﻴﺮ
  
 
 
INTRODUCTION 
 
The donkey (Equus asinus L.), also known as the ass, in the wild is 
an example of unrestrained liberty, but in bondage is often an object of 
abject slavery, overladen, underfed, beaten and generally ill used ‘To the 
smallest ass shall go the biggest stick’ (Soulsby, 1997). The donkey is 
widely, if somewhat erratically, distributed throughout the tropics. In 
spite of the low status, which is generally accorded to it, the donkey in 
fact plays an important role in the provision of energy for agricultural 
production by way of traction for cultivation and transport of produce and 
fetching water from distant water holes to the village.  
The ass is hardier than the horse, survives with much less attention, 
derives sustenance from poor – quality foods. The donkey in its natural 
habitat will wander and browse on sparse fibrous vegetation over long 
distances in an arid semi-desert environment, and can tolerate 
considerable heat and dehydration. It is used more frequently than the 
horse in the tropics and also constitutes the second parent in mule 
breeding. 
The health and welfare of the donkey is of crucial importance to 
those who depend on it for their livelihood. Should a donkey fall out of 
work or die, the family depending on it may suffer great hardships and 
even non-recoverable adversities. 
A major draw-back regarding donkeys is the objectionability of 
consuming its flesh or milk, although in Sudan, it is widely believed that 
donkey milk is a good remedy for whooping cough. A donkey’s main 
role is that of a beast of burden, though in some areas it has a traditional 
role as a drought animal. This use is currently being much expanded and 
relatively recent developments have improved its efficiency when used in 
carts (Wilson, 1990). 
Donkeys are becoming increasingly important animals in the 
Sudan given the new socio-economic situation with an increased use of 
donkeys instead of horses in labour. This new situation can be noticed in 
many urban and suburban areas (Hamid et al., 2001). 
Horses, ponies and donkeys are hosts to a large variety of parasites, 
and it is hardly possible to find any grazing animal of these equines not 
harbouring a number of species at any particular time (Duncan, 1983). 
The number of donkeys referred to veterinary clinics has shown an 
obvious increase during the last decade (Mohamed et al., 1998), which 
raises increased concern about this animal. Often it is presumed, without 
any scientific verification, that the epidemiology of parasites will be 
similar to that in horses (Pandey, 1980a). In the Sudan, to our knowledge, 
very little work has been done on the parasites of donkeys (Eisa et al., 
1979; Kheir and Kheir, 1981; Fadia, 2000). 
Pastoral grazing, limited nutrition, parasite control and 
management systems justify the need for innovative measures. For 
example application of new strategic programs for helminths control and 
consideration of some emerging problems such as anthelmintic resistance 
substantiate probing investigations. 
According to Lichtenfels (1975) equids are host for helminths 
belonging to 28 genera and 75 species of nematodes, 2 genera and 5 
species of trematodes as well as 3 genera and 24 species of cestodes. 
The avermectins (AVM) are naturally – occurring compounds 
produced by fermentation of the soil-dwelling actinomycetes 
Streptomyces avermitilis. Ivermectin (IVM), is a semi-synthetic 
derivative of Ivermectin B1, consisting of an 80:20 mixture of the 
equipotent homologues 22, 23 dihydro B1a and 22, 23 dihydro B1b (Fisher 
and Mrozik, 1989). Doramectin (DRM) is another avermectin compound 
obtained by mutational biosynthesis, by feeding cyclohexane carboxylic 
acid to a genetically – engineered strain of S. avermitilis and, as a result, 
has a cyclohexyl group at the C25 position (Goudie et al., 1993). 
Doramectin and Ivermectin are endoectocide compounds with 
exceptional potency; they have broad nematode and arthropod spectra of 
activity (Mckellar and Benchaoui, 1996). 
The prominent importance of donkeys in the Sudan coupled with 
rarity and scantiness of data and information about this species of 
domestic animals seems to justify the present work. It aims mainly at 
addressing problems such as control, prophylaxis and treatment of trouble 
endoparasites. Also it is envisaged to attain baseline data pertaining to 
biochemical and endocrinological profiles in donkeys of the Sudan. Such 
data is particularly non-existent or deficient at present. Additional 
manipulations with the drug under investigation include pharmaco-
toxicological studies alongside its clinical efficacy.   
The main objectives of this study are thus to: 
1. Study the prevalence and the seasonal and monthly incidence of 
gastrointestinal nematodes in donkeys in Khartoum State.  
2. Attain baseline data, and compare seasonal variation, with respect to:  
•  Haematological,  
• Biochemical, and 
• Endocrinological profiles. 
3. Study the therapeutic efficacy of Doramectin Injectable in donkeys 
naturally infected with gastrointestinal nematodes. 
4. Study the biochemical changes that may follow drug administration. 
5. Investigate the sub-acute toxicity of Doramectin Injectable 
formulation in donkeys. 
LITERATURE REVIEW 
 
1.1 Avermectins  
Avermectins (AVM) and milbemycins have been used intensively to 
control parasites of animals, human and crops worldwide. Both chemical 
groups are naturally derived 16 – membered macrocyclic lactones (MLs) 
(Takiguchi et al., 1980) produced by the soil – dwelling actinomycetes, 
Streptomyces spp. Milbemycins are structurally related to the avermectins 
and share physiochemical properties with avermectins. The main 
structural difference between these two groups is a disaccharide group 
found at the C13 position of the macrolide ring of avermectins. The 
milbemycins have no disaccharide group at C13. Avermectins and 
milbemycins have excellent activity against nematodes and have systemic 
activity against several pathogenic ectoparasites of domestic animals at 
low dosage rates. Due to the high activity of avermectins and 
milbemycins against both nematodes and arthropods, they are now 
classified as ‘endectocides’ (Mckellar and Benchaoui, 1996). However, 
these drugs have no useful activity against trematodes or cestodes (Shoop 
et al., 1995). 
 Ivermectin (IVM) was the first macrocyclic lactone anthelmintic, 
introduced as a veterinary antiparasitic agent in France in 1981 and is 
marketted as a mixture of 22, 23 dihydro- B1a (>80%) and 22, 23 dihydro- 
B1b (<20%) (Fisher and Mrozik, 1989). Doramectin (DRM) is an 
avermectin, which is obtained from the biosynthesis of a mutant strain of 
Streptomyces avermetilis (Goudie et al., 1993). Doramectin differs from 
IVM through substitution of a cyclohexyl group at the C25 position. 
Doramectin, a new anthelmintic, is effective against recent field 
strains of the most prevalent gastrointestinal parasites found in cattle in 
the United States, and could provide another alternative for control of 
these parasites (Couvillion et al., 1997).  
1.1.1 Identity 
1.1.1.1 Chemical composition 
Avermectins are a series of macrocyclic lactone derivatives, which 
are fermentation products of the actinomycete Streptomyces avermitilis 
(Martin, 1985; Urquhart et al., 1988). Doramectin, 25 – cyclohexyl – 5 – 
O – demthyl – 25 – de (1- methylpropyl) avermectin A1a, was selected as 
best of a series of novel avermectins prepared by mutational biosynthesis 
(Goudie et al., 1993). 
1.1.1.2 Chemical name 
25 – Cyclohexyl – 5 – O – demthyl – 25 – de (1– methylpropyl) 
avermectin A1a. 
1.1.1.3 Molecular Formulae 
H2A1a: C49H76O14 
1.1.2 Structure of naturally occurring avermectins 
The avermectins structures are closely related complex 16 –
membered macrocyclic lactones. Although they share structural features 
with the antibacterial macrolides and the antifungal macrocyclic 
polyenes, they are not usually grouped with those compounds (Fisher and 
Mrozik, 1989). 
Fermentation of the actinomycete Streptomyces avermitilis 
produces 4 homologues pairs of closely related compounds: avermectin 
A1, A2, B1 and B2. The A – compounds have a 5 methoxy, whereas the B-
compounds have a 5 – hydroxyl substituent; and the 1-compounds have a 
22, 23 – double bond which is formally obtained by dehydration of the 
axial 23-dihydroxy group of the 2–compounds. The 4 pairs are further 
divided into the major components A1a, A2a, B1a, B2a with a secondary 
butyl side chain at carbon position 25 and the minor components (usually 
present in amounts of 1% to 20%) A1b, A2b, B1b, B2b with an isopropyl 
substituent at C-25 (Figure 1.1). Because the separation of the major 25 –  
iso – propyl components A1b through B2b is very tedious and impractical 
on a large scale, and because the biological activities of two homologues 
are practically identical, the avermectin components are often used as a 
mixture of these homologues. In such cases they are just defined as A1, 
A2, B1 and B2, which means a mixture of not less than 80% components 
“a”, and not more than 20% of components “b” (Fisher and Mrozik, 
1989). 
1.1.3 Mode of action 
It is likely that the entire series of the avermectins share a common 
mode of action; therefore, all avermectins are referred to with generic 
abbreviation AVM. The mode of action of these compounds, however, 
has remained elusive. Identifying the mode of action is all the more 
difficult because the AVM have been studied in so many different model 
systems with an array of experimental protocols. Although the most 
parsimonious explanation for how AVM work is that they specifically 
increase membrane chloride permeability, there is clearly other sites of 
action at which AVM affect either the host or target organism (Turner 
and Schaeffer, 1989).  It was hypothesized that these responses to AVM 
were caused by an increase of membrane permeability to chloride ions 
(Fritz et al., 1979; Martin, 1985). There is an excellent correlation 
between the biological activity of AVM and their ability to bind to a high 
affinity Ivermectin binding site and directly activate or potentiate a 
glutamate – gated chloride channel expressed in Xenopus oocyte. These 
support the hypothesis that AVM – sensitive glutamate - gated chloride 
channels represent the target protein for binding and paralysis, and that 
paralysis of Caenorhbitis elegans is mediated through potentiation, direct 
activation, or both, of glutamate–gated chloride channels (Joseph et al.,

1995). Or perhaps due to its interaction with gamma amino butyric acid 
(GABA) binding sites or by potentiating the release of GABA (Fritz et 
al., 1979; Urquhart et al., 1988). These inhibitory effects of AVM were 
antagonized by picrotoxin, which is an antagonist of a putative 
transmitter, GABA (Bartlet, 1985; Martin, 1985). 
 Turner and Schaeffer (1989) concluded that it is not possible to 
assign a single mechanism of action for AVM in the various systems that 
have been studied. In target organisms the effect of AVM is mediated via 
specific, high affinity binding site. The physiological response to AVM 
binding is an increase in membrane permeability to chloride ions, which 
is independent of GABA – mediated chloride ion channels. GABA – 
gated chloride ions may also interact with AVM, but at significantly 
greater AVM concentrations. In addition to their interaction with chloride 
channels, several other actions of the AVM have been proposed; the 
importance of these remains to be resolved. 
 Although much is known about the mode of action of the AVM on 
nematodes, little is known about the means by which these drugs enter 
the nematode body and thus gain access to the relevant receptors (Smith 
and Campbell, 1996). Geary et al., (1993), suggest that the drug may 
enter the nematode body by crossing the cuticle or by entering openings 
other than the mouth. Recent studies on the transport kinetics of 
anthelmintics when applied to parasitic nematodes in vitro suggest that 
trans-cuticular absorption may be a common mode of entry for anti-
nematodal drugs (Ho et al., 1994). 
1.1.4 Toxicology 
 The avermectins mechanism of toxicity in mammals is unknown 
but GABA is a mammalian nervous system neurotransmitter and effect 
on GABA may be relevant to their safety in mammals (Lankas and 
Gordon, 1989). The fact that much higher concentrations of these 
compounds are needed in mammals as compared to nematodes to affect 
neurological function clearly appears in case of cattle as toxicity and 
death occurred when the animals were given 40 times the therapeutic 
dose but 30 times the normal dose did not produce signs of toxicity 
(Bartlet, 1985). This may be due to the lack of a specific, high affinity 
site associated with neuronal function or to the relatively poor penetration 
of these large molecular weight compounds into the CNS (Lankas and 
Gordon, 1989). 
 In contrast to lower organisms, GABA is found only in the brain 
and spinal cord of mammals, with no detectable levels in the peripheral 
nervous system (Cooper, 1982). Therefore, it was expected that the acute 
toxicity of AVM would be due to their effect in the CNS. This hypothesis 
has proved correct in acute toxicity studies conducted in a variety of 
laboratory animal species, although the exact mechanism of neurotoxicity 
remains unknown (Lankas and Gordon, 1989).  
Lankas and Gordon (1989) stated that Ivermectin effects in mice 
were similar after either oral or intra-peritoneal administration: they 
consisted of ataxia, bradypnoea, and tremors at all dosage levels with 
approximately 1 hour after treatment. Death, preceded by loss of righting, 
occurring from 75 minutes to 6 days after dosing, with most occurring 
within 24 hours. There were no significant sex-related differences in 
acute toxicity in mice after either routes of administration. In rats and 
rabbits acute dermal LD50 values for Ivermectin after 24 hours of 
occluded exposure were > 660 and 406 mg/kg, respectively. These values 
are significantly greater than those discussed previously for oral exposure 
in rats and mice, which suggests that Ivermectin is poorly absorbed 
percutaneously. 
 Clinical signs of the acute toxic syndrome were first identified 
when horses were given Ivermectin intramuscularly at 12.0 mg/kg (60 
times use level). All 4 treated horses showed depression, ataxia, 
mydriasis, lower lip droop, and depressed respiratory rate, and one was 
euthanized after becoming recumbent. The other three recovered 
gradually over two weeks. Some horses in the same trial given 3.0 and 
6.0 mg/kg also developed mydriasis (Campbell and Benz, 1984). 
 Biologically significant changes in haematologic or serum 
biochemical values, with possible exception of serum iron, have not been 
observed in samples from Ivermectin – treated horses. In the first of 2 
experiments, Herd and Kociba (1985), observed small – although 
statistically significant changes in 8 serum biochemical constituents, viz: 
calcium, phosphorus, urea nitrogen, creatinine, bilirubin, sodium, 
potassium, and sorbitol dehydrogenase. But changes in these same 
measures were not seen when they repeated the study. They concluded 
that these minor alterations were biologically insignificant and probably 
related to feeding, handling and husbandry. Asquith and Kulwich (1981) 
also found no untoward haematologic or blood biochemical changes 
following Ivermectin treatment. 
 Ivermectin in paste was also given 3 times at 2-week intervals at 
0.6, 1.2, or 1.8 mg/kg to horses. The repeated doses of 3 or 6 times use 
level elicited no toxic signs, but 9 times the use level was associated with 
a slow papillary light response and a decreased menace reflex after 2 of 
the 3 treatments (Lankas and Gordon, 1989). 
In bovines Injectable Doramectin at a dosage of 0.2 mg/kg is safe 
for treatment of gastrointestinal nematodiasis and louse infestations under 
field conditions (Phillips et al., 1996). All treatments were easily 
administered, and adverse behavioral or tissue reactions were not seen to 
result from Doramectin administration (Panadero et al., 1997; Conder et 
al., 1998). 
In canines the administration of Doramectin caused no local or 
generalized side effects in the bitches. All puppies of the treated bitches 
were born healthy and remained so during the whole trial period 
(Schneider et al., 1994). 
1.1.5 Pharmacokinetics of Doramectin 
 The pharmacokinetics of Doramectin is such that it is a function of 
the species in which the compound is studied. The results of 
pharmacokinetics and bioavailability studies of this drug in horses have 
shown that horses treated with Ivermectin (IVM) and Doramectin (DRM) 
by the oral route showed maximum plasma concentration (Cmax): IVM 
21.4 (13.2 – 36.3) ng/ml obtained at (Tmax): 7.9 (5.0 – 11.0) hours, DRM 
(Cmax): 21.3 ( 14.2 – 45.3) ng/ml obtained at (Tmax): 8 (4.1 – 17.9) hours. 
The area under the concentration time curve (AUC): IVM: 46.1, DRM: 
53.3 ng.day/ml, and mean residence time (MRT): DRM: 3 days was 
significantly longer than that of IVM: 2.3 days. The AVM with longer 
residence times may have extended prophylactic activity in horses and 
may be more effective against emerging and maturing cyathostomes 
during therapy (Gokbulut et al., 2001). Another study conducted by Perez 
and his colleagues (2002) demonstrated that oral administration of 
Doramectin (DRM) and Ivermectin (IVM) revealed t½a (h): IVM: 1.06; 
DRM: 1.50, Cmax (ng/ml): IVM: 51.32 ± 16.1; DRM: 51.62 ± 22.2, Tmax 
(days): IVM: 0.15 ± 0.038; DRM: 0.20 ± 0.074, AUC (ng. day/ml): IVM: 
137.1 ± 35.9; DRM: 178.6 ± 53.7, t½∝(days): IVM: 0.19; DRM: 0.81, t½β 
(days): IVM: 2.89; DRM: 5.18, MRT (days): IVM: 4.20 ± 0.43; DRM: 
7.72 ± 0.93. 
Ivermectin (IVM- Eqvalan® paste, 1.87%) and Doramectin (DRM- 
Dectomax® 1%) were each administered orally to donkeys at 200 µg kg-1 
body weight. Maximum plasma concentrations (Cmax): of IVM: 23.6 ng 
ml-1 and DRM: 33.9 ng ml-1 were obtained at (Tmax): 19.2 and 24 h, 
respectively. The area under the concentration curve (AUC) of DRM: 
228.9 ng day ml-1 was significantly larger than that of IVM: 119.3 ng day 
ml-1 and mean residence time (MRT) was 6.5 days for IVM and 9.1 days 
for DRM (Gokbulut et al., 2005). 
1.1.6 Use of Doramectin in equines 
Anthelmintic products form the basis of helminth control practices 
on horse stud farms at present. Regular evaluation of the efficacy of these 
products is advisable, as it will provide information on the worm egg 
reappearance period and the resistance status in the worm population. 
The development of anthelmintic resistance has indicated the need 
for an alternative or complementary method of parasite control and 
additional effective drugs (Davies and Schwalbach, 2000). An example of 
the more recently developed drugs is Doramectin, an avermectin 
currently registered for use in sheep, cattle and swine (Dectomax® 
injection, Pfizer, France). In South Africa, although not registered for use 
in equines, Doramectin was used by many horse owners. Davies and 
Schwalbach (2000) claimed excellent results and no adverse side-effects 
were reported. 
Doramectin was administered to horses by intramuscular injection 
at a dose rate of 200 µg/ kg. A faecal egg count reduction of 100% was 
found after treatment with Doramectin. Larval cultures showed that 
cyathostomes accounted for between 86 to 96% of pre – treatment 
parasite burdens. Other helminths identified in the faecal samples were 
Strongylus spp. and Trichostrongylus axei (Davies and Schwalbach, 
2000). In South Africa, Doramectin and Moxidectin (both Injectable and 
given at 200 µg/kg) did not have any effect on worm egg counts 
(Matthee, 2003).  
1.1.7 Persistent effect 
For many years, the control of internal parasites of horses has 
relied almost entirely on the routine administration of anthelmintics to 
remove the adult parasites, thus preventing contamination of the 
environment with eggs or larvae. The greatest challenges in equine 
parasite control are to know how anthelmintics should be used to achieve 
good parasite control, foster host – acquired immunity to parasites, and 
avoid drug resistance problems. 
Traditional programmes that depend on repeated use of chemicals 
throughout the year are unsustainable and should no longer be 
recommended. 
The persistent efficacy of some anthelmintics brings advantages in 
nematode control in domestic animals. However, scientific assessment of 
persistent efficacy is relatively new, and a feature of published data has 
been variability in the reported end point for this activity. Trial design 
and calculating efficacy have a large bearing on the results obtained. 
Three types of studies are used to evaluate the persistent efficacy of 
anthelmintics; here they are briefly discussed and compared. In the first 
type of study, animals are treated followed by a single infection at 7, 14 
or more days after treatment. The reduction in worm counts compared to 
an untreated control group gives a good indication of the persistent 
efficacy of the product at each time point. In the second type of study, the 
animals are treated and then infected daily from day 1 until 7 days, 14 
days longer after treatment. The animals are slaughtered approximately 3 
weeks after the last infection. This approach may better mimic a natural 
infection but the results obtained are an average reduction over the whole 
infection period. At the end of the evaluation period, the actual protection 
may be considerably lower than the average. From this test, it is difficult 
to define when the protection decreases or disappears. In this test, a 
control group is required for each period. In the third type of study, a 
modification of the second, the animals are treated and infected as before 
but slaughtered sooner (2 – 5 days) after the last infection. Based on the 
reduction of, for example, the different Ostertagia stages a more specific 
determination of the persistent efficacy 0 – 3 days (L3), 3 – 7 days (EL4), 
4-14 days (LL4+EL5) and more than 14 days (LL5 adults) before slaughter 
can be obtained. Only two groups of animals are required to cover a 3 
week period and the average efficacies can be reduced to about one week 
(Deroover et al., 1997). 
1.2 The donkey 
  Equidae are classed in four groups. These are: true horses (Equus 
caballus); pseudo – asses of the E. hemionus group; true asses               
(E. asinus); and quaggas (E. quagga, E. greyvi, etc...). The original 
geographical distribution was: Europe and northern Asia for horses, 
central and southern Asia for pseudo-asses, north and northeast Africa for 
donkeys and Africa south of the Sahara for zebras and quaggas (Wilson, 
1990). 
 With a close look at a group of donkeys one notices how they 
differ in size, shape, colour, markings, and even in the texture of their 
coats (Camac, 1997). Grey in various shades is the predominant colour. 
Brown donkeys are fairly plentiful. Other colours are black, roan (which 
is a mixture of white hair and another colour, usually brown) or broken 
coloured, that is a combination of brown- and- white or black – and - 
white markings. Finally there are the rarer colours of pure white and 
chestnut. 
 Because size is important, it will be useful to have some idea of the 
height of the donkey. This is measured in ‘hands’, which is the average 
breadth of a person’s hand, four inches. The measurement is taken at the 
withers (the highest point of the donkey’s shoulder), where the neck joins 
the back, and most of the donkeys will be between 9½ and 11 hands (38 
and 44 inches or to be right up – to – date 96.5 and 111.8 centimeters). 
The ancestors of the donkey were wild asses from Africa and Asia. 
In Africa there were two separate species: the Nubian, standing 12 hands, 
from the north between the Mediterranean coast and the Sahara Desert; 
and the Somali; standing 14 hands, from further east to the south of the 
Red Sea. The Nubian wild ass had a shoulder cross which was not very 
marked, being either rather short or very thin, but it had no stripes on its 
legs; in contrast Somali wild ass had no shoulder cross, but very 
prominent leg stripes, reminiscent of the zebra. 
The present world donkey population is about 40 million (Wilson, 
1990). It is now found in every continent of the world except the Polar 
Regions, following its introduction by Europeans into the Americas and 
Australia. Although widely distributed in terms of countries it is most 
commonly found in the drier areas and in mountainous regions. In Africa 
it is restricted in its distribution mainly by the presence of the tsetse fly, 
such that its numbers are very small or it is totally absent from the 
forested areas of west and central Africa. 
 There are 18 million donkeys in Asia (about 45% of these being in 
China), 12 million in Africa, just over 1 million in Europe, 400 000 in the 
USSR and, by official figures at least, 5000 in Oceania. Almost 10% of 
the world’s donkeys are found in Ethiopia (Wilson, 1990). 
 The total numbers of donkeys, their number in relation to the total 
biomass of domestic herbivores are considered to be useful indicators of 
their economic importance. 
With regard to livestock population, Sudan resembles one of the 
richest African and Arab countries. Most of these animals are owned by 
nomadic or semi-nomadic tribes living in the semi arid regions. Livestock 
population was reported to be about 121 million head, composed of 
35.825, 44.802, 37.346, 3.031, 0.65, 6.35 million head of cattle, sheep, 
goats, camels, horses and donkeys respectively (SBAR, 2000). However, 
donkey’s population is relatively large compared to camels and horses. 
Appendix table (1.1) shows the distribution of donkeys in the Sudan 
according to country States. Moreover, donkeys are used in carrying 
water, commodities, ploughing and as means of transportation. 
In Sudan, donkeys are becoming increasingly important animals 
with the increased use of donkeys instead of horses in labour as drought 
animal and in carrying water in addition to horses (Figures. 1.2  & 1.3), 
and in transportation (Figure 1.4). This new situation can be noticed in 
many urban and suburban areas (Hamid et al., 2001). 
1.2.1 Donkeys of the Sudan 
In Sudan, both horses and donkeys have not attracted the attention 
of the scientist researchers despite their prominent contribution in the 
socio-economic activities of the low income groups in rural and urban 
areas. Donkeys have received less attention than horses as far as 
development policies are concerned although they cost less to manage 
and have remarkable   tolerance to diseases. The domestic donkey (Equus 
asinus) is a member of the horse family. Unfortunately there is scantiness 
and rarity of information at both national and international levels 
concerning the donkeys and their production. This may partly be ascribed 
to the small population of donkeys worldwide. Some authorities consider 
the donkey as endangered species that is likely to be extinct unless efforts 
are made to increase their numbers. The wild donkey (African wild ass) 
was domesticated before the horse along the Nile valley around 4000 BC. 
Small numbers of the African wild asses are to be found essentially in the 
arid areas of the Horn of Africa. It is usually considered to be two sub-
species: Nubian and Somali asses. Few of these wild asses are to be found 
in East Sudan. Few numbers of the Nubian and Somali wild asses still  
  
 
 
 
 
 
 
Figure 1.2 a typical donkey-drawn water tank used by water vendors 
  
 
 
 
 
 
 
Figure 1.3 Horse used for drawing water-laden carts. 
  
 
 
 
 
 
 
 
Figure 1.4 Donkey used for riding. 
survive in the very dry and stony regions of   Ethiopia and Somalia are on 
the way to extinction. 
 1.2.1.1 Breeds of donkeys in Sudan 
 Few breeds of donkeys are available in the Sudan (Wilson, 1978, 
Mason, 1996, and Medani, 2003). The following types are included in the 
list of donkeys that are to be found in the Sudan. 
Pack donkey is found in north Sudan. It has grey skin and is similar 
to Abyssinian ass. The latter is slate-grey in colour and occasionally 
chestnut-brown colour is found. Sudanese pack donkeys are represented 
by Makawi (or Derawi). These are widely spread donkeys and represent 
the majority of Sudanese donkeys. These are strong donkeys 90-100 cm 
high, have short legs and ears but long back. The neck is short and thick. 
They have slow movement and are often crossed with the Sudanese 
riding donkey known as Al-Reefawi to produce strong and fast 
crossbred donkeys.  
Riding donkeys are mainly found in northern Sudan. The individual is 
dark-brown to reddish-grey sometimes pale grey or white and is larger 
than Sudanese Pack donkey.  Synonymous to Sudanese Riding donkey is 
Kassala (North West Eritrea) and a variant of it is the Etbai. Sudanese 
riding donkeys are represented by Al-Reefawi donkey. It is 100-120 cm 
high with better conformation and faster movement than the pack donkey. 
The predominant coat colors are white and black. This type of donkeys 
probably originated from Egypt and is found along the banks of the Nile 
in northern Sudan north of Khartoum. 
Nubian wild ass is found along Sudan-Eritrea border and is nearly 
extinct. It is considered the origin of present domestic ass. It is grey with 
pale under parts and legs, dark mane, with dorsal stripes; tail is tuft and 
shoulder stripped.  
 Taposa ass This is found in south eastern Sudan and is similar to Somali 
ass. It is grey in colour.   
1.2.2 Haematological and biochemical values of the donkey 
 The idea of the metabolic profile test is not new. It has been carried 
out in human medicine to assess the nutritional health status of 
populations and as a routine screening test for patients admitted to 
hospital (Williams et al., 1970). However, Payne et al., (1970) and many 
other researchers in the late 60s gave considerable interest in monitoring 
the metabolic status in the site of animal herds, in order to assess the 
adequacy of dietary intake for production and to help diagnose the nature 
of existing metabolic problems. Thereafter, the use of this test was 
developed to describe various aspects which are associated with this 
measurement (Rowland and Pecock, 1971; Payne et al., 1973). 
 The metabolic profile test can be used routinely to predict the 
metabolic diseases before their appearance. It can act as a monitor for 
detecting any abnormality which may affect animal health, production or 
performance. Then quick preventive strategies could be taken to 
minimize harmful situations. 
 The use of physiological, biochemical and haematological indices 
as a screening method for diagnostic purposes has become a standard 
procedure in veterinary medical practice. Of all the livestock in the 
Sudan, the donkey has received the least attention. Studies reported on 
equine blood constituents have been concerned with horses (Jain, 1986; 
Harvey, 1990; Bauer, 1990, Kaneko et al., 1997).  
 The concentrations of blood components were often measured 
during the course of disease, either as an aid to diagnosis or to elucidate 
consequence of the disease metabolic process (McMurray et al., 1978).  
Given a set of haematologic and serum biochemical data derived 
from clinically normal animals, several alternative reference ranges can 
be calculated. One can use the sample range (the smallest to the largest 
observed value), some multiple of the standard deviation around the 
mean, or the range of certain percentiles of the data set. The common 
choice has been 2 standard deviations above and below the mean 
(Herrera, 1958). If the data have a Gaussian (normal) distribution, 2 
standard deviations above and below the mean include about 95% of the 
values. This approach has been widely criticized, however, because the 
values of many analytes do not have a Gaussian distribution (Reed et al., 
1971). 
During recent years, biochemical investigations have played a 
pivotal role in the diagnosis and prognosis of diseases both in human and 
veterinary medicine. Paucity of comparative studies of biochemical 
indices in donkeys tempted us to undertake the present studies. 
Laboratory aids are used extensively in the diagnosis of disease, in 
preventive medicine, and as management tools. Reference values of 
clinically healthy animals serve as a guide to the clinician evaluating 
parameters (Mori et al., 2003). Whereas there have been considerable 
studies of the blood constituents of the horse, very little work seems to 
have been published on the donkey. There have been studies of donkeys’ 
blood values, but these were derived from small numbers of animals, 
used different laboratory methods, or did not cover all the values of 
interest to us. Biochemical values obtained abroad may not be fully 
applicable to our conditions because they are influenced by breed and 
environmental and management differences.  
Very little work seems to have been published in the donkey, 
whereas there has been a considerable report of the haematology of the 
horse (Kaneko et al., 1997) as shown in appendix table (1.2). In Iran 
Nayeri (1978) was the first who reported the normal values in some 
haematological and biochemical parameters of the donkey. The values are 
reported in appendix table (1.3).  Nayeri (1978) conducted his experiment 
in 100 adult Iranian (Fares province of Iran) donkeys, 50 of each sex. 
Nayeri results showed that female animals showed higher mean values 
for total erythrocytes, eosinophil, neutrophil, and basophil, serum 
calcium, glucose, Na and K. Male animals showed higher mean values 
for Hb concentration, PCV, MCV, MCH, MCHC and serum cholesterol 
and inorganic phosphate. 
Haematological and serum biochemical values were also 
determined in donkeys (Equus asinus) in United States of America by 
Zinkl et al., (1990).  Results obtained by Zinkl et al., (1990) are shown in 
appendix tables (1.4 & 1.5).  
Gupta et al., (1994) reported different haematological and 
biochemical values for the donkeys in India (appendix tables 1.6 & 1.7). 
French and Patrick (1995) reported the reference values for 
haematological, physiological and biochemical parameters in domestic 
donkey (Equus asinus) in United Kingdom as shown in appendix tables 
(1.8 & 1.9). In Spain Folch et al., (1997), described the reference range 
and influence of age and sex on haematological values of the endangered 
Catalonian donkey as shown in appendix table (1.10). Also Jordana et al., 
(1998) set the clinical biochemical parameters of the endangered 
Catalonian donkey as shown in appendix table (1.11). In Brazil, Mori et 
al., (2003, 2004), reported the reference values on serum biochemical 
haematological parameters of Brazilian donkey breed as shown in 
appendix tables (1.12 & 1.13).  
1.2.3 Thyroid hormones of equines 
Thyroid hormones affect many organ systems – cardiovascular, 
nervous, gastrointestinal, respiratory, musculoskeletal, integument, 
reproductive, and lactation. The thyroid hormones have many functions 
in the body. In fact, every cell of the body is a target of thyroid hormones. 
A generalization can be made that the thyroid hormones regulate growth, 
cell differentiation, and oxidative metabolism. 
Thyroid hormones stimulate oxygen utilization by all cells; it has 
been suggested that the metabolic rate is increased by the thyroid 
hormones acting on the cytochrome oxidase system. Thyroid hormones 
increase utilization of carbohydrate, protein catabolism, and oxidation of 
fats. 
According to our knowledge, there is no report concerning the 
level of thyroid hormones in donkeys in the Sudan. The frequency of 
thyroid disease in horses may be high up to 66% in the United States 
(Schlotthauer, 1931), and is especially prevalent in young horses and 
older mares (Irvine and Evans, 1975). Hypothyroidism in equine foetuses 
and neonates have been liked to clinical signs of prematurity (Irvine and 
Evans, 1977) and defective ossification, leading to collapse of the central 
and 3rd tarsal bones (Irvine and Evans, 1975). 
Normal thyroid hormone concentrations reported for horses have a 
wide range of values (Kallfelz and Erali, 1973; Reap et al., 1978; and 
Thomas and Adams, 1978). Several intrinsic and extrinsic factors 
influence the concentrations, including age (Irvine and Evans, 1975), 
season (Katovich et al., 1974), stage of training (Takagi et al., 1974) and 
pregnancy (De Martin, 1977). Using of medicines also had an effect for 
example phenylbutazone has been shown to decrease thyroid hormone 
concentrations (Morris and Garcia, 1983).   
Until the advent of radioimmunoassay, thyroid function was 
evaluated on the basis of protein – bound iodine. Hightower et al., (1971) 
evaluated serum thyroxine (T4) in 25 horses by a competitive protein – 
binding assay and was reported to be from 1.68 to 2.46 µg/dl. Another 
study using radioimmunoassay (RIA) technique reported T4 concentration 
in 13 horses to be from 1.58 to 3.0 µg/dl (Kallfelz and Erali, 1973). In a 
study of the thyroid gland function during the estrous cycle of 9 mares, a 
mean T4 concentration, determined by competitive protein binding ± 
standard error, was reported to be 1.47 ± 0.07 µg/dl (Kelley et al., 1974). 
With the introduction of RIA came the ease and rapidity needed to 
facilitate routine T4 determinations in clinical studies; therefore, we think 
that it is now a suitable time to state the reference values for Sudanese 
donkeys.  
Thomas and Adams (1978) reported a mean of 1.57 ± 0.62 µg/dl 
and a range of 0.30 to 2.90 µg/dl for T4 for different breeds of horses in 
USA using RIA technique. They found no significant differences among 
breeds, sexes and ages. But there is some indication that younger horses 
may have T4 values greater than that of adult horses (Kallfelz and Erali, 
1973). Chen and Riley (1981), found that neonatal foals had high serum 
concentrations of T4 (mean 4.02 µg/dl) and T3 (192.9 ng/dl) as compared 
with the values in mature horses (T4, mean of 1.76 µg/dl; T3, mean of 
98.69 ng/dl). 
There were significant differences in the thyroid hormones 
concentration related to time of blood collection during the day. The 
mean (±SD) T3 concentration peaked around 08.00 h at a level of (54.06 
±14.02 ng/dl) significantly (P<0.001) higher than the lowest 
concentration (38.71±10.81 ng/dl) around midnight. Although the highest 
mean T3 level was 08.00 h, this value was not significantly different from 
the noon and 16.00 h level. Likewise, the mean T3 level at midnight was 
not significantly different from the 20.00 h and 04.00 h levels, resulting 
in a plateau from 08.00 to 16.00 h and a trough from 20.00 h to 04.00 h. 
with an overall mean (±SD) T3 concentration of (47.38 ± 13.66 ng/dl) and 
the range was 13.30 to 97.70 ng/dl.  The mean (±SD) T4 concentration 
peaked around 16.00 h at a level (2.43 ± 0.81 µg/dl) significantly (P< .01) 
higher than the lowest concentration (1.79 ± 0.63 µg/dl) around 04.00 h 
with an overall mean (±SD) T4 concentration of (2.13 ± .76 µg/dl) and the 
range was 0.93 to 4.31 µg/dl (Duckett et al., 1989).  
The results of Duckett et al., (1989) indicated that there is a daily 
thyroid hormone rhythm contributing significantly to hormone 
concentration variation in healthy adult geldings. The animals used in 
their study were aged two years and older and they were not in any 
training or exercise programme which avoided any possible influence of 
exercise in hormone levels.  
Thyroid hormone levels were found to be lower in mares than in 
stallions by one group of investigators (Reap et al., 1978), but lower in 
stallions and geldings than mares by others (Motley, 1972; and Irvine, 
1967). Chen and Riley (1981) reported no differences in T4 concentration 
between sexes, but higher T3 concentrations in males than females. Other 
investigators have found no differences in thyroid hormone 
concentrations between sexes (kallfelz, 1982). The inconsistent results 
among investigators may be associated with laboratory, regional and 
assay technique differences. Markedly higher serum thyroid hormone 
concentrations are seen during pregnancy in mares (De Martin, 1977). 
Sojka et al., (1993) reported that baseline values ranged from 0.21 
to 0.80 ng of T3/ml, 6.2 to 25.1 ng of T4/ml, and 0.07 to 0.47 ng of fT3/dl. 
Administration of 4.4 mg of phenylbutazone/kg, every 12 hours for 7 
days significantly decreased T4 and free T4 (fT4) values, but did not 
significantly affect serum T3 concentrations. 
1.2.4 Helminths of donkeys and horses 
Horses, ponies and donkeys are hosts to a large population of 
parasites (Duncan, 1983). There are two main groups of parasites in the 
donkey: ecto-parasites and endo-parasites. Unfortunately there is little 
available literature to convey useful information on those parasites which 
affect the donkeys and it is therefore often assumed that the occurrence, 
symptoms, pathogenicity, treatment and control of the donkey parasites 
are similar to the horse. Specific references will be, however, given when 
literature on the donkey is available. 
There are two main groups of parasites in the donkey: ecto-
parasites and endo-parasites. Some parasites have stages in their life cycle 
which enable them to be classified as both ecto- and endo-parasites 
(Trawford, 1997). 
Endo-parasites of donkey may be grouped into: intestinal 
helminths or gut worms which include Ascarids (Parascaris equorum), 
large strongyles (Strongyles spp.), small strongyles (Trichonema spp.), 
Pin worms (Oxyuris equi), Thread worms (Strongyloides), Tapeworms 
(Anoplocephala spp.), and Bots   (Gastrophilus spp.), while lungworms 
comprise (Dictyocaulus arnfieldi), and platyhelminths or flukes which 
inhabit the liver (Fasciola hepatica).    
Intestinal helminths produce a wide range of clinical syndromes 
from those focused on the gastrointestinal tract such as diarrhoea and 
colic and more systemic conditions such as anaemia or poor condition. 
The variation in clinical syndromes will occur according to the age, 
nutritional status and resistance of the donkey and also according to the 
species of parasite involved and the sheer number of that parasite in the 
host.  
Roundworms (Manger, 1991) 
Trichostrongylus spp. - T. axei occurs in the stomach. Large numbers 
cause loss of condition and emaciation, and may be fatal. 
Strongylus spp. – widespread, large worms of the large intestine. 
Migratory larvae develop in the major arteries and may cause severe 
colic. Adult are voracious feeders on gut tissue and heavy infections may 
be fatal to young animals. 
Craterostomum spp., Oesophagodontus spp., Triodontophorus spp. - 
common large forms, similar in most respects to Strongylus, but larvae do 
not migrate. Inhabit large bowel. 
Cyathostomiasis (Manger, 1991) 
Trichonemas – a family of small red worms which inhabit the large 
intestine in their thousands. Tissue damage and host reaction to the larvae 
in gut tissues produces pathogenicity and formation of nodules on the gut 
wall. Symptoms include poor condition and diarrhoea. 
Acute verminous enteritis (larval cyathostomiasis) may occur in 
late winter (March and April)/ early as larvae emerge in large numbers 
simultaneously. Initially symptoms of abdominal pain, anorexia and 
depression are presented and hyperlipaemia quickly follows. Severe 
inflammation with submucosal oedema and haemorrhage in the caecum 
and colon may result in severe diarrhoea but, in the donkey, death due to 
‘toxic shock’ may occur before diarrhoea develops. On post mortem the 
mucosa of the caecum and colon is congested with gross oedema of the 
sub-mucosa (Trawford, 1997). Treatment 2 doses of Ivermectin at 200 
mcg/kg 7 days apart combined with normal supportive therapy. 
Lungworms (Manger, 1991) 
Dictyocaulus arnfieldi – the equine lungworm. Egg (not larvae) expelled 
with the faeces. It is very common in donkeys which act as reservoir 
hosts, sometimes pathogenic, even fatal, to young horses. 
Without doubt the donkeys ‘claim to fame’ in the parasitic world is 
as the reservoir host of D. arnfieldi and every text book on respiratory 
disease will include contact with a donkey as a causal agent for a 
coughing horse. Certainly the donkey tolerates even a large infestation of 
lungworms without apparent symptoms and the relatively low prevalence 
of patent infection in the horse means that the donkey is the source of 
contamination of pasture grazed by donkeys. 
Threadworms (Manger, 1991) 
Strongyloides spp. – small worms of the small intestine. Neonates 
become infected via mother’s milk. They are non-pathogenic. These 
usually affect foals under 6 months of age, and infestations tend to 
disappear spontaneously after this age. Dormant infestations in pregnant 
mares are transmitted to foals via milk. 
Ascarids (Manger, 1991) 
Parascaris equorum – worms up to 50 – cm long in small intestine. They 
are commonly present in the young horses and foals, but not usually 
pathogenic. It mainly affects foals with adult equines acquiring an 
effective resistance. The larvae are the cause of liver damage and 
respiratory symptoms, whilst the adults can physically block the gut, and 
may even cause rupture of the small intestine. 
Pinworms (Manger, 1991) 
These usually affect younger animals more than mature equines. 
The main damage is confined to anal irritation and stress from this 
irritation. Tail rubbing is therefore a frequent diagnostic feature. 
Oxyuris equi – non pathogenic worms found in the large intestine. Main 
cause for concern is the irritation caused by the presence of worm eggs 
around horse’s anus. 
Flukes (Manger, 1991) 
Although very occasionally horses may acquire Fasciola hepatica 
infections, flukes are not a problem in equines. 
Tapeworms (Manger, 1991) 
 Horses are parasitized with tapeworms of the genera 
Paranoplocephala and Anoplocephala which are not usually considered to 
be pathogenic. An increasing number of cases in horses suggest that 
Anoplpcephala perfoliata may have increased in prevalence with a 
consequential increase in intussusceptions induced by parasite mediated 
inflammation of the ileo-caecal junction. 
Hydatid cysts (Manger, 1991) 
Hydatid cysts of a subspecies of Echinococcus granulosus can be 
found. The cysts are seen in the liver and lungs of the donkey and can, in 
large numbers or size, affect liver and lung function. 
1.2.5 Diagnosis of helminth parasites 
The diagnosis of endoparasitic infection can be made from routine 
examination of faeces for parasite eggs. Identification of eggs in the 
faeces does not however, indicate the presence of a clinical disease and 
only when a large numbers of eggs per gram have been identified can the 
possibility of clinical disease be considered. Better indication of clinical 
helminthiasis may be given by weight loss, as shown in figures (1.9 and 
1.10) lethargy and depression, diarrhoea and, more severe cases, colic and 
fever. Other laboratory diagnostic indicators include: anaemia, changes in 
packed cell volume (PCV) and serum albumins and globulins (Trawford, 
1997).  
1.2.6 Prevalence of gastrointestinal nematodes in donkeys 
In Sudan, the available data on helminth parasites of equines were 
compiled by Eisa et al., (1979).  In these records only two helminth 
parasites (Oxyuris equi & Setaria equina) were recorded from Darfur 
region, since this region is comparatively the most populated region with 
equines in the Sudan. In a field survey conducted by Kheir and Kheir 
(1981), five nematode genera were encountered in donkeys in South 
Darfur State: Strongylus spp., Oxyuris spp., Strongyloides spp., 
Parascaris spp., and Trichuris spp. The incidence of infection with one 
species (74.9%) was found higher than that of two (19.8%) or three 
species (4.8%). The overall incidence of infection with nematode 
parasites was found higher in town animals (58%) than in animals kept in 
  
 
 
 
 
 
 
 
Figure 1.5 Donkey severely infected with gastrointestinal helminths-
emaciated. 
  
 
 
 
 
 
 
 
Figure 1.6 Donkey harbouring different species of gastrointestinal 
helminths. 
nomadic areas (22%). 
In Egypt, Hilali et al., (1987) reported the incidence and monthly 
prevalence of Gastrophilus spp. larvae in the stomach of donkeys. Out of 
118 donkeys examined, 98.3% were infected with G. intestinalis and 
87.3% with G. nasalis. The percentage of donkeys with 1-100, 101-200 
and 201-300 larvae was 72.0, 18.6 and 4.3% for G. intestinalis and 76.3, 
8.5 and 0.8% for G. nasalis. 
In Morocco, Pandey (1980a) studied the seasonal prevalence of 
Strongylus vulgaris in the anterior mesenteric artery of the donkey. The 
mean monthly percentage of arteries infected varied from 61.5 to 100, 
with an overall mean of 90.5. The mean monthly larvae number varied 
from 3 to 104 with the annual mean of 32.6. The number of the larvae 
was least in December – January, but rose gradually thereafter to reach a 
peak in April-May. A steep decline in June – July was followed by a 
progressive diminution until January.In Zimbabwe, Pandey and Eysker 
(1988) reported that examination of fourteen donkeys for stomach 
parasites revealed that all of the 14 donkeys were infected. Habronema 
muscae occurred in twelve, Drashia megastoma in 11, H. majus in 9, 
Trichostrongylus axei in 9, Gastrophilus intestinalis in 14, and G. nasalis 
in 1 donkey. The lowest level of infection was in January for the 
helminths and in April for Gastrophilus larvae. The peak burdens of 
parasites were in July for Habronema spp. and in November for D. 
megastoma and Gastrophilus larvae. Infections with spirurid worms and 
Gastrophilus develop mainly from the middle of the rainy season to the 
beginning of the dry season (January to May/June). 
In Zimbabwe, Pandey and Eysker (1989) also reported the 
presence of Strongylus vulgaris in the cranial mesenteric arteries, caecum 
and colon of 14 donkeys. Adult parasites were present in all animals and 
larvae in the cranial mesenteric arteries of 12 animals. The number of 
adult parasites varied from 63 to 1255 (mean 382) and of larvae in the 
arteries from 0 to 181 (mean 69). They observed that infection with S. 
vulgaris takes place during the rainy season resulting in the heavy arterial 
larval population from January onwards and the heavy adult population 
during the dry season. 
In Zimbabwe, Pandey and Eysker (1990) also reported that thirteen 
species of small strongyles were found in the above mentioned 14 
donkeys. Numbers of worms found in each of the donkeys ranged 
between 3900 and 222,767.  
Over two consecutive years Pandey et al., (1992a) were studying 
stomach worms in donkeys in Morocco. Trichostrongylus axei was found 
in 93.5% of animals. Habronema muscae in 89.7%, H. majus in 85.4% 
and Drashia megastoma in 1.1% of donkeys. Most animals are infected 
by two (23.8%) or three (71.9%) species. High burdens of T. axei were 
found in winter of both years and in the mid summer of second year. In 
another report Pandey et al., (1992b) examined the presence of 
Gastrophilus larvae in the above mentioned animals. Out of 198 animals 
Gastrophilus intestinalis was found in 97.5% and G. nasalis in 95.5%. 
Over 75% of the animals had up to 200 larvae and 1.5% had over 600 
larvae.  
Svendsen (1994) stated that without anthelmintic treatment, the 
average life of a donkey varied from 9 years in Ethiopia to 15 years in 
Mexico, the average life in the UK being 37. The concern with donkey 
health is very important as purchase of a new donkey could often 
financially cripple a poor family on the border line of starvation. In many 
Third World countries, donkeys are very important as they support the 
whole family. So the question why donkeys are not bred more. This may 
be explained that poor health and parasite burdens prevent pregnancy. 
Suggestions for best time for treatment for prophylaxis of parasitic 
infection are that once at the end of the dry season and once at the end of 
the rainy season were the most suitable. Avermectins were preferred 
owing to their broad spectrum activity.  
 1.2.7 Anthelmintics commonly used in equines 
Drugs commonly used as anthelmintics in equines are 
demonstrated in appendix table (1.15), of these drugs the efficacy of 
fenbendazole as an anthelmintic in donkeys and horses had been 
investigated by Malan and Reinecke (1979). In donkeys, they proved that 
fenbendazole is highly effective against adults of the following genera: 
Cyathostomum, Cylicocyclus, Cylicostephanus, Cylicodontophorus, 
Poteriostomum, Cabellonema, Craterostomum, and Triodontophorus; 
similarly high efficiency was obtained against the following species: 
Habronema majus, Strongylus vulgaris, and Oxyuris equi and worms 
identified as belonging to subfamily Cyathostominae. These results were 
confirmed in horses by the same authors (1981). 
Ivermectin was used successfully in equines, although a variety of 
adverse reactions have been reported in horses after parenteral 
administration of the drug in the recommended dose of 0.2 mg/kg body 
weight. DiPietro et al., (1982) reported more than 99% efficacy of 
Ivermectin administered intramuscularly to horses against Gastrophilus 
spp., Trichostrongylus axei, Habronema muscae, H. majus and Drashia 
megastoma. 98 to 99% against adult Cyathostomes, 86 to 97% against 4th 
– stage cyathostomes, and 100% against adult large strongyles. They also 
reported the incompleteness of activity against arterial stages of 
Strongylus vulgaris. 
Evaluation of Ivermectin at the dose rate of 200 mcg/kg in 29 
equids (13 donkeys, 16 horses) indicated excellent activity against 
lungworms. None of the treated equids in the controlled tests harboured 
lungworms at the time of necropsy. In the field tests, all treated animals 
had faecal samples negative for lungworm larvae at each post treatment 
sampling. The Injectable formulation of Ivermectin appeared to be 
equally effective against lungworms whether administered 
intramuscularly or per os (Lyons et al., 1985). 
In a herd of donkeys 30 (86%) were lungworm positive by the 
Baermann faecal technique. Eleven donkeys treated with fenbendazole 
and eleven treated with thiabendazole were still lungworm positive two 
week’s post treatment. Subsequent treatment of 21 donkeys with 
Ivermectin resulted in negative lungworm evaluations two weeks post 
treatment. At 20 weeks post treatment, all 8 donkeys evaluated were 
negative, while 7 of 12 donkeys evaluated were lungworm negative at 35-
40 weeks post treatment (Taylor and Craig, 1993). 
The efficacy of moxidectin at 0.3 mg/kg and 0.4 mg/kg against 
most gastrointestinal parasites of ponies was similar to that of Ivermectin 
at 0.2 mg/kg. Both drugs were highly efficacious against nematode adults 
and luminal cyathostome and O. equi L4, but ineffective against 
cyathostome EL3. Moxidectin and Ivermectin, however, differed in their 
efficacies against encysted cyathostome LL3 and L4 and Gastrophilus 
spp. third instar stage. Moxidectin was moderately effective in removing 
encysted cyathostome LL3 and L4 and ineffective against Gastrophilus 
spp. Third instar stage. By contrast, Ivermectin was highly efficacious 
against Gastrophilus spp. and ineffective against encysted cyathostome 
LL3 and L4 (Xiao et al., 1994). 
The efficacy of moxidectin oral gel 2% in reducing strongyle FECs 
ranged from 99.8% to 100% from 3 to 14 days after treatment. 
Moxidectin efficacy was 100% against Trichostrongylus axei and 
Triodontophorus spp., >99.9% against cyathostomes adults and L5, 92% 
against S. edentatus L5, 100% against O. equi L5, 99% against O. equi L4, 
and 92% against G. intestinalis. Moxidectin showed to be safe in young 
ponies (Dorchies et al., 1998). 
Both moxidectin and Ivermectin reduced initial EPG from a mean 
of 1600 to 0 on days 5, 7 and till day 14. Efficacy of percentages of 
moxidectin and Ivermectin against immature and adult nematodes were 
as follows: Trichostrongylus axei, Parascaris equorum, Strongylus 
edentatus, S. vulgaris, Triodontophorus spp., and Gyalocephalus 
capitatus, 100% for both products; Habronema muscae 99.5 and 99.6%, 
respectively, Strongyloides westeri, 100 and 99.2% respectively; Oxyuris 
equi, 99.6 and 100% , respectively; small strongyles, 99.7% for both 
products. No Gastrophilus nasalis were found in horses from either 
treated groups, while two of eight control horses had infections with this 
parasite. Moxidectin showed greater efficacy (84.9%) than Ivermectin 
(67.8%) against Strongylus vulgaris larvae found in the mesenteric artery 
aneurisms, but the difference was not statistically significant. Total 
parasite counts for both treated groups were significantly lower (P < 0.01) 
than in the non-treated group. No significant differences were noted 
between moxidectin and Ivermectin. Efficacy against the 30 nematode 
species found in this study was very evident for both products. As 
expected, neither moxidectin nor Ivermectin was effective in controlling 
the tapeworm Anoplocephala perfoliata (Costa et al., 1998). 
MATERIALS AND METHODS 
2.1 Survey of gastrointestinal nematodes in donkeys  
A field survey was conducted to study the monthly and seasonal 
incidence of helminth nematodes in donkeys. The present study was 
undertaken to provide further information on the incidence and seasonal 
prevalence of infection with gastrointestina1 nematodes over a 
consecutive 12– month period in Khartoum State during the period 
January to December 2003.  
2.1.1 Study area 
This study was conducted in Khartoum State, which is located in 
the semi arid zone, between latitudes 15 ْand 40 ْN and longitudes 32 and 
32 ْ E (Figure, 2.1). Faecal samples were collected from donkeys in 
different localities in Khartoum North and Omdurman. 
2.1.2 Samples collection and examination  
Fresh faecal samples were collected from one thousand and two 
hundred donkeys and submitted to the diagnostic laboratory of the 
Department of Medicine, Pharmacology and Toxicology, Faculty of 
Veterinary Medicine, University of Khartoum. Egg counts were carried 
using modified McMaster technique (Anonymous, 1986) and the eggs 
were identified according to Thienpont et al. (1979). The percentage of 
infestation and differential egg counts for nematodes were also 
determined.  
2.1.3 Time schedule 
A total of 100 faecal samples were collected monthly for a whole 
year. Mars to June months constitute the hot season, and July to October 
the rainy season, whereas November to February as cold season months  
 
 
 
 
 
 
  
 
Figure 2.1 Sudan map, in the centre find the location of 
Khartoum state. 
2.1.4 Intensity of infection  
The severity of infection as obtained from the number of eggs per 
gram of faeces was determined according to Soulsby (1982) as following: 
500 eggs/gram of faeces = Mild infection  
800 – 1000 eggs/gram of faeces = Moderate infection  
1500 – 2000 eggs/ gram of faeces = Severe infection.  
2.1.5 Techniques used for faecal egg count and identification  
Fresh faecal samples were collected into long plastic bags from the 
recta of individual donkeys. The bags were labeled and taken directly to 
the laboratory for examination. The number of eggs per gram of faeces 
(EPG) was determined using a modified McMaster technique 
(Anonymous, 1986). Three grams of faeces were mixed with 42 ml of tap 
water and the faecal suspension was then passed through 80 um/square 
inch sieve to remove debris. The filtrate was collected in a clean dry 
bowl. 15 ml of this filtrate were taken into a centrifuge tube, centrifuged 
(Baird and Tatlock Ltd, England) for 2 minutes at 1500 rpm and the 
supernatant was then discarded. The sediment was emulsified by gentle 
agitation and saturated NaCl was added until the volume became equal to 
the initial aliquot of the filtrate. The centrifuge tube was inverted several 
times to obtain an even suspension of the contents. The two chambers of 
the McMaster slide were filled using a clean Pasteur pipette. The average 
number of eggs present in these chambers was multiplied by 100 to 
obtain the number of eggs per gram of faeces (EPG). 
2.2 Haematological and biochemical parameters, and 
endocrinological profiles of donkeys 
The purpose of this study was to determine the reference, and to 
study seasonal variation, with respect to haematologic, serum 
biochemical, and endocrinological values for donkey breed in the Sudan 
to form a basis for clinical interpretation. 
2.2.1 Experimental animals 
A total of 20 donkeys (10 male and 10 females), 4-10 years, were 
utilized in this study. They were divided into two groups and penned 
according to sex at different pens (Figure 2.2) at the Department of 
Radioisotopes, Central Veterinary Research Laboratory (CVRL), Soba. 
They were examined before the beginning of the study to ascertain their 
freedom from diseases. 
2.2.2 Sampling and time schedule 
Blood samples were collected bimonthly for a whole year 
(February 2004 to January 2005). Months from March to June were 
considered as hot season, July to October as rainy season, and November 
to February as cold season.  
2.2.3 Haematological methods 
2.2.3.1 Collection of blood 
Blood samples for whole blood and serum were withdrawn from 
the jugular vein. Whenever blood samples were taken they were divided 
into two portions, one portion was taken in plain vacutainer and was 
allowed to clot, the clotted blood samples were centrifuged and sera were 
separated and stored at -20 ºC until analyzed. While the other one was 
taken in a vacutainer containing ethylenediaminetetraacetic acid (EDTA) 
as anticoagulant.  
2.2.3.2 White blood cells (WBCs) 
Leukocytes (WBC) were counted in an improved Neubauer 
haemocytometer (Hawksley and Sons Ltd., England) using turk’s solution 
as a diluting fluid consisting of 1.0% glacial acetic acid coloured with 
gentian violet as described by Jain (1986). 
2.2.3.3 Haemoglobin concentration (Hb) 
       Haemoglobin (Hb) was determined by cyanomethaemoglobin 
method (Kelly, 1984) using Jenway colorimeter (Jenway 6030 
colorimeter, Jenway Ltd. U. K.). The haemoglobin concentration was 
measured in g/100 ml of blood. 
2.2.3.4 Packed cell volume 
Blood samples were drawn into heparinized capillary tubes sealed 
at one end with cristaseal (Hawksley and Sons Ltd., England) and 
centrifuged for five minutes using microhaematocrit centrifuge 
(Hawksley and Sons Ltd., England). The PCV percent was read in a 
Hawksley microhaematocrit reader.  
2.2.3.5 Red blood indices 
Mean corpuscular haemoglobin concentration (MCHC) 
Values for mean corpuscular haemoglobin concentration (MCHC) 
were calculated with standard equation using the determined values of 
haematocrit and haemoglobin according to Wintrobe (1976). 
 The MCHC% was calculated from PCV and Hb as follows: 
MCHC (%) =          Hb (in g/100 ml) 
                                      PCV (%) 
2.2.4 Serological Methods 
2.2.4.1 Total serum protein 
Total serum protein (TSP) was analyzed using two different 
methods due to the availability of the kits according to the following 
methods.  
Biuret method 
 Total serum protein was analyzed by Biuret method (King and 
Wooton, 1956) using kits (Randox laboratories Ltd., United Kingdom). 
Copper ion in alkaline solution reacts with the peptide linkage of amino 
acids of the serum protein producing a violet colour. The optical density 
of the developing colour was measured at 540 nm using Jenway 
spectrophotometer (Jenway 6105 U. V. /vis. Spectrophotometer, U. K.).  
  
 
 
 
 
 
 
Figure 2.2 Donkeys left loose “untied’ in separate pens at the 
Radioisotopes Department, Soba. 
The total serum protein values were measured in g/ 100 ml of serum and 
then converted to g/l. 
Bradford method 
 Total serum protein also was analyzed by Bradford method 
(Bradford, 1976). The optical density of the developing colour was 
measured at 595 nm using Pharmacia LKB, Ultrospec III UV/visible 
spectrophotometer (Pharmacia LKB Biochrom Ltd., Science Park, 
Cambridge CB4 4FJ, England). The total serum protein values were 
measured in g/l. 
The Bio-rad protein assay is a dye binding assay based on the 
differential colour change of a dye in response to various concentrations 
of proteins. 
The Bio – Rad Protein Assay is based on the observation that the 
absorbance maxima for an acidic solution of Coomassie brilliant Blue G-
250 shifts from 465 nm to 595 nm when binding to protein occur 
(Sedmark and Grossberg, 1977). Bradford (1976) first demonstrated the 
usefulness of this principle in protein assay. Spector (1978) found that the 
extinction coefficient of a dye – albumin complex solution was constant 
over a 10 – fold concentration range. 
2.2.4.2 Serum albumin 
Serum albumin also was analyzed using two different types of kits 
according to the following methods:- 
Bromocresol green (BCG) 
Albumin is the most abundant serum protein representing 55-65% 
of the total protein. It is synthesized in the liver and has a half life of 2 to 
3 weeks. The main biological functions of albumin are to maintain the 
water balance in serum and plasma and to transport and store a wide 
variety of ligands e.g. fatty acids, calcium, bilirubin and hormones such 
as thyroxine. Albumin also provides an endogenous source of amino 
acids. Hypoalbuminaemia is associated with the following conditions: an 
albuminaemia; impaired albumin synthesis in the liver; liver disease; 
malnutrition or mal-absorption; generalized shock; burns or dermatitis; 
kidney disease and intestinal disease. Hyperalbuminaemia has little 
diagnostic relevance except, perhaps in dehydration. 
The serum albumin concentration was determined by Bromocresol 
green method (BCG) according to Bartholomew and Delany (1966) using 
kits (Randox laboratories Ltd., United Kingdom). The BCG solution 
(buffer indicator consists of 17.3 ml of 1 M sodium citrate plus 32.7 ml of 
1 M citric acid plus 6 ml of 0.01 M bromocresol green plus 800 ml of 
distilled water) reacts with the serum albumin producing a blue colour. 
The absorbance was red at 630 nm using spectrophotometer (Jenway 
6105 U. V. /vis. Spectrophotometer, U. K.). Albumin values were 
measured in g/100 ml of serum and then converted to g/l. 
Albumin plus (BCG method) 
Summary (Marshall, 1989) 
Albumin is a carbohydrate – free protein, which constitutes 55-
65% of total plasma protein in humans. It maintains oncotic plasma 
pressure, and is also involved in the transport and storage of a wide 
variety of ligands and is a source of endogenous amino acids. Albumin 
binds and solubilizes various compounds, e.g. bilirubin, calcium and long 
– chain fatty acids. Furthermore albumin is capable of binding toxic 
heavy metals ions as well as numerous pharmaceuticals, which is the 
reason why lower albumin concentrations in blood have a significant 
effect on pharmacokinetics. 
Hyperalbuminaemia is of little diagnostic significance except in the 
case of dehydration. Hypoalbuminaemia occurs during many illnesses 
and is caused by several factors; compromised synthesis due either to 
liver disease or as a consequence of reduced protein uptake, elevated 
catabolism due to tissue damage (severe burns) or inflammation; 
malabsorption of amino acids (Crohn’s disease); proteinuria as a 
consequence of nephritic syndrome; protein loss via the stool (neoplastic 
disease). In severe cases of hypoalbuminaemia, the maximum albumin 
concentration of plasma is 2.5 g/dl. Due to the low osmotic pressure of 
the plasma, water permeates through blood capillaries into tissue 
(oedema). The determination of albumin allows monitoring of a 
controlled patient dietary supplementation and serves also as an excellent 
test of liver function. 
Test principle 
Albumin + BCG ⎯(pH 4.1) → albumin BCG complex 
The serum albumin concentration was determined using kits (ALB 
plus, Roche Diagnostics GmbH, D-68298 Mannheim, Germany) by 
Bromocresol green method (BCG) according to Doumas et al., (1971). 
The BCG solution reacts with the serum albumin producing a blue – 
green colour. The colour intensity of the blue – green colour is directly 
proportional to the albumin concentration and can be determined 
photometrically. The absorbance was red at 630 nm using Pharmacia 
LKB, Ultrospec III UV/visible spectrophotometer (Pharmacia LKB 
Biochrom Ltd., Science Park, Cambridge CB4 4FJ, England). Albumin 
values were measured in g/100 ml of serum and then converted to g/l. 
2.2.4.3 Serum globulin 
 The serum globulins (g/l) were determined by deduction of the 
values of serum albumin from total serum protein values. 
2.2.4.4 Serum Total Bilirubin 
Bilirubin is formed by the breakdown of haemoglobin in the 
spleen, liver and bone marrow. In the liver, bilirubin is conjugated with 
glucouronic acid to form a soluble compound. This conjugated bilirubin 
passes down the bile duct and is excreted into the gastrointestinal tract. 
An un-conjugated, albumin bound form is also present in the circulation. 
It is insoluble and does not normally pass through the kidneys into the 
urine. An increase in bilirubin concentration in the serum or tissues is 
called jaundice. Jaundice occurs in toxic or infectious diseases of the liver 
e.g. hepatitis B or obstruction of the bile duct and in rhesus incompatible 
babies. Useful information may be obtained by determining which form 
of bilirubin is elevated.  
High levels of conjugated or direct bilirubin indicate that bile is not 
being properly excreted; therefore an obstruction may be present in the 
bile duct or gall bladder. Un-conjugated or indirect bilirubin can also be 
determined by subtracting the direct bilirubin level from the total 
bilirubin result. High levels of unconjugated bilirubin indicate that too 
much haemoglobin is being destroyed or that the liver is not actively 
treating the haemoglobin it is receiving. 
Colorimetric method 
Colorimetric method was based on that described by Heinemann 
and Vogt (1988). Direct (conjugated) bilirubin reacts with diazotized 
sulphanilic acid in alkaline medium to form a blue coloured complex. 
Total bilirubin is determined in the presence of caffeine, which releases 
albumin bound bilirubin, by the reaction with diazotized sulphanilic acid. 
The serum bilirubin concentration was determined by spectrophotometric 
method using kits (Randox laboratories Ltd., United Kingdom). The 
intensity of the developing colour was measured at 560 nm using Jenway 
spectrophotometer (Jenway 6105 U.V. /vis. Spectrophotometer, U. K). 
2.2.4.5 Serum urea 
 Serum urea concentration was measured by an enzymatic 
colorimetric method using a commercial kit (Randox laboratories Ltd., 
United Kingdom) according to Fawcett and Scott (1960). The intensity of 
the developing colour was measured at 600 nm using Jenway 
spectrophotometer (Jenway 6105 U. V. /vis. Spectrophotometer, U. K.). 
Principle  
Urea in the presence of water and urease is hydrolyzed to produce 
ammonia and carbon dioxide. In a modified Berthelot reaction, ammonia 
ions react with hydrochloride and salicylate to give a green dye, the 
increase of absorbance at 600 nm is proportional to urea concentration in 
sample. 
2.2.4.6 Serum creatinine 
Creatinine is derived from creatine and creatine phosphate in 
muscle tissue and may be defined as a nitrogenous waste product. 
Creatinine is not reutilized but is excreted from the body in the urine via 
the kidney. It is produced and excreted at a constant rate which is 
proportional to the body muscle mass. As a consequence of the way in 
which creatinine is excreted by the kidney, creatinine measurement is 
used almost exclusively in the assessment of kidney function. Creatinine 
is regarded as the most useful endogenous marker in the diagnosis and 
treatment of kidney disease. 
Creatinine is measured primarily to assess kidney function and has 
certain advantages over the measurement of urea. The plasma level of 
creatinine is relatively independent of protein ingestion, water intake, rate 
of urine production and exercise. Since its rate of production is constant, 
elevation of plasma creatinine is indicative of under- excretion, 
suggesting kidney impairment. Depressed levels of plasma creatinine are 
rare and not clinically significant. 
Colorimetric method 
Principle   
The serum creatinine concentration was determined by 
spectrophotometric method using kits (Randox laboratories Ltd., United 
Kingdom). Creatinine in alkaline solution reacts with picric acid to form a 
coloured complex. The amount of the complex formed is directly 
proportional to the creatinine concentration. The intensity of the 
developing colour was measured at 492 nm using Jenway 
spectrophotometer (Jenway 6105 U. V. /vis. Spectrophotometer, U. K) 
according to Bartels et al., (1972). 
2.2.4.7 Serum uric acid  
Uric acid concentration is measured using a colorimetric method 
according to Fossati et al., (1980). Uric acid is converted by uricase to 
allantoin and hydrogen peroxide, which under the catalytic influence of 
peroxidase, oxidizes 3, 5 – Dicholoro – 2 – hydroxybenzensulfonic acid 
and 4 – aminophenazone to form a red – violet quinonemine compound. 
Principle 
Uric acid + O2 + 2H2O → (uricase) Allantoin + CO2 + H2O2 
2H2O2 + 3, 5 – dicholoro – 2 – hydroxybenzensulfonic acid → 
(peroxidase) N – (4 – antipyrlyl) – 3 – chloro – 5 – sulfonate –p- benzo – 
quinonemine. 
2.2.4.8 Serum glucose 
Glucose was determined using kits (Randox laboratories Ltd., 
United Kingdom, BT29 4QY) after enzymatic oxidation in the presence 
of glucose oxidase. The hydrogen peroxide formed reacts, under catalysis 
of peroxidase, with phenol and 4-aminophenazone to form red – violet 
quinoneimine dye as indicator. The formed colour was measured at 500 
nm using Pharmacia LKB, Ultrospec III UV/visible spectrophotometer 
(Pharmacia LKB Biochrom Ltd., Science Park, Cambridge CB4 4FJ, 
England) according to Barham and Trinder (1972). 
            Glucose + O2 ⎯POD → gluconic acid + 4 H2O 
   2H2O2 + 4-aminophenazone + phenol ⎯POD → quinoneimine + 4H2O 
2.2.4.9 Serum total cholesterol 
Cholesterol is a steroid with 27 carbon atoms and β OH on C3 
position. It is synthesized in many types of tissue, but particularly in the 
liver and intestinal wall. Approximately three quarters of cholesterol is 
newly synthesized and a quarter originates from dietary intake. 
Cholesterol assays are used for screening for atherosclerotic risk and in 
the diagnosis and treatment of disorders involving elevated cholesterol 
levels as well as lipid and lipoprotein metabolic disorders. 
Cholesterol analysis was first reported by Liebermann in 1885 
followed by Burchard in 1889. In the Libermann – Burchard reaction, 
cholesterol forms a blue – green dye from polymeric unsaturated 
carbohydrates in an acetic acid/acetic anhydride/concentrated sulfuric 
acid medium. The Abell and Kendall method is specific for cholesterol, 
but is technically complex and requires the use of corrosive reagents. In 
1974, Roeschlau and Allain described the first enzymatic method. 
The method is based on the determination of ∆4 – cholestenone 
after enzymatic cleavage of the cholesterol ester by cholesterol esterase, 
conversion of cholesterol by cholesterol oxidase, and subsequent 
measurement by the Trinder reaction of the hydrogen peroxide formed. 
Optimization of ester cleavage (>99.5%) allows standardization using 
primary and secondary standards and a direct comparison with the CDC 
and NIST reference method. Non fasting results may be slightly lower 
that fasting results. 
Cholesterol and its esters are released from lipoproteins by 
detergents. Cholesterol esterase hydrolyzes the esters. In the subsequent 
enzymatic oxidation by cholesterol oxidase, H2O2 is formed. This is 
converted into a coloured quinonimine in a reaction with 4-
aminoantipyrine and phenol catalyzed by peroxidase. 
Cholesterol was analyzed by enzymatic colorimetric method 
according to Allain et al., (1974) and Tietz (1995). The optical density of 
the developing colour was measured at 505 nm using Pharmacia LKB, 
Ultrospec III UV/visible spectrophotometer (Pharmacia LKB Biochrom 
Ltd., Science Park, Cambridge CB4 4FJ, England).  
2.2.4.10 Serum Triglycerides 
Triglycerides are esters of the trihydric alcohol glycerol with 3 long 
– chain fatty acids. They are partly synthesised in the liver and partly 
ingested in food. The determination of triglycerides is utilized in the 
diagnosis and treatment of patients having diabetes mellitus, nephrosis, 
liver obstruction, lipid metabolism disorders and numerous other 
endocrine diseases. 
The enzymatic triglycerides assay as described by Eggestein and 
Kreutz (1966) still required saponification with potassium hydroxide. 
Numerous attempts were subsequently made to replace alkaline 
saponification by enzymatic hydrolysis with lipase. Bucolo and David 
(1973) tested a lipase/protease mixture; Wahlefeld and Bergmeyer 
(1974), used an estrase from the liver in combination with a particularly 
effective lipase from Rhizopus arrhizus for hydrolysis. 
This method is based on the work by Wahlefeld using a lipoprotein 
lipase from microorganisms for the rapid and complete hydrolysis of 
triglycerides to glycerol followed by oxidation to dihdroxyacetone 
phosphate and hydrogen peroxide. The hydrogen peroxide produced then 
reacts with 4-aminophenazone and 4-chlorophenol under the catalytic 
action of peroxidase to form a red dyestuff. 
Triglycerides were analyzed by enzymatic colorimetric method 
according to Bucolo and David (1973), and Stein and Myers (1995).  The 
optical density of the developing colour was measured at 505 nm using 
Pharmacia LKB, Ultrospec III UV/visible spectrophotometer (Pharmacia 
LKB Biochrom Ltd., Science Park, Cambridge CB4 4FJ, England).  
2.2.4.11 Serum phospho – and sphingolipids 
Due to their several positive activities they exert in the human 
body, phospholipids have received renewed interest in recent years. For 
example, their role in reducing blood cholesterol levels (Eckhardt et al., 
2002) and enhance brain functioning (Pepeu et al., 1996), their 
antioxidative properties (Saito and Ishihara, 1997) their bacteriostatic 
properties (Sprong et al., 2002), and the inhibitory effect of sphingolipids 
on colon cancer have been studied intensively (Vesper et al., 1999). 
Serum phospho - and sphingolipids were measured using HPLC 
according to Becart et al., (1990) and Caboni et al., (1996). Chloroform 
and methanol used for extraction were 99% HPLC grade and obtained 
from (Sigma-Aldrich, Taufkirchen, Germany). Chloroform, methanol, 
ammonia (NH3) and water for the mobile phase were of HPLC grade and 
obtained from (Sigma-Aldrich, Taufkirchen, Germany). The 
phospholipids standards of PG, PE, PI, PS, PC, and SM) were obtained 
from (Fluka, Sigma-Aldrich, Taufkirchen, Germany). 
Chromatographic analysis 
Phospholipids separation was performed on a Kaneur Maxi Star 
HPLC system with 4 solvent lines, a degasser SEDEX 55, evaporating 
light detector (SEDEX 55 Lichtstreudetector, S.E.D.E.R.E., France) 
which was coupled with Apex M 625 software (Autochrom, USA). As 
the nebulizing gas, N2 was used at a flow rate of 4 L/min, and a 
nebulizing temperature of 40°C. The gain was set at 8 and 2.0 bar N2. 
A 125Χ4.0 mm Si – 60 column with 5 µm particle diameter 
(Lichrospher) was used. The elution program was a linear gradient with 
80: 19.5: 0.5 (v/v) chloroform: methanol: ammonia (NH3) at t = 0 min to 
60: 34: 5.5: 0.5 (v/v) chloroform: methanol: water: ammonia (NH3) at t = 
22 min and the column was allowed to equilibrate until the next injection 
at t = 27 min. The injection volume was 50 µl.  
Phospholipids extraction 
A liquid phase extraction procedure adapted from the method 
described by Bligh and Dyer (1959) was used to extract the serum 
samples. Briefly, 50 µl of sample were diluted with 750 µl of deionised 
water and was mixed well, and then 2.0 ml of methanol and 1.0 ml of 
chloroform were added to the sample and mixed well. Then the mixture 
was homogenised in (rotary mixture 34526, Snijders) for 15 minutes. The 
mixture was centrifuged for 5 minutes by 4000 rpm (Varifuge 3.0 R, 
Heraeus-Sepatech, Omnilab). After centrifugation the supernatant was 
transferred to another tube then 1.0 ml of chloroform and 1.0 ml of water 
were added to the tube, mixing and centrifugation for 10 minutes at 4000 
rpm (Varifuge 3.0 R, Heraeus-Sepatech, Omnilab). The methanol: water 
phase was sucked up with a water stream pump. The CHCl3 – phase was 
evaporated under a gentle stream of nitrogen to dryness. The purified 
extract of lipids was dissolved in 400 µl CHCl3: MeOH (2:1 v/v) 
transferred into capped test tubes and before injection the samples were 
filtered using 0.2 µm filter unit (Restek, Germany). Finally, from this 
filtrate 50 µl were injected in the chromatographic system. 
2.2.4.12 Aspartate aminotransferase (EC 2.6.1.1) (Glutamic – 
Oxaloacetic transaminase (GOT) 
Aspartate aminotransferase (AST) catalyze the transamination of 
L-aspartate and 2-oxoglutarate to oxaloacetate and glutamate. The 
enzyme occurs in almost all cells, but it is used primarily as a diagnostic 
enzyme for liver and muscle disease because of its high activity in these 
tissues, serum AST has high sensitivity for liver disease (Duncan et al., 
1994). 
Glutamic – Oxaloacetic transaminase (GOT) was measured by 
monitoring the concentration of oxaloacetate hydrazone formed with 2, 4 
– dinitrophenylhydrazine according to Reitman and Frankel (1957). The 
formed colour was measured at 530 nm using Jenway spectrophotometer 
(Jenway 6105 U. V. /vis. Spectrophotometer, U. K). 
2.2.4.13 Alanine aminotransferase (EC 2.6.1.2) (Glutamic – Pyruvic 
Transaminase (GPT) 
Alanine aminotransferase (ALT) is a soluble cytosolic enzyme that 
catalyzes the reversible transamination of L-alanine and 2-oxoglutarate to 
pyruvate and glutamate. Hepatic ALT activity in horses, cattle, sheep, 
goats, and pigs is very low, which precludes its use for detecting liver 
disease in these species (Duncan et al., 1994). 
Glutamic – Pyruvic Transaminase (GPT) was measured using kits 
(Randox laboratories Ltd., United Kingdom, BT29 4QY) by monitoring 
the concentration of pyruvate hydrazone formed with 2, 4- 
dinitrophenylhydrazine according to Reitman and Frankel (1957). The 
formed colour was measured at 530 nm using Jenway spectrophotometer 
(Jenway 6105 U. V. /vis. Spectrophotometer, U. K). 
2.2.4.14 Serum inorganic phosphorus 
 Phosphorus outside the skeleton plays an even fascinating role. It is 
involved in vital cellular structures and serves in the degredation and 
synthesis of numerous carbon compounds. High-energy phosphate bonds 
play a fundamental role in storage, liberation and transfer of energy 
(Kaneko et al., 1997). 
The serum inorganic phosphorus was determined according to 
Taussky and Shorr (1953) and Goldenburg and Fernandez, (1966) using 
kits (Randox laboratories Ltd., United Kingdom). Serum inorganic 
phosphorus reacts with molybdate in strong acid medium to form 
phosphomolybdate complex. The phosphomolybdate reacts with metol 
solution to form a blue colour which is read at 690 nm using Jenway 
spectrophotometer (Jenway 6105 U. V. /vis. Spectrophotometer, U. K.). 
Serum phosphorus values were measured in mmol/l of serum.  
2.2.4.15 Serum calcium 
 Calcium in the extracellular fluid is critical for normal 
neuromuscular excitability, capillary and membrane permeability, normal 
muscle contraction, normal transmission of nerve impulses, and normal 
blood coagulation (Kaneko et al., 1997). 
The serum calcium concentration was determined by photometric 
colorimetric test-cresolphthalein method kit (Randox laboratories Ltd., 
United Kingdom). Calcium ions form a violet complex with o-
cresolphthalein complexone in alkaline medium. The intensity of the 
developing colour was measured at 570 nm using Jenway 
spectrophotometer (Jenway 6105 U. V. /vis. Spectrophotometer, U. K.). 
The calcium values were calculated in mmol/l of serum according to 
Sarkar and Chauhan (1967) and Barnett et al., (1973). 
2.2.4.16 Serum Copper 
Copper is an essential trace element in human and animal nutrition 
and a component of many metallo-enzymes. Copper is important to the 
function of caeruloplasmin and for the synthesis of melanin and collagen. 
Copper deficiency is characterized by growth failure and hypochromic – 
microcytic anaemia; acute copper toxicity can cause gastroenteritis and 
acute renal failure. 
Copper concentration in serum was determined using kits (Randox 
laboratories Ltd., United Kingdom, BT29 4QY) after reduction according 
to Abe et al., (1989). The formed colour was measured at 580 nm using 
Pharmacia LKB, Ultrospec III UV/visible spectrophotometer (Pharmacia 
LKB Biochrom Ltd., Science Park, Cambridge CB4 4FJ, England). 
Abe et al., (1989) developed a sensitive procedure for 
determination of serum copper, at pH 4.7 copper, which is bound to 
Caeruloplasmin, is released by a reducing agent, it then reacts with a 
specific colour reagent, 3,5 – Di-Br - PAESA 4 - (3, 5 – Dibromo – 2 - 
pyridylazo) – N – Ethyl – N - (3 -sulphopropyl) aniline, to form a stable, 
coloured chelate. After mixing serum sample and reagent, and incubating 
at 37 °C for 5 min, the absorbance of the resulting chelate complex is 
measured at 580 nm. The intensity of the colour is directly proportional to 
the amount of copper in the sample. 
2.2.4.17 Serum Zinc 
Zinc is an essential trace metal, which is second only to Iron. It is 
present in zinc metallo-enzymes e.g. carbonic anhydrase, alkaline 
phosphatase, RNA and DNA polymerases, thimidine kinase, 
carboxypeptidases and alcohol dehydrogenase. 
Zinc present in the sample is chelated by 5-Br-PAPS 2-(5-bromo-
2-pyriddylazo)-5-(N-propyl-N-sulfoprpylamino)-phenol in the reagent.  
Zinc was determined using kits (Randox laboratories Ltd., United 
Kingdom, BT29 4QY) after chelation according to Homsher and  Zak  
(1985). The formed colour was measured at 560 nm using Pharmacia 
LKB, Ultrospec III UV/visible spectrophotometer (Pharmacia LKB 
Biochrom Ltd., Science Park, Cambridge CB4 4FJ, England). 
2.2.4.18 Serum Sodium and Potassium 
Sodium and potassium concentrations in the serum were 
determined by flame photometery technique as described by Wootton 
(1974). A volume of 0.1 ml of serum was diluted with 9.9 ml of 
deionized water in a test tube. The knob of the light filter was adjusted to 
sodium and potassium then the power was connected and the 
galvanometer light switched on. The gas switch was turned and the flame 
was ignited. The high standards were adjusted to full scale and the diluted 
serum samples and low standards were measured. Sodium and potassium 
values were measured in mEq/L and then converted to mmol/L according 
to Kaneko et al., (1997). 
2.2.5 Determination of hormones 
The thyroid hormones triiodothyronine (T3), thyroxine (T4), and 
thyroid stimulating hormone (TSH) from the anterior pituitary, were 
measured in donkey’s serum using RIA & IRMA technique (Beijing 
Atom Hightech. Co. LTD, Beijing, P. R. China) according to Mardell 
(1978). Simply the technique depends on antigen – antibody reaction 
which was detected by radioactive iodine (I125). The individual values 
were obtained in ng/ml for T3 and T4 whereas for TSH in mIU/L. 
2.2.5.1 Determination of serum total thyroxine (T4) concentration 
Thyroxine (T4) is one of the two hormones secreted by the thyropid 
gland. In blood, T4 like T3 is transported bound prinicipally to thyroxine 
binding globulin (TBG) and secondarily to prealbumin (TBPA) and 
albumin. While more than 99.9% of T4 is bound to these proteins, it is the 
free fraction which is considered to be biologically active. 
Total thyroxine levels in serum or plasma have long been 
recognized as an important indicator for thyroid status. In overt 
hypothyroidism T4 levels are generally depressed and in overt 
hyperthyroidism T4 levels are generally raised. The T4 assay can be also 
used as a complement in the screening of neonatal hypothyroidism. 
Principle of the method 
The T4 radioimmunoassay method depends on the competition 
between iodine-125 labeled T4 and T4 contained in standards or in 
specimens to be assayed, for a fixed and limited number of T4 antibody 
binding sites. After the incubation, the amount of iodine-125 labeled T4 
bound to the antibody is inversely related to the amount of T4 present in 
the sample. In the antibody suspension of this kit the antibody is 
covalently bound to magnetizable particles. Separation of the antibody 
bond fraction is achieved by magnetic separator and decanting the 
supernatant. By measuring the proportion of iodine-125 labeled T4 bound 
in the presence of reference standards containing various known amounts 
of T4, the concentration of T4 present in unknown sample can be 
interpolated. 
Assay procedure 
1. Assay tubes were labeled and arranged in the assay rack. 
2. 50 µl aliquots of the standards or samples were pipetted into the pre-
labeled tubes. 
3. 500µl (125I) thyroxine solution (red), were dispensed into each tube. 
4. 500µl T4 antibody suspension were dispensed into the pre-labeled 
tubes. 
5. Tubes were mixed thoroughly using vortex mixer, and they were 
incubated at 37°C for 45 minutes. 
6. Test tube rack was placed on the magnetic separator and allowed to 
stand for 10 minutes. Supernatant was decanted and keeping the 
separator inverted, tubes were placed on a pad of absorbent paper and 
allowed to drain for 5 minutes. 
7. The tubes were counted using a gamma counter. 
2.2.5.2 Determination of serum total triiodothyronine (T3) 
concentration 
 The main part of the circulating triiodothyronine (T3) is, however, 
produced by peripheral deiodonation of thyroxine (T4). T3 is transported 
in serum primarily by thyroxine binding globulin (TBG) although its 
affinity for TBG is considerably less than T4. Approximately 80% of 
serum T3 is believed to bind to TBG, 10% to prealbumin and 10% to 
albumin. T3 is known to have more metabolic activity than T4 and it is 
thought to contribute significantly to the maintenance of the euthyroid 
state.  
Assay procedure 
1. Assay tubes were labeled and arranged in the assay rack. 
2. 50 µl aliquots of the standards or samples were pipetted into the pre-
labeled tubes. Zero standards should be used for non specific binding 
(NSB) reagent tubes which are recommended for logit-log plotting but 
are not required for lin-log plotting. 
3. 500µl (125I) triiodothyronine (T3) solution (red), were dispensed into 
each tube. 
4. 500µl T3 antibody suspension were dispensed into the pre-labeled 
tubes. 
5. Tubes were mixed thoroughly using vortex mixer, and they were 
incubated at 37°C for 60 minutes. 
6. Test tube rack was placed on the magnetic separator and allowed to 
stand for 10 minutes. Supernatant was decanted and keeping the 
separator inverted, tubes were placed on a pad of absorbent paper and 
allowed to drain for 5 minutes. 
7. The tubes were counted using a gamma counter. 
2.2.5.3 Determination of serum Thyroid stimulating hormone (TSH) 
concentration 
TSH is a glycoprotein hormone of molecular weight approximately 
28.000, consisting of two subunits designated α and β. The α subunit of 
TSH, LH, FSH, and HCG are biochemically identical. The β subunit 
confers biologic and immunologic specificity to each hormone. 
TSH is primarily responsible for the control of synthesis and 
secretion of the thyroid hormones, T3 and T4. TSH secretion is regulated 
by thyrotropin releasing hormone (TRH) and by T4 through negative 
feedback mechanism. Measurement of serum TSH has become one of the 
most important tools in the diagnosis of thyroid disorders. 
Principle of the assay 
CIAE TSH IRMA kit utilizes a two-site sandwich 
immunoradiometric assay for the measurement of TSH in serum. This 
involves the reaction of TSH present in serum with monoclonal and 
polyclonal antibody. The monoclonal antibody is labeled with 125I as 
tracer (125I-McAb) and the polyclonal antibody is coupled to magnetic 
iron oxide particles (PcAb {M}). The formed 125I-McAb-TSH-PcAb {M} 
complex (sandwich) is separated from unbound tracer by placing the 
assay tubes in the magnetic separator and decanting supernatant. The 
radioactivity of tracer in the tubes is directly proportional to the 
concentration of TSH in the specimens. 
Assay procedure 
1. 200 µl of standards, controls, and unknown serum were added to pre-
labeled tubes. 
2. 50 µl 125I-anti-hTSH solution, were added to each tube including total 
count tubes with gentle vortexing. 
3. The tubes were incubated at 37°C for 1 hour. 
4. 500 µl well mixed antibody suspension were added with gentle 
vortexing. 
5. The tubes were incubated for 1 hour at room temperature (18 25°C). 
6. Test tube rack was placed on magnetic separator and allowed to stand 
for 10 minutes. Supernatant was decanted and the rack removed from 
the separator. 
7. 1 ml wash buffer was added and vortexing. 
8. Test tube rack was replaced on magnetic separator and allowed to 
stand for 10 minutes. Supernatant decanted and drained thoroughly on 
absorbent paper. 1 ml wash was repeated. 
9. All tubes were counted in gamma counter. 
2.3 Therapeutic efficacy of doramectin Injectable against 
gastrointestinal nematodes in donkeys  
The aim of this study was to investigate the therapeutic efficacy of 
Doramectin as an anthelmintic in donkeys harbouring natural 
gastrointestinal nematodes, and to compare the results with Ivermectin.  
2.3.1 Experimental animals 
 Fifty donkeys aging 4-10 years were utilized in this experiment. 
The donkeys had naturally acquired mixed parasitic infections, 
comprising gastrointestinal nematodes.  
2.3.2 Experimental Drugs 
Doramectin injection: Dectomax injection (1.0% w/v sterile 
solution of Doramectin) manufactured by: Pfizer. France. Ivermectin 
injection: Ivermectin 10® injection, ANUPco. England.  
2.3.3 Design of study  
 Faecal samples were collected from all donkeys and analyzed the 
same day using a modified McMaster technique as described in 2.1.5 
above. Donkeys were allocated to 3 treatment groups (each group 
comprising 5 female and 9 male donkeys) according to the EPG count 
and, where possible, sex and age. They were weighed and treated as 
follows: Doramectin – treated group1 (DRMT1) received a single 
intramuscular injection of 200 µg/kg Doramectin (Dectomax ® injection, 
Pfizer France), Doramectin- treated group 2 (DRMT2) received a single 
subcutaneous injection of 200 µg/kg Doramectin, and Ivermectin treated 
group 3 (IVMT) received a single intramuscular injection of 200 µg/kg 
Ivermectin (Ivermectin 10® injection, ANUPco. England). Injections 
were administered in the lateral mid-line of the neck. Donkeys were then 
observed for possible adverse reactions for 2 hours after injection. 
Experimental animals were penned by treatment groups until the end of 
the observation period. The animals were kept on water from taps and 
straw ad libitum. Faecal egg counts were performed on each animal 
before treatment (day zero) and then daily for the first week and then on 
days 14, 21 and 28. 
Additional eight animals (intended for slaughter) were divided to 
four groups, each group comprising two animals. The three treatment 
groups DRMT1, DRMT2 and IVMT were treated as described above, and 
the fourth group remained as untreated control group. On each of days 15, 
16, 17, 18, 19, and 20 after treatment the animals from the four groups 
were killed and necropsied. Day of slaughter for each animal had been 
determined on day zero by random assignment.   
2.3.4 Necropsy of animals and sample preparation 
Animals were euthanized and methods used for worm recovery 
were the same as those previously described (Reinecke and Le Roux, 
1972). After donkeys were euthanized as shown in figure (2.3), the 
thoracic and abdominal cavities were opened by making an incision along 
the ventral line of the animal and the left half of the thorax and the 
abdominal wall were removed. The organs from the thoracic and 
abdominal cavities were removed from the carcass. The different organs 
from the gastro-intestinal tract were then isolated by tying double 
ligatures around the gut to separate it into the stomach, small intestine, 
caecum, colon and rectum as shown in figure (2.4). The contents of the 
different organs were removed and then sieved through a 150 µm sieve to 
obtain residue samples. Iodine was added and the residues preserved in 
10% formalin. Residue samples of ingesta were examined 
macroscopically. Nematodes present were placed in a specimen bottle  
  
 
 
 
 
 
 
 
Figure 2.3 donkey exsanguinated by bleeding of the jugular vein.
 
 
 
 
 
 
 
 
 
Figure 2.4 isolation, tying double ligature around the gut to 
separate the different organs of the gastro-intestinal tract.
containing 10% formalin. Helminths were identified at a later stage by 
placing them on glass slides, examining them microscopically and 
classifying them using the early description (Lichtenfels, 1975).   
2.3.5 Data analysis 
The anthelmintic effect of Doramectin was estimated using the 
faecal egg count reduction test (FECR) for nematode burdens. Arithmetic 
means of the egg counts and nematode burdens were calculated to 
determine the mean percentage reductions within each group, according 
to the following formula: 
        FECR% =    Pre- treatment EPG- Post- treatment EPG × 100 
                                                Pretreatment EPG 
2.4 Assay of some biochemical parameters in donkeys medicated at 
therapeutic level with Doramectin Injectable 
A controlled experiment was conducted to study the acute effect of 
Doramectin injection in naturally parasitized animals with gastrointestinal 
nematodes. Selected blood biochemical constituents were examined 
before and after Doramectin treatment.  
2.4.1 Treatment procedure  
Twenty (10 male and 10 female) donkeys, 4 -10 years, purchased 
by Central Veterinary Research Laboratory (CVRL), Soba were used in 
this study. They were penned at two separate pens according to sex at the 
Radioisotope unit soba. Donkeys had naturally acquired gastrointestinal 
infection.  They were divided into two treated groups according to sex 
and, where possible, level of infection. Treatment group one (DRMT1) 
received a single dose of Doramectin Injectable (Dectomax®, Pfizer. 
France), at the manufacturer recommended dose rate 200 µg/kg bwt by 
intramuscular (IM) injection of the cervical muscles. Treatment group 
two (DRMT2), which received a single dose of Doramectin Injectable 
(Dectomax®, Pfizer. France), at the manufacturer’s recommended dose 
rate of 200 µg/kg bwt by subcutaneous (S/C) injection at the neck region. 
2.4.2 Blood collection 
Blood samples were taken from each of the treated animals just 
before treatment and at four day intervals for 28 days post treatment. All 
samples were collected between 09.30 h and 10.30 h on the collection 
dates and placed in plain evacuated tubes. Serum samples were stored at -
20ºC until analysis was done on a single batch according to the methods 
described in 2.2.2 above.  
2.5 Sub acute toxicity of Doramectin Injectable in donkeys  
The objective of this study is to investigate the subacute toxicity of 
Doramectin injected intramuscularly in donkeys, through examination of 
the changes that may occur in some blood biochemical constituents.   
2.5.1 Design of the experiment 
Four groups of animals were used in this study each group 
comprising five animals (three male and two female donkeys). They were 
4-10 years old. The animals in the treatment groups (DRMTOX1, 
DRMTOX2 and DRMTOX3) received a daily intramuscular injection of 
Doramectin for a whole week, at three different dose levels viz: 100, 200 
and 300 µg/kg bwt, respectively. The fourth group remained untreated as 
control group. 
Then blood samples were collected for biochemical and hormonal 
assays. After each injection animals were monitored for two hours for any 
untoward effects. 
2.5.2 Collection of blood 
Blood samples were collected before the administration of the drug 
(day zero) and then daily for the first week after the administration of the 
drug and then every week for four additional weeks. Whenever blood 
samples were taken they were allowed to clot, the clotted blood samples 
were centrifuged and sera were separated and stored at -20 ºC until 
analyzed. Biochemical and hormonal constituents of the serum were 
analyzed using standard methods as described in 2.2.2 and 2.2.3 above, 
repsctively. 
2.6 Statistical methods 
SPSS 11.5 for Windows computer package was utilized in 
assessing significant differences, if any. Paired T – test and Analysis of 
variance (ANOVA) were used to compare between means.  
 
RESULTS 
 
3.1 Survey of gastrointestinal nematodes in donkeys (Equus asinus) in 
Khartoum State. 
The seasonal and monthly prevalence of gastrointestinal nematodes 
encountered during this study, intensity of infection, type of infection 
mean EPG counts, differential egg counts and percentage of infection are 
presented in tables (3.1.1-3.1.10). 
All examined donkeys were male pack donkeys belonging to 
Nubian ass (Equus africanus africanus). From table (3.1.1), the overall 
prevalence was 70.1%. December showed the highest parasitic infection 
(76%), and April, June, and September showed the lowest percent (64%). 
The seasonal prevalence of gastrointestinal nematodes from table (3.1.2) 
revealed that gastrointestinal parasites were more prevalent in cold season 
(72.5%) than hot (69.3%), or rainy season (68.5%).  
From table (3.1.3 and 3.1.4), 58.6% of the examined animals 
harboured mild infection, whereas 21.9% and 19.5% of the animals 
harboured moderate and severe infection respectively.  
From table (3.1.5 and 3.1.6) it is noteworthy to observe that the 
prevalence of infection with single nematode species (53.3%) was higher 
than with multiple infections (46.7%).  
As shown in table (3.1.8) the total mean EPG count was (1016.6 ± 
363.6). The rainy season recorded higher EPG (1198.75 ± 558.3), 
compared to cold season (961.1 ± 120.3) or hot (888.6 ± 297.5).  
From table (3.1.9 and 3.1.10) the prevalence of helminths recorded 
for the first time with high prevalence the presence of Dictyocaulus 
arnfieldi (70.5%), Strongylus spp. (35.8%), Cyathostomes (36.7%), 
Parascaris equorum (10.7%), Trichostrongylus axei (12%), and 
Strongyloides westeri (3.4%),  
  
 
 
Table 3.1.1 Prevalence of gastrointestinal nematodes in donkeys per 
month (No. = 100/month). 
 
 
Month Prevalence %  
January 72 
February 70 
March 75 
April 64 
May 74 
June 64 
July 72 
August 66 
September 64 
October 72 
November 72 
December 76 
Total 70.1 
 
  
 
 
 
Table 3.1.2 Prevalence of gastrointestinal nematodes in donkeys per 
season (No. = 400 animal / season). 
 
 
Season 
% per season  
(out of 400 animal) 
% of total  
(out of 1200 animal) 
Hot 69.3 (277) 32.94 (277) 
Rainy 68.5  (274) 32.58 (274) 
Cold 72.5 (290) 34.48 (290) 
 
* Number in brackets indicates number of + ve animals. 
  
 
 
Table 3.1.3 Severity of infestation with gastrointestinal nematodes in 
donkeys per month (No. = 100 animal / month). 
 
Severity 
Month 
Mild % Moderate % Severe % 
January 65.3 (47) 19.4 (14) 15.3 (11) 
February 74.3 (52) 14.3 (10) 11.4 (8) 
March 41.3 (31) 25.3 (19) 33.3 (25) 
April 60.9 (39) 21.9 (14) 17.2 (11) 
May 63.5 (47) 20.3 (15) 16.2 (12) 
June 68.8 (44) 15.6 (10) 15.6 (10) 
July 50 (36) 29.2 (21) 20.8 (15) 
August 53 (35) 24.2 (16) 22.7 (15) 
September 59.4 (38) 21.8 (14) 18.8 (12) 
October 65.3 (47) 20.8 (15) 13.9 (10) 
November 55.6 (40) 22.2 (16) 22.2 (16) 
December 48.7 (37) 26.3 (20) 25 (19) 
Total 58.6 (493) 21.9 (184) 19.5 (164) 
 
* Number in brackets indicates number of + ve animals. 
 
  
  
 
 
 
 
Table 3.1.4 Severity of infestation with gastrointestinal nematodes in 
donkeys per season (No. = 400 animal / season). 
 
 
Severity 
Season 
Mild % Moderate % Severe % 
Hot 58.2 (161) 20.9 (58) 20.9 (58) 
Rainy 56.9 (156) 24.1 (66) 19.0 (52) 
Cold 60.7 (176) 20.7 (60) 18.6 (54) 
Total 58.6 (493) 21.9 (184) 19.5 (164) 
 
* Number in brackets indicates number of + ve animals. 
  
 
Table 3.1.5 Type of gastrointestinal nematode infestation in donkeys 
per month (No. = 100 animal / month). 
 
Type  
Month 
Mixed  % Single % 
January 38.9 (28) 61.1 (44) 
February 34.3 (24) 65.7 (46) 
March 53.4 (40) 46.6 (35) 
April 40.6 (26) 59.4 (38) 
May 44.6 (33) 55.4 (41) 
June 39.1 (25) 60.9 (39) 
July 56.9 (41) 43.1 (31) 
August 43.9 (29) 56.1 (37) 
September 46.9 (30) 53.1 (34) 
October 51.4 (37) 48.6 (35) 
November 41.7 (30) 58.3 (42) 
December 65.8 (50) 34.2 (26) 
Total 46.7 (393) 53.2 (448) 
 
* Number in brackets indicates number of + ve animals. 
 
  
 
 
 
 
Table 3.1.6 Type of gastrointestinal nematode infestation in donkeys 
per season (No. = 400 animal / season). 
 
 
Type 
season 
Mixed % Single % 
Hot 44.8 (124) 55.2 (153) 
Rainy 50 (137) 50 (137) 
Cold 45.5 (132) 54.5 (158) 
Total 46.7 (393) 53.4 (448) 
 
* Number in brackets indicates number of + ve animals. 
 
  
 
Table 3.1.7 Range and Mean ±SD of egg per gram of faeces (EPG) 
count for the different genera encountered in donkeys infested with 
gastrointestinal nematodes per month (No. = 100 animal / month).  
 
Month  Mean ± SD Range 
January 759.7 ±1238.1 100 – 8100 
February 535.7 ± 653.2 100 – 3100 
March 1981.3 ± 2786.2 100 – 16300 
April 1029.7 ±1570 100 – 9400 
May 1122  ± 2387 100 – 17700 
June 662 ± 856 100 – 5800 
July 1044 ± 1807 100 – 13500 
August 1070.5 ± 1688.9 100 – 9900 
September 920.3 ± 1287.1 100 – 6800 
October 809.7 ± 1297 100 – 8300 
November 1194 ± 2120 100 – 13300 
December 1065 ± 1233 100 – 5900 
Total 1016.6 ± 363.6 100 – 17700 
 
  
 
 
 
 
Table 3.1.8 Range and mean ±SD of egg per gram of faeces (EPG) 
count for the different genera encountered in donkeys infested with 
gastrointestinal nematodes per season (No. = 400 animal / season). 
 
 
Season Mean ± SD Range 
Hot 1198.8 ± 558.3 100 – 17700 
Rainy 961.1 ± 120.3 100 – 13500 
Cold 888.6 ± 297.5 100 – 13300 
Total 1016.6 ± 363.6 100 – 17700 
 
  
 
Table 3.1.9 Prevalence percent of helminths of donkeys per month 
(No. = 100 animal / month). 
 
 
Month +ve % Dictyo. Syus. Cyatho. Pscar. Trich. Sdes.
1 72 55.6 36.1 52.8 8.3 16.7 2.8 
2 70 64.3 31.4 51.4 4.3 14.3 0 
3 75 80 22.7 34.6 13.3 4 9.1 
4 64 70.3 26.6 25 10.9 20.3 9.4 
5 74 79.7 23 27 12.2 18.9 8.1 
6 64 89.1 23.4 14.1 9.4 15.6 1.6 
7 72 81.9 44.4 29.2 12.5 6.9 5.6 
8 66 84.8 39.4 30.3 10.6 1.5 1.5 
9 64 76.6 48.4 29.7 12.5 4.7 0 
10 72 63.9 54.2 34.7 13.9 5.6 0 
11 72 55.6 22.2 58.3 11.1 12.5 0 
12 76 48.7 56.6 48.7 9.2 22.4 1.3 
 
 
Dictyo. = Dictyocaulus arnfieldi 
Syus. = Strongylus spp. 
Cyatho. =Cyathostomes 
Pscar. =Parascaris equorum 
Trich. =Trichostrongylus axei 
Sdes. =Strongyloides westeri 
  
 
 
Table 3.1.10 Prevalence percent of helminths in donkeys per season  
(No. = 400 animal / season). 
 
 
Season +ve % Dictyo. Syus. Cyatho. Pscar. Trich. Sdes. 
Hot 
69.3% 
(277) 
79.8% 
(221) 
23.8% 
(66) 
25.6% 
(71) 
11.6% 
(32) 
14.4% 
(40) 
7.6% 
(21) 
Rainy 
68.5% 
(274) 
76.6% 
(210) 
46.7% 
(128) 
31% 
(85) 
12.4% 
(34) 
4.7% 
(13) 
1.8% 
(5) 
Cold 
72.5% 
(290) 
55.9% 
(162) 
36.9% 
(107) 
52.8% 
(153) 
8.3% 
(24) 
16.6% 
(48) 
1% 
(3) 
Total 
70.1% 
(841) 
70.5% 
(593) 
35.8% 
(301) 
36.7% 
(309) 
10.7% 
(900 
12% 
(101) 
3.4% 
(29) 
 
* Number between brackets indicates number of + ve animals. 
 
 
 
Dictyo. = Dictyocaulus arnfieldi 
Syus. = Strongylus spp. 
Cyatho. =Cyathostomes 
Pscar. =Parascaris equorum 
Trich. =Trichostrongylus axei 
Sdes. =Strongyloides westeri 
                              
  
 
3.2 Some haematological and biochemical parameters of Sudanese 
donkeys 
3.2.1 Haematological parameters 
The normal haematological values for male and female donkeys 
are presented in tables (3.2.1 - 3.2.5). Table (3.2.1) shows the normal 
haematological values for the donkeys in the whole year. From table 
(3.2.2) we could observe that the female animals showed significant 
(P<0.05) decrease in the white blood cells count in the hot season when 
compared with the rainy season. Seasonally, the packed cell volume 
values as shown in table (3.2.4) did not show any significant difference 
(P>0.05) for the male donkeys, while in female donkeys there is 
significant (P<0.05) decrease in the values reported in the hot season 
when compared with the rainy season. For haemoglobin as shown in table 
(3.2.3), the same as reported in the (PCV) the (Hb) values showed 
significant (P<0.05) decrease in the hot season when compared with the 
rainy season. The values of the mean corpuscular haemoglobin 
concentration (MCHC) reported in this study (table 3.2.5) show 
significant (P<0.05) decrease in the hot season when compared with the 
cold and rainy seasons in the female animals. In this study, generally we 
could observe that the haematological values reported in the hot season 
are less than those reported in the rainy or cold seasons. The female 
haematological values reported in this study are generally less, although 
non significant, than that of the male animals. 
  
 
 
 
 
 
Table 3.2.1 Normal haematological values for donkeys in Sudan. 
 
 
 
Male  Female  All donkeys  
Parameters 
Mean ± SD Mean ± SD Mean ± SD 
PCV % 31.59 ± 3.80 30.92 ± 2.95 31.27 ± 3.43 
Hb g/dl 10.43 ± 1.45 10.18 ± 1.19 10.31 ± 1.33 
WBC (x 103/µl) 10.72 ± 1.94 10.72 ± 1.84 10.72 ± 1.89 
MCHC (g/dl) 32.96 ± 1.63 32.87 ± 1.24 32.91 ± 1.45 
 
  
 
 
 
 
 
Table 3.2.2 Seasonal variation in white blood cells count (WBC) 
(x103/ul) in male and female donkeys. 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  10.56 ± 2.06 10.22 ± 1.63a 10.39 ± 1.86a 
Rainy  10.72 ± 1.82  10.95 ± 1.60b 10.84 ± 1.71b 
Cold  10.87 ± 1.93 10.68 ± 1.72 10.77 ± 1.82 
Total  10.71 ± 1.94 10.61 ± 1.67 10.66 ± 1.81 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
  
 
 
 
 
 
Table 3.2.3 Seasonal variation in haemoglobin concentration (Hb) 
(g/dl) in male and female donkeys. 
 
 
Male  Female  All donkeys 
Sex 
Mean ± SD Mean ± SD Mean ± SD 
Hot  10.53 ± 1.38 9.86 ± 1.05a  10.20 ± 1.27  
Rainy  10.23 ± 1.73 10.50 ± 1.39b 10.36 ± 1.58 
Cold  10.52 ± 1.16 10.20 ± 1.05 10.37 ± 1.12 
Total  10.43 ± 1.45 10.18 ± 1.19 10.31 ± 1.33 
 
  
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
  
 
 
 
 
 
Table 3.2.4 Seasonal variation in packed cell volume (PCV) (%) in 
male and female donkeys. 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  32.09 ± 3.71 30.30 ± 2.46 a 31.20 ± 3.27 
Rainy  31.69 ± 3.48 31.18 ± 4.47
b 31.42 ± 4.03 
Cold  31.50 ± 3.11 30.84 ± 2.74 31.18 ± 2.94 
Total  31.59 ± 3.80 30.92 ± 2.95 31.27 ± 3.43 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
  
 
  
 
 
 
 
 
Table 3.2.5 Seasonal variation in mean corpuscular haemoglobin 
concentration (MCHC) (g/dl) in male and female donkeys. 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  32.79 ± 1.49a 32.49 ± 1.24a 32.65 ± 1.38 
Rainy  32.72 ± 2.03a 33.08 ± 1.31
b 32.89 ± 1.74 
Cold  33.36 ± 1.18 b 33.05 ± 1.09b 33.21 ±  1.14 
Total  32.96 ± 1.63 32.87 ± 1.24 32.91 ± 1.45 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
3.2.2 Biochemical parameters 
Generally, from tables (3.2.6 and 3.2.7), we could observe that the 
values of the serum constituents obtained in this study are higher in the 
male than female animals for the following parameters: total serum 
protein, albumin, total globulins, urea, creatinine, uric acid, glucose, 
triglycerides, AST, calcium, zinc, copper and potassium. In this study, for 
the first time, we did the break down analysis of the phospho - and 
sphingolipids components using the high performance liquid 
chromatography technique (HPLC). The method used in this study 
enables separation of phosphatidylglycerol (PG), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), 
phosphatidylcholine (PC), and sphingomyelin (SM), within 27 minutes as 
shown in Figures (3.2.1 – 3.2.6), including the regeneration of the 
column. The SM resulted in two peaks. By this method it was not posible 
to separate phosphoatidylserine from phosphatidylinositol. In one animal 
there is an abnormal rise in phosphatidylglycerol as shown in Figure 
(3.2.7). 
As shown in table (3.2.8) total protein concentration is significantly 
low in the cold season when compared with the hot and rainy season 
(P<0.05). The values of the rainy season are higher than that of the hot 
season. As shown in table (3.2.9) serum albumin is significantly (P<0.05) 
low in the cold season than the hot and rainy season. From table (3.2.10) 
we could observe that in female animals there is significant (P<0.05) 
difference in total globulin values between the rainy, cold, and hot 
seasons. 
In total bilirubin concentration, as shown in table (3.2.11) it is to be 
noted that male animals showed significant (P<0.05) decrease in the hot 
season when compared with the cold season, similar to the totality of all 
animals, while females did not show any significant change.  
As shown in table (3.2.12) there is significant difference (P<0.05) 
in the level of blood urea between the seasons. The hot season showed 
higher serum urea concentration when compared with the rainy and cold 
seasons. From table (3.2.13) we could observe that there is significant 
increase (P<0.05) in the level of blood creatinine in the cold season when 
compared with the hot season in both male and female animals. As shown 
in table (3.2.14), blood uric acid level reported in this study is 
significantly (P<0.05) low in the cold season when compared with the 
rainy and hot seasons in both male and female animals. 
Serum glucose as shown in table (3.2.15), is significantly (P<0.05) 
higher in the cold season than the hot season which is also significantly 
(P<0.05) higher than the rainy season.   
As shown in table (3.2.16), serum cholesterol level in the male 
animals is significantly (P<0.05) higher in the hot season when compared 
with the cold season. Serum triglycerides as we could observe from table 
(3.2.17), is significantly (P<0.05) low in the cold season when compared 
with the hot and rainy seasons.  
As shown in table (3.2.18), total phospho and sphingolipids 
concentration show significant (P<0.05) increase in the rainy season 
when compared with the cold season. Phosphatidylglycerol (PG) 
concentration in the female donkeys is significantly (P<0.05) low in the 
cold season when compared with the rainy and hot seasons as shown in 
table (3.2.20). In table (3.2.19), we could find that 
phosphatidylethanolamine concentration is significantly (P<0.05) low in 
the cold season than the hot and rainy season in the male animals. As 
shown in table (3.2.19) phosphatidylinositol concentration is significantly 
(P<0.05) low in the cold season when compared with the rainy season in 
the male animals. From table (3.2.18), phosphatidylcholine concentration 
did not show any significant difference between the three seasons. As 
shown in table (3.2.19) total sphingolipids concentration is significantly 
(P<0.05) low in the cold season when compared with the hot and rainy 
seasons in the male animals.  
The level of aspartate aminotransferase (AST) enzyme in male and 
female animals as shown in table (3.2.21), is significantly (P<0.05) low in 
the rainy season when compared with the cold and hot seasons, while the 
level of alanine aminotransferase (ALT) enzyme in the female animals is 
significantly (P<0.05), higher in the rainy season when compared with 
the cold and hot seasons as shown in table (3.2.22).  
There is significant decrease (P<0.05) in the inorganic phosphorus 
concentration in the cold season when compared with the rainy and hot 
seasons in both male and female animals as shown in tables (3.2.23, 
3.2.24 and 3.2.25). Serum calcium concentration (tables 3.2.24 and 
3.2.25) did not show any significant (P>0.05) change between the 
different seasons. From table (3.2.24), we could observe that serum zinc 
concentration in the male animals is significantly (P<0.05) low in the hot 
season when compared with the rainy and cold seasons, while in the 
female animals it is significantly (P<0.05) low in the rainy season when 
compared with the hot and cold seasons. Serum copper concentration as 
shown in tables (3.2.24 and 3.2.25) did not show any significant change 
between the different seasons. 
Sodium blood level showed significant increase (P<0.05) in the 
cold season when compared with the hot and the rainy seasons as shown 
in table (3.2.23). As shown in table (3.2.23), serum potassium 
concentration is significantly (P<0.05) higher in the cold season when 
compared with the rainy or hot seasons. 
 
Table 3.2.6 Normal biochemical constituents of the donkey serum 
(according to new SI units). 
 
Male  Female  All donkeys 
Parameter 
Mean ± SD Mean ± SD Mean ± SD 
T. protein  56.98 ± 4.63 54.48 ± 4.06 55.73 ± 4.52 
Albumin 28.22 ± 2.99 28.17 ± 3.39 28.19 ± 3.19 
T. globulin 28.78 ± 4.07 26.30 ± 3.51 27.54 ± 3.99 
T. bilirubin 4.89 ± 1.17 5.25 ± 1.12 5.07 ± 1.16 
Urea 3.24 ± 1.31 3.16 ± 1.15 3.20 ± 1.23 
Creatinine 95.16 ± 12.34 93.73 ± 11.59 94.44 ± 11.97 
Uric acid 40.08 ± 36.68 33.29 ± 16.94 36.71 ± 28.82 
Glucose 3.31 ± 0.68 3.25 ± 0.61 3.28 ± 0.64 
Cholesterol  1.78 ± 0.29 2.10 ± 0.34 1.94 ± 0.36 
Triglycerides  1.01 ± 0.37 0.93 ± 0.34 0.97 ± 0.35 
Phospholipids 1.32 ± 0.34 1.40 ± 0.38 1.36 ± 0.36 
Sphingolipids 0.09 ± 0.04 0.12 ± 0.09 0.11 ± 0.076  
AST 38.97 ± 12.77 35.28 ± 13.12 35.50 ± 12.87 
ALT 7.68 ± 3.05 8.06 ± 4.15 7.87 ± 3.64 
Phosphorus 0.92 ± 0.22 1.08 ± 0.22 1.00 ± 0.23 
Calcium 2.33 ± 0.31 2.31 ± 0.30 2.32 ± 0.30 
Zinc 9.93 ± 1.57 9.88 ± 2.12 9.91 ± 1.86 
Copper 12.02 ± 1.93 10.15 ± 1.84 11.08 ± 2.10 
Sodium 111.41 ± 7.61 112.09 ± 9.04 111.28 ± 11.02 
Potassium  3.90 ± 0.50 3.03 ± 0.51 3.96 ± 0.53 
 
 
Table 3.2.7 Clinical normal biochemical constituents of the Sudanese 
donkey breed. Reference ranges, interval from the 5th to the 95th % 
about the Mean, and minimum-, and maximum-values. 
95% Confidence 
Interval for Mean Parameter Mean ± SD 
Lower 
Bound 
Upper 
Bound 
Range  
T. protein 55.73 ± 4.52 55.16 56.31 44.20 - 66.90 
Albumin 28.19 ± 3.19 27.79 28.60 20.62 - 36.00 
T. globulin 27.54 ± 3.99 27.03 28.05 18.57 - 40.98 
T. bilirubin 5.07 ± 1.16 4.92 5.21 2.04 - 8.33 
Urea 3.20 ± 1.23 3.09 3.32 1.07 - 9.22 
Creatinine 94.44 ± 11.97 92.92 95.97 61.03 - 128.32
Uric acid 36.71 ± 28.82 34.12 39.31 4.69 - 119.47 
Glucose 3.28 ± 0.64 3.22 3.33 1.72 - 6.26 
Cholesterol  1.94 ± 0.36 1.89 1.98 1.11 - 2.76 
Triglyceride  0.97 ± 0.35 0.93 1.02 0.29 - 2.27 
Phospholipids 1.36 ± 0.36 1.32 1.41 0.55 - 2.45 
Sphingolipids 0.11 ± 0.076 0.10 0.11 0.05 - 1.09 
AST 35.50 ± 12.87 33.71 37.30 8.40 - 63.50 
ALT 7.87 ± 3.64 7.41 8.33 3.90 - 26.10 
Phosphorus 1.00 ± 0.23 0.97 1.03 0.53 - 1.75 
Calcium 2.32 ± 0.30 2.28 2.36 1.95 - 3.71 
Zinc 9.91 ± 1.86 9.64 10.17 3.71 - 17.87 
Copper 11.08 ± 2.10 10.59 11.58 5.91 - 17.10 
Sodium 111.28 ± 
11.02  109.87 112.68 85.56 -129.35 
Potassium  3.96 ± 0.53 2.89 3.03 2.43 - 4.72 
  
 
 
 
 
 
 
Table 3.2.8 Seasonal variation in total protein concentration (g/l) 
normal values in donkeys. 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  57.50 ± 4.92a 55.42 ± 3.96a 56.46 ± 4.56a 
Rainy  58.10 ± 3.88a 56.00 ± 4.27a 57.05 ± 4.19a 
Cold  55.34 ± 4.68b 52.03 ± 2.63b 53.69 ± 4.12b 
Total  56.98 ± 4.63 54.48 ± 4.06 55.73 ± 4.52 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
 
 
 
  
 
 
 
 
 
 
Table 3.2.9 Seasonal variation in albumin concentration (g/l) normal 
values in donkeys. 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  28.82 ± 3.16a 28.07 ± 3.71a 28.44 ± 3.45a 
Rainy  28.91 ± 2.76a 30.00 ± 2.55b 29.46 ± 2.70b 
Cold  26.93 ± 2.65b 26.44 ± 2.86c 26.68 ± 2.75c 
Total  28.22 ± 2.99 28.17 ± 3.39 28.19 ± 3.19 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
  
 
 
 
 
 
 
Table 3.2.10 Seasonal variation in total globulin concentration (g/l) 
normal values in donkeys. 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  28.75 ± 4.17 27.34 ± 3.94a 28.04 ± 4.09 
Rainy  29.16 ± 3.68 25.98 ± 3.46 27.57 ± 3.89 
Cold  28.42 ± 4.39 25.59 ± 2.89b 27.01 ± 3.96 
Total  28.78 ± 4.07 26.30 ± 3.51 27.54 ± 3.99 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
 
 
 
 
 
 
 
 
 
Table 3.2.11 Seasonal variation in total bilirubin concentration 
(µmol/l) normal values in donkeys. 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  4.49 ± 0.95a 5.14 ± 1.12 4.81 ± 1.08a 
Rainy  4.89 ± 1.23 5.22 ± 1.24 5.06 ± 1.23 
Cold  5.28 ± 1.22b 5.38 ± 1.00 5.33± 1.11b 
Total  4.89 ± 1.17 5.25 ± 1.12 5.07 ± 1.16 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2.12 Seasonal variation in urea concentration (mmol/l) 
normal values in donkeys. 
 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  3.75 ± 1.22a 3.34 ± 1.24a 3.55 ± 1.24a   
Rainy  3.28 ± 1.39b 3.25 ± 1.14 3.27 ± 1.26b 
Cold  2.55 ± 1.00c 2.89 ± 1.02b 2.73 ± 1.02c 
Total  3.24 ± 1.31 3.16 ± 1.15 3.20 ± 1.23 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
 
 
  
 
 
 
 
 
 
Table 3.2.13 Seasonal variation in creatinine concentration (µmol/l) 
normal values in donkeys. 
 
 
Male  Female  All donkeys 
Season 
Mean ± SD Mean ± SD Mean ± SD 
Hot  90.76 ± 10.49a 90.05 ± 11.42a 90.41 ± 10.90a 
Rainy  97.17 ± 12.63 92.96 ± 10.78 95.06 ± 11.86b 
Cold  97.56 ± 12.85b 98.18 ± 11.32b 97.87 ± 12.04b 
Total  95.16 ± 12.34 93.73 ± 11.59 94.44 ± 11.97 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
 
 
  
 
 
 
 
 
 
Table 3.2.14 Seasonal variation in uric acid concentration (µmol/l) 
normal values in donkeys. 
 
 
Male  Female  All donkeys 
Season Mean ± SD Mean ± SD. Mean ± SD 
Hot  52.10 ± 16.37a 39.43 ± 21.74a 45.85 ± 20.17a 
Rainy  40.10 ± 56.05b 33.61 ± 13.09b 36.90 ± 40.93b 
Cold  28.04 ± 19.16c 26.98 ± 12.17c 27.51 ± 16.01c 
Total  40.08 ± 36.68 33.29 ± 16.94 36.71 ± 28.82 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
 
  
 
 
 
 
 
Table 3.2.15 Seasonal variation in glucose concentration (mmol/l) 
normal values in donkeys. 
 
 
Male  Female  All donkeys 
Season Mean ± SD Mean ± SD Mean ± SD 
Hot  3.43 ± 0.58a 3.22 ± 0.54a 3.32 ± 0.57a 
Rainy  2.86 ± 0.40b 3.03 ± 0.36b 2.94 ± 0.39b 
Cold  3.64 ± 0.75c 3.49 ± 0.77c 3.56 ± 0.76c 
Total  3.31 ± 0.68 3.25 ± 0.61 3.28 ± 0.64 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
  
 
 
 
 
 
 
Table 3.2.16 Seasonal variation in cholesterol concentration (mmol/l) 
normal values in donkeys. 
 
 
Male  Female  All donkeys 
Season Mean ± SD Mean ± SD Mean ± SD 
Hot  1.84 ± 0.29a 2.09 ± 0.36 1.97 ± 0.35 
Rainy  1.81 ± 0.29 2.17 ± 0.33 1.99 ± 0.36a 
Cold  1.68 ± 0.27b 2.04 ± 0.34 1.86 ± 0.35b 
Total  1.78 ± 0.29 2.10 ± 0.34 1.94 ± 0.36 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
  
 
 
 
 
 
 
Table 3.2.17 Seasonal variation in triglycerides concentration 
(mmol/l) normal values in donkeys. 
 
 
Male  Female  All donkeys 
Season Mean ± SD Mean ± SD Mean ± SD 
Hot  1.08 ± 0.34a 0.90 ± 0.31a 0.99 ± 0.34a 
Rainy  1.10 ± 0.37a 1.09 ± 0.35b 1.09 ± 0.36b 
Cold  0.86 ± 0.34b 0.80 ± 0.28a 0.83 ± 0.31c 
Total  1.01 ± 0.37 0.93 ± 0.34 0.97 ± 0.35 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
 
 
 
 
 
 
 
  
Table 3.2.18 Seasonal variation in total phospho- and sphingolipids concentration (mmol/l) in all donkeys’ serum 
 
 
Season 
PG 
Mean ± SD 
PE 
Mean ± SD 
PI 
Mean ± SD 
PC 
Mean ± SD 
SM 
Mean ± SD 
Total 
Mean ± SD 
Hot 0.101 ± 0.041 0.027 ± 0.012a 0.034 ± 0.015a 1.222 ± 0.379 0.11 ± 0.05 1.49 ± 0.42 
Rainy 0.110 ± 0.048 0.027 ± 0.007a 0.040 ± 0.014b 1.225 ± 0.270 0.11 ± 0.03 1.51 ± 0.32a 
Cold  0.087 ± 0.112 0.022 ± 0.008b 0.036 ± 0.015 1.151 ± 0.357 0.10 ± 0.12 1.38 ± 0.38b 
Total  0.102 ± 0.064 0.025 ± 0.010 0.037 ± 0.015 1.199 ± 0.339 0.11 ± 0.08 1.46 ± 0.38 
 
* Means on the same column having different asterisk are significantly (P<0.05) different. 
  
Table 3.2.19 Seasonal variation in total phospho- and sphingolipids concentration (mmol/l) in male donkeys’ serum 
 
 
Season 
PG 
Mean ± SD 
PE 
Mean ± SD 
PI 
Mean ± SD 
PC 
Mean ± SD 
SM 
Mean ± SD 
Total 
Mean ± SD 
Hot 0.082 ± 0.029 0.025 ± 0.008a 0.032 ± 0.011 1.193 ± 0.353 0.10 ± 0.07a 1.43 ± 0.39 
Rainy 0.090 ± 0.043 0.025 ± 0.007a 0.036 ± 0.010a 1.237 ± 0.271 0.10 ± 0.02a 1.49 ± 0.32a 
Cold  0.087 ± 0.112 0.020 ± 0.006b 0.032 ± 0.008b 1.112 ± 0.345 0.07 ± 0.02b 1.32 ± 0.34b 
Total  0.086 ± 0.071 0.024 ± 0.007 0.033 ± 0.010 1.181 ± 0.327 0.09 ± 0.04 1.42 ± 0.36 
 
* Means on the same column having different asterisk are significantly (P<0.05) different. 
 
  
Table 3.2.20 Seasonal variation in total phospho- and sphingolipids concentration (mmol/l) in female donkeys’ serum 
 
 
Season 
PG 
Mean ± SD 
PE 
Mean ± SD 
PI 
Mean ± SD 
PC 
Mean ± SD 
SM 
Mean ± SD 
Total 
Mean ± SD 
Hot 0.119 ± 0.043a 0.029 ± 0.016 0.036 ± 0.019 1.251 ± 0.406 0.12 ± 0.03 1.55 ± 0.44 
Rainy 0.130 ± 0.044a 0.029 ± 0.008 0.043 ± 0.017 1.213 ± 0.272 0.12 ± 0.03 1.53 ± 0.32 
Cold  0.088 ± 0.029b 0.024 ± 0.009 0.040 ± 0.019 1.189 ± 0.369 0.12 ± 0.16 1.44 ± 0.41 
Total  0.112 ± 0.043 0.027 ± 0.011 0.040 ± 0.018 1.218 ± 0.352 0.12 ± 0.09 1.51 ± 0.39 
 
* Means on the same column having different asterisk are significantly (P<0.05) different. 
 
 
Figure 3.2.1 HPLC chromatogram of phospho- and sphingolipids concentration 
(mmol/l) in female donkey serum during the hot season.
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Figure 3.2.2 HPLC chromatogram of phospho- and sphingolipids concentration (mmol/l) in 
female donkey serum during the rainy season.
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Figure 3.2.3 HPLC chromatograph of phospho- and sphingolipids concentration (mmol/l) in 
female donkey serum during the cold season.
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Figure 3.2.4 HPLC chromatogram of  phospho- and sphingolipids concentration 
(mmol/l) in male donkey serum during the hot season
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Figure 3.2.5 HPLC chromatogram of phospho- and sphingolipids concentration 
(mmol/l) in male donkey serum during the rainy season
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Figure 3.2.6 HPLC chromatogram of phospho- and sphingolipids concentration (mmol/l)  in 
male donkey serum during the cold season
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Figure 3.2.7 HPLC chromatogram of phospho- and sphingolipids concentration (mmol/l) in 
male donkey serum during the hot season with abnormal phosphatidylglycerine level.
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Table 3.2.21 Seasonal variation in AST concentration (UI) normal 
values in donkeys. 
 
 
Sex  Male  Female  All donkeys 
Season Mean ± SD Mean ± SD Mean ± SD 
Hot  39.41 ± 14.74a 34.53 ± 12.39a 36.97 ± 13.75a 
Rainy  31.02 ± 9.19b 26.08 ± 8.09b 28.55 ± 8.95b 
Cold  46.47 ± 8.56c 45.23 ± 10.82c 46.47 ± 8.56c 
Total  38.97 ± 12.77 35.28 ± 13.12 35.50 ± 12.87 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
  
 
 
 
 
 
Table 3.2.22 Seasonal variation in ALT concentration (UI) normal 
values in donkeys. 
 
 
Sex  Male  Female  All donkeys 
Season Mean ± SD Mean ± SD Mean ± SD 
Hot  7.11 ± 1.139 6.76 ± 1.91a 6.94 ± 1.57a 
Rainy  8.23 ± 4.82 10.04 ± 6.38b 9.14 ± 5.69b 
Cold  7.69 ± 1.78 7.38 ± 1.39a 7.53 ± 1.59a 
Total  7.68 ± 3.05 8.06 ± 4.15 7.87 ± 3.64 
 
* Means on the same column having different asterisk are significantly 
(P<0.05) different. 
 
Table 3.2.23 Seasonal variation in some macro- and micro minerals concentration in all donkeys’ serum. 
 
 
Season 
P 
mmol/l 
Ca 
mmol/l 
Zn 
µmol/l 
Cu 
mmol/l 
Na 
mmol/l 
K 
mmol/l 
Hot 1.10 ± 0.21a 2.29 ± 0.28 9.98 ± 1.90 10.80 ± 2.07 107.74 ± 7.58
a 2.88 ± 0.43a 
Rainy 1.01 ± 0.25b 2.29 ± 0.21 9.43 ± 1.77a 11.26 ± 1.96 108.09
 ± 14.45a 2.63 ± 0.30b 
Cold  0.88 ± 0.18c 2.37 ± 0.39 10.31 ± 1.83b 11.19 ± 2.31 118.08
 ± 5.57b 3.39 ± 0.52c 
Total  1.00 ± 0.23 2.32 ± 0.30 9.91 ± 1.86 11.08 ± 2.10 111.28 ± 11.02 3.96 ± 0.53 
 
* Means on the same column having different asterisk are significantly (P<0.05) different. 
Table 3.2.24 Seasonal variation in some macro- and micro minerals concentration in male donkeys’ serum. 
 
 
Season 
P 
mmol/l 
Ca 
mmol/l 
Zn 
µmol/l 
Cu 
mmol/l 
Na 
mmol/l 
K 
mmol/l 
Hot 1.08 ± 0.20a 2.32 ± 0.33 9.27 ± 1.49a 11.76 ± 1.72 107.30 ± 6.05
a 2.83 ± 0.28a 
Rainy 0.89 ± 0.18b 2.30 ± 0.24 10.38 ± 0.91b 12.04 ± 1.44 109.78
 ± 6.90a 2.56 ± 0.16b 
Cold  0.79 ± 0.16c 2.36 ± 0.35 10.15 ± 1.94b 12.26 ± 2.58 117.14
 ± 6.23b 3.23 ± 0.58c 
Total  0.92 ± 0.22 2.33 ± 0.31 9.93 ± 1.57 12.02 ± 1.93 111.41 ± 7.61 3.90 ± 0.50 
 
* Means on the same column having different asterisk are significantly (P<0.05) different. 
Table 3.2.25 Seasonal variation in some macro- and micro minerals concentration in female donkeys’ serum. 
 
 
Season 
P 
mmol/l 
Ca 
mmol/l 
Zn 
µmol/l 
Cu 
mmol/l 
Na 
mmol/l 
K 
mmol/l 
Hot 1.13 ± 0.21a 2.27 ± 0.22 10.68 ± 2.02a 9.84 ± 2.00 108.19 ± 8.91
a 2.01 ± 0.50a 
Rainy 1.13 ± 0.25a 2.28 ± 0.17 8.49 ± 1.93b 10.47 ± 2.15 109.13
 ± 8.57a 2.70 ± 0.28b 
Cold  0.98 ± 0.17b 2.39 ± 0.43 10.47 ± 1.73a 10.12 ± 1.40 119.05
 ± 4.68b 2.40 ± 0.47c 
Total  1.08 ± 0.22 2.31 ± 0.30 9.88 ± 2.12 10.15 ± 1.84 112.09 ± 9.04 3.03 ± 0.51 
 
* Means on the same column having different asterisk are significantly (P<0.05) different. 
 
 
 
3.2.3 Hormonal profiles 
In this study, we performed the normal values of the thyroid 
hormones T3 and T4 as well as TSH from the anterior pituitary, in 
donkeys, which according to our knowledge is non existent or deficient, 
the methods used (RIA and IRMA) are able to detect the hormones under 
investigation. 
Serum thyroxine (T4), triiodothyronine (T3), and thyroid 
stimulating hormone (TSH) concentrations were assayed in normal male 
and female donkeys by radioimmunoassay (RIA). As shown in table 
(3.2.26), male donkeys had low serum concentrations of T3 (0.50 ± 0.21 
ng/ml) as compared with the values in female donkeys (0.53 ± 0.21 
ng/ml). From table (2.3.26) we could observe that females had low T4 
values (6.28 ± 5.21 ng/ml) as compared with the values in male donkeys 
(11.01 ± 7.94 ng/ml). As shown in table (2.3.35), there is no difference in 
thyroid stimulating hormone concentration in male and female donkeys 
(0.86 ± 0 .14 mIU/ml in both). 
The range values for T3, T4, and TSH total values are: 0.20 - 1.03, 
1.40 - 25.73 ng/ml, and 0.64 – 1.15 mIU/ml, respectively. 
 The total values (male and female animals) for T3, T4 and TSH are: 
0.52 ± 0.21, 8.46 ± 7.19 ng/ml and 0.86 ± 0.13 mIU/ml, respectively. 
 
 
Table 3.2.26 Mean ± SD, minimum and maximum values of T3, T4 and TSH concentration in donkeys serum. 
 
 
 
Hormone Male Female All donkeys Minimum Maximum 
T3 (ng/ml) 0.50 ± 0.21 0.53 ± 0.21 0.52 ± 0.21 0.20 1.03 
T4 (ng/ml) 11.01 ± 7.94 6.28 ± 5.21 8.46 ± 7.19 1.40 25.73 
TSH (mIU/L) 0.86 ± 0 .14 0.86 ± 0.14 0.86 ± 0.13 0.64 1.15 
 
 
3.3 Therapeutic efficacy of Doramectin against gastrointestinal 
nematodes in donkeys (Equus asinus). 
3.3.1 Faecal egg count reductions. 
The results of day zero to day 28 mean EPG values from the 
treatment groups are presented in tables (3.3.1, 3.3.2 and 3.3.3), together 
with the mean faecal egg count reductions. Doramectin produced 100% 
reduction of nematode eggs on day 6 onwards on DRMT1 
(intramuscularly injected), whereas on DRMT2 (injected subcutaneously) 
Doramectin showed 94.78% reduction after the same time. Ivermectin 
produced 100% reduction of nematode eggs on day 7 onwards.  
On day 0 all donkeys had positive egg counts with a range of 100-
2800 EPG at DRMT1, 100-4100 at DRMT2, and 100-5150 at IVMT. On 
day 14, at DRMT1 and IVMT all donkeys had zero egg counts, whereas 
in DRMT2 group only one animal had positive egg counts ranging from 
200- 50 at day 14 to end of the experiment.  
3.3.2 Postmortem findings 
The results of postmortem findings and the nematodes collected 
were present in tables (3.3.4, 3.3.5, and 3.3.6). The results obtained 
indicated that animals that received Doramectin and Ivermectin 
intramuscularly showed zero nematode burdens except for the larval 
stages of Strongylus vulgaris larvae (L4) present in the cranial mesenteric 
artery. In the trunk of the cranial mesenteric artery (and its main 
branches), in the iliac, celiac, femoral arteries larvae cause inflammation 
of the arterial wall, formation of thrombuses, thickening and dilatation of 
the wall of arteries, aneurysms.  Where animals treated with Doramectin 
subcutaneously in addition to Strongylus vulgaris larvae (L4) present in 
the cranial mesenteric artery showed some Gastrophilus larvae in the 
stomach, caecum and rectum, and Cyathostomes in the colon.  
 
 
 
 
 
 
 
Table 3.3.1 Mean faecal egg counts (± SD) and reductions for 
Doramectin – treated donkeys (DRMT1) (intramuscular injection). 
 
 
 
Day 
Arithmetic mean 
(EPG) 
Range 
Mean % 
reduction 
0 1553.6 ± 968.2 100 – 2800 - 
1 1139.3 ± 1033.9 0 – 3050 26.26 % 
2 714.3 ± 571.2 50 –1800 54.02 % 
3 185.7 ± 265.6 0 – 900 88.09 % 
4 146.4 ± 294.5 0 – 1100 90.60 % 
5 17.6 ± 31.7 0 – 100 98.91 % 
6 0 ± 0 0 – 0 100 % 
7 0 ± 0 0 – 0 100 % 
14 0 ± 0 0 – 0 100 % 
21 0 ± 0 0 – 0 100 % 
28 0 ± 0 0 – 0 100 % 
 
 
 
 
 
 
 
 
 
Table 3.3.2 Mean faecal egg counts (± SD) and reductions for 
Doramectin – treated donkeys (DRMT2) (subcutaneous injection). 
 
 
 
Day 
Arithmetic mean 
(EPG) 
Range 
Mean % 
reduction 
0 1839.3 ± 1209.9 100 – 4100 – 
1 1303.6 ± 1033.9 50 – 3200 29.15 % 
2 889.3 ± 623.6 50 – 2250 51.66 % 
3 339.3 ± 596.5 0 – 2300 81.57 % 
4 167.9 ± 371.4 0 – 1400 90.92 % 
5 50 ± 135.9 0 – 500 97.28 % 
6 96.4 ± 346.7 0 – 1300 94.78 % 
7 57.1 ± 150.5 0 – 500 96.90 % 
14 14.3 ± 53.5 0 – 200 99.24 % 
21 3.6 ± 13.4 0 – 50 99.80 % 
28 3.6 ± 13.4 0 – 50 99.80 % 
 
 
 
 
 
 
 
 
Table 3.3.3 Mean faecal egg counts (± SD) and reductions for 
Ivermectin (IVMT) – treated donkeys. 
 
 
Day 
Arithmetic mean 
(EPG) 
Range 
Mean % 
reduction 
0 1545.0 ± 1589.6 100 – 5150 – 
1 1270.0 ± 545.3 650 – 2400 17.80 % 
2 744.4 ± 1015.9 0 – 3300 51.82 % 
3 195.0 ± 279.3 0 – 800 87.38 % 
4 20.0 ± 35.0 0 – 100 98.71 % 
5 15.0 ± 24.2 0 – 50 99.03 % 
6 5.0 ± 15.8 0 – 500 99.68 % 
7 0 ± 0 0 – 0 100 % 
14 0 ± 0 0 – 0 100 % 
21 0 ± 0 0 – 0 100 % 
28 0 ± 0 0 – 0 100 % 
 
Figure 3.3.1 Therapeutic efficacy (%) of the three treatments 
(DRMT1, DRMT2 & IVMT) in donkeys.
0
20
40
60
80
100
120
0 1 2 3 4 5 6 7 14 21 28
Days
E
f
f
i
c
a
c
y
 
%
DRMT1 DRMT2 IVMT
3
 Table 3.3.4 Summary of worms recovered from control and animals 
treated with Doramectin intramuscularly (DT1) at necropsy. 
 
 
DRMT1 
Organs examined Control 
No. Reduction %
Cranial mesenteric artery 
Strongylus vulgaris 130 110 15.4 
Stomach 
Gastrophilus spp. 667 0 100 
Habronema spp. 320 0 100 
Trichostrongylus axei 50 0 100 
Small Intestine 
Parascaris equorum 10 0 100 
Caecum 
Gastrophilus spp. 30 0 100 
Strongylus spp. 820 0 100 
Cyathostomes spp. 1000 0 100 
Colon 
Strongylus spp. 3360 0 100 
Cyathostomes spp. 
+ Strongyloides westeri  
+ Oxyuris equi 
22500 0 100 
Rectum 
Gastrophilus spp. 110 0 100 
Oxyuris equi 20 0 100 
 Table 3.3.5 Summary of worms recovered from control and animals 
treated with Doramectin subcutaneously (DRMT2) at necropsy. 
 
 
 
DRMT2 
Organs examined Control 
No. Reduction %
Cranial mesenteric artery 
Strongylus vulgaris 130 5 96.5 
Stomach 
Gastrophilus spp. 667 1 99.9 
Habronema spp. 320 0 100 
Trichostrongylus axei 50 0 100 
Small Intestine 
Parascaris equorum 10 0 100 
Caecum 
Gastrophilus spp. 30 10 66.7 
Strongylus spp. 820 0 100 
Cyathostomes spp. 1000 0 100 
Colon 
Strongylus spp. 3360 0 100 
Cyathostomes spp. 
+ Strongyloides westeri  
+ Oxyuris equi 
22500 240 98.9 
Rectum 
Gastrophilus spp. 110 10 90.9 
Oxyuris equi 20 0 100 
 Table 3.3.6 Summary of worms recovered from control and animals 
treated with Ivermectin intramuscularly (IVMT) at necropsy. 
 
 
 
 
IVMT 
Organs examined Control 
No. Reduction%
Cranial mesenteric artery 
Strongylus vulgaris 130 40 69.23 
Stomach 
Gastrophilus spp. 667 0 100 
Habronema spp. 320 0 100 
Trichostrongylus axei 50 0 100 
Small Intestine 
Parascaris equorum 10 0 100 
Caecum 
Gastrophilus spp. 30 0 100 
Strongylus spp. 820 0 100 
Cyathostomes spp. 1000 0 100 
Colon 
Strongylus spp. 3360 0 100 
Cyathostomes spp. 
+ Strongyloides westeri  
+ Oxyuris equi 
22500 0 100 
Rectum 
Gastrophilus spp. 110 0 100 
Oxyuris equi 20 0 100 
3.4 Assay of some biochemical parameters in donkeys (Equus asinus) 
medicated at therapeutic level with Doramectin Injectable 
Tables (3.4.1 to 3.4.6) show the changes in total serum protein, 
albumin, total globulins, urea, sodium and potassium following 
administration of Doramectin. In treatment group 2 from table (3.4.1) 
there is significant (P < 0.05) increase in total serum protein in days 16, 
20 and 24 post treatment when compared with pretreatment concentration 
while in treatment group 1 there is non significant (P>0.05) increase in 
total serum protein concentration in days 20, 24 and 28 post treatment 
when compared with pretreatment values. 
From table (3.4.2) serum albumin showed fluctuation in level 
through the four weeks of the experiment in both treatment groups. In 
table (3.4.3) there is non significant (P>0.05) difference in total globulins 
concentration in the two treatment groups. Urea concentration in the two 
treatment groups showed significant increase (P<0.05) in days 20 and 24 
post treatment, but it returned to almost the same level of day zero. 
Sodium level in treatment group2 showed significant (P<0.05) reduction 
in day 16 post treatment but returned to non significant difference 
(P>0.05) at the end of the experiment, while in the second group 
(DRMT2), sodium level showed significant increase (P<0.05) in days 4, 8 
and 12 post-treatment, but also returned to almost the same level of day 
zero at the end of the experiment. As shown in table (3.4.6) potassium 
concentration showed significant increase 4 days post treatment until the 
end of the experiment in the second group (DRMT2), in the first group 
(DRMT1) the increase occurred 8 days post treatment till the end of the 
experiment.  
 
 
 
 
 
Table 3.4.1 Change in total protein concentration (g/l) due to 
Doramectin injection in donkeys naturally infected with 
gastrointestinal nematodes. 
 
DRMT1  DRMT2  
Days 
Mean ± SD Mean ± SD 
0 69.40 ± 4.70 67.58 ± 5.34a 
4 70.39 ± 6.14 66.96 ± 5.73 
8 72.01 ± 4.95 66.30 ± 5.83 
12 69.24 ± 5.62 69.34 ± 5.55 
16 69.43 ± 5.60 72.67 ± 3.54b 
20 70.88 ± 6.32 71.21 ± 4.08b 
24 73.70 ± 4.05 73.25 ± 4.46b 
28 73.40 ± 3.77 70.58 ± 6.31 
 
* Means on the same column having different asterisk with day zero are 
significantly (P<0.05) different. 
 
  
 
 
 
Table 3.4.2 Change in albumin concentration (g/l) due to Doramectin 
injection in donkeys naturally infected with gastrointestinal 
nematodes. 
 
DRMT1  DRMT2  
Days 
Mean ± SD Mean ± SD 
0 24.96 ± 3.39 25.14 ± 3.94 
4 27.07 ± 4.82 26.69 ± 5.47 
8 27.40 ± 4.11 26.78 ± 4.41 
12 28.20 ± 5.19 25.90 ± 2.37 
16 26.15 ± 4.51 26.83 ± 3.74 
20 26.76 ± 4.17 26.33 ± 3.57 
24 28.01 ± 3.75 28.08 ± 4.75 
28 24.87 ± 5.28 27.21 ± 3.41 
 
 
  
 
 
 
Table 3.4.3 Change in total globulins (g/l) concentration due to 
Doramectin injection in donkeys naturally infected with 
gastrointestinal nematodes. 
 
DRMT1  DRMT2  
Days 
Mean ± SD Mean ± SD 
0 44.44 ± 6.27 42.44 ± 6.04 
4 43.32 ± 7.77 40.27 ± 3.99 
8 44.61 ± 3.85 39.52 ± 4.16 
12 41.04 ± 4.78 43.44 ± 6.03 
16 43.28 ± 6.92 45.84 ± 3.54 
20 44.12 ± 5.08 44.88 ± 3.43 
24 45.69 ± 5.70 45.17 ± 5.73 
28 48.53 ± 6.14 43.37 ± 6.13 
 
 
 
 
  
 
 
 
Table 3.4.4 Change in urea concentration (mmol/l) due to 
Doramectin injection in donkeys naturally infected with 
gastrointestinal nematodes. 
 
DRMT1   DRMT2  
Days 
Mean ± SD Mean ± SD 
0 3.03 ± 1.15a 2.86 ± 1.36a 
4 2.18 ± 1.00b 2.02 ± 0.90 
8 2.59 ± 1.36 2.09 ± 0.77 
12 3.10 ± 1.49 2.64 ± 0.88 
16 3.72 ± 1.47 2.71 ± 1.25 
20 4.47 ± 0.82b 4.64 ± 1.90b 
24 4.88 ± 0.81b 5.03 ± 1.05b 
28 2.62 ±0.68  2.46 ± 0.97 
 
* Means on the same column having different asterisk with day zero are 
significantly (P<0.05) different. 
 
 
 
 
 
 
 
  
 
Table 3.4.5 Change in sodium concentration (mmol/l) following 
administration of Doramectin injection in donkeys naturally infected 
with gastrointestinal nematodes. 
 
DRMT1 DRMT2 
Days 
Mean ± SD Mean ± SD 
0 123.10 ± 4.63a 125.20 ± 4.24a 
4 128.70 ± 4.62b 124.20 ± 5.27 
8 130.80 ± 6.44b 126.10 ± 3.99 
12 126.60 ± 4.62b 125.50 ± 5.28 
16 122.30 ± 4.14 120.00 ± 4.11b 
20 123.10 ± 5.36 122.10 ± 4.73 
24 127.00 ± 4.97 128.00 ± 4.92 
28 124.40 ± 3.75 126.40 ± 3.72 
 
* Means on the same column having different asterisk with day zero are 
significantly (P<0.05) different. 
  
 
 
 
Table 3.4.6 Change in potassium concentration (mmol/l) following 
administration of Doramectin injection in donkeys naturally infected 
with gastrointestinal nematodes. 
 
DRMT1 DRMT2 
Days 
Mean ± SD Mean ± SD 
0 2.71 ± 0.29a 2.54 ± 0.32a 
4 3.35 ± 0.41 3.00 ± 0.54b 
8 3.37 ± 1.10b 3.58 ± 0.81b 
12 3.25 ± 0.38b 3.21 ± 0.51b 
16 3.63 ± 0.72b 3.50 ± 0.46b 
20 3.41 ± 0.46b 3.38 ± 0.68b 
24 3.18 ± 0.35b 3.48 ± 0.64b 
28 3.38 ± 0.23 b 3.47 ± 0.49b 
 
* Means on the same column having different asterisk with day zero are 
significantly (P<0.05) different. 
3.5 Sub acute toxicity of Doramectin Injectable in donkeys (Equus 
asinus). 
As shown in table (3.5.1) there is non significant (P>0.05) 
difference between the three treatment groups and the control in total 
protein concentration during the whole period of the experiment. The 
albumin concentration as shown in table (3.5.2) showed significant 
difference (P<0.05) at day zero (before injection of the drug) between 
treatment groups 2 and 4 (DRMTOX1 and DRMTOX3). At day 2 there is 
significant (P<0.05) increase in albumin concentration in treatment 
groups DRMTOX1 and DRMTOX2. At the last three weeks of the 
experiment there is no significant (P>0.05) difference between the 
treatment groups and the control.  
As shown in table (3.5.3), there is significant decrease (P<0.05) in 
total globulins concentration at day 7 in DRMTOX1 and DRMTOX2 
groups, on day 35 there is also significant decrease (P<0.05) in 
DRMTOX2. When compared with the pre treatment level it was found 
that there was considerable increase in total globulin concentrations. 
Urea concentration as shown in table (3.5.4) showed significant 
increase (P<0.05) in day 4 in treatment group (DRMTOX3) when 
compared with the control group. At day 35 treatment group 
(DRMTOX1) showed significant (P<0.05) decrease when compared with 
control group.  
As shown in table (3.5.5) calcium concentration in the three 
treatment groups did not show any significant difference when compared 
with the control group  
In table (3.5.6), the inorganic phosphorus concentration showed 
significant (P<0.05) decrease at days 4 and 6 post treatment when 
compared with the control group. In this study at the last three weeks 
there is no significant (P>0.05) difference between the treatment groups 
and the control group. 
In this study the effect of Doramectin injection on T3, T4 and TSH 
profile was investigated, as shown in Figure (3.5.1). There is no 
significant (P>0.05) difference in triiodothyronine (T3) level between the 
treatment groups and the control group. The level of T3 showed 
simulataneous increase in the control and treated groups when compared 
with pretreatment level from day 5 post treatment to the end of the 
experiment as shown in table (3.5.7). 
From Figure (3.5.2), it is to be seen that thyroxine level (T4) did 
not show any significant difference between the treatment groups and the 
control. The level of the hormone showed simultaneous increase in all 
groups from day 5 post treatment and onwards when compared with the 
pretreatment level as shown in table (3.5.8). 
From Figure (3.5.3), we could observe that thyroid stimulating 
hormone (TSH) level did not show any significant difference between the 
treatment groups, and when compared with the pretreatment level within 
the treatment groups as shown in table (3.5.9). 
  
 
Table 3.5.1 Changes in total protein concentration (g/l) following 
administration of three different doses of Doramectin injected 
intramuscularly in donkeys. 
 
 
Days 
Control  
Mean ± SD 
DRMTOX1 
Mean ± SD 
DRMTOX2 
Mean ± SD 
DRMTOX3 
Mean ± SD 
0 75.2 ± 1.8 71.2 ± 0.8 73.1 ± 0.8 75.2 ± 1.2 
1 70.7 ± 1.5 72.0 ± 0.7 69.5 ± 2.6 72.8 ± 2.4 
2 72.1 ± 2.2 71.9 ±  2.0 69.6 ± 3.7 72.5 ± 3.2 
3 73.6 ± 2.0 69.3 ± 3.8 70.6 ± 1.1 71.9 ± 2.9 
4 66.9 ± 3.7 70.7 ± 3.4 73.1 ± 1.7 70.4 ± 3.1 
5 75.4 ± 2.6 73.7 ± 1.7 75.7 ± 0.8 71.4 ± 3.0 
6 75.1 ± 1.1 74.8 ± 1.2 76.4 ± 1.5 72.9 ± 1.5 
7 75.4 ± 1.1 74.2 ± 1.0 73.0 ± 1.5 77.3 ± 1.3 
14 74.2 ± 0.8 74.3 ± 1.0 72.1 ± 1.1 75.2 ± 2.3 
21 73.6 ± 1.5 73.4 ± 2.6 76.3± 2.6 73.8 ± 1.9 
28 74.7 ± 0.6 70.1 ± 2.9 70.8 ± 2.6 71.3 ± 2.1 
35 73.3 ± 2.1 68.7 ± 2.2 68.2± 2.7 70.2 ± 2.4 
 
 
  
 
 
 
  
 
Table 3.5.2 Changes in albumin concentration (g/l) following 
administration of three different doses of Doramectin injected 
intramuscularly in donkeys. 
 
 
Days 
Control  
Mean ± SD 
DRMTOX1 
Mean ± SD 
DRMTOX2 
Mean ± SD 
DRMTOX3 
Mean ± SD 
0 37.2 ± 3.8 41.5 ± 1.4a 39.8 ± 3.1 33.1 ± 0.6b 
1 37.8 ± 1.9 36.6 ± 3.1 34.8 ± 2.1 34.9 ± 1.8 
2 33.2 ± 3.9a 41.5 ± 1.8b 41.2 ± 1.2b 37.0 ± 2.3 
3 40.5 ± 4.1 41.0 ± 3.3 37.3 ± 2.6 40.6 ±.2.2 
4 34.3 ± 2.1 39.9 ± 2.7 40.7 ± 2.7 38.5 ± 1.5 
5 37.4 ± 2.5 43.5 ± 1.9 38.8 ± 4.4 39.3 ± 4.9 
6 39.0 ± 3.0 40.4 ± 3.5 45.5 ± 4.6a 31.7 ± 4.8b 
7 31.1 ± 0.9 37.8 ± 2.4 36.8 ± 2.8 36.4 ± 3.1 
14 36.6 ± 1.9 31.6 ± 0.6a 36.7 ± 3.4 38.8 ± 2.3b 
21 29.8 ± 1.2 27.1 ± 1.6 31.5 ±2.5 31.4 ± 3.3 
28 29.1 ± 3.2 28.6 ± 3.4 27.9 ± 2.8 28.1 ± 1.5 
35 28.7 ± 1.8 29.5 ± 1.3 30.4 ± 2.6 30.9 ± 1.1 
 
* Means on the same raw having different asterisk are significantly 
(P<0.05) different. 
 
 
 
 
  
 
Table 3.5.3 Changes in total globulins concentration (g/l) following 
administration of three different doses of Doramectin injected 
intramuscularly in donkeys. 
 
 
Days 
Control  
Mean ± SD 
DRMTOX1 
Mean ± SD 
DRMTOX2 
Mean ± SD 
DRMTOX3 
Mean ± SD 
0  38.0 ± 4.1 29.7 ± 1.1a 33.3 ± 2.9b 42.1 ± 1.4 
1 32.9 ± 2.3 35.4 ± 3.4 34.7 ± 1.0 37.9 ± 1.4 
2 38.9 ± 5.5 30.4 ± 1.0 28.4 ± 3.6 35.5 ± 4.6 
3 33.2 ± 5.0 28.3 ± 6.8 33.3 ± 1.7 31.2 ± 4.9 
4 32.5 ± 5.4 30.8 ± 4.5 32.3 ± 3.8 32.0 ± 4.4 
5 33.0 ±  5.2 3.0.3 ± 0.8 36.9 ± 4.3 32.1 ± 5.7 
6 36.2 ± 2.5 34.5 ± 4.2 30.8 ± 4.2 41.2 ± 5.1 
7 44.3 ± 1.5a 36.4 ± 1.7b 36.2 ± 2.7b 40.9 ± 2.4 
14 37.7 ± 2.2 42.7 ± 0.6a 35.4 ± 3.3b 36.4 ± 2.0 
21 43.8 ± 2.0 39.9 ± 1.3 41.7 ± 2.0 42.4 ± 3.0 
28 45.6 ± 2.8 41.5 ± 6.0 42.9 ± 2.6 43.2 ± 2.7 
35 44.6 ± 3.5a 39.2 ± 1.1 37.8 ± 1.7b 39.3 ± 1.7 
 
* Means on the same raw having different asterisk are significantly 
(P<0.05) different. 
 
 
 
  
 
Table 3.5.4 Changes in urea level (mmol/l) following administration 
of three different doses of Doramectin injected intramuscularly in 
donkeys. 
 
 
Days 
Control  
Mean ± SD 
DRMTOX1 
Mean ± SD  
DRMTOX2 
Mean ± SD 
DRMTOX3 
Mean ± SD 
0 2.25 ± 0.51 1.96 ± 0.33 1.71 ± 0.27 2.26 ± 0.40 
1 2.21 ± 0.61 2.12 ± 0.17 1.79 ± 0.23 2.24 ± 0.10 
2 3.06 ± 0.49 3.14 ± 0.27 2.92 ± 0.41 3.29 ± 0.27 
3 3.49 ± 0.31 3.48 ± 0.19 3.60 ± 0.47 3.94 ± 0.21 
4 2.94 ± 0.22 2.44 ± 0.26a 2.72 ± 0.42 3.73 ± 0.54b 
5 3.72 ± 0.48 2.58 ± 0.62 2.58 ± 0.66 2.84 ± 0.29 
6 2.41 ± 0.37a 2.39 ± 0.47 2.68 ± 0.34 3.57 ± 0.08b 
7 1.85 ± 0.19 1.93 ± 0.33 2.49 ± 0.40 2.56 ± 0.27 
14 3.62 ± 0.27 3.03 ± 0.42 2.99 ± 0.69 3.69 ± 0.41 
21 1.79 ± 0.58 1.61 ± 0.38 1.78 ± 0.67 2.34 ± 0.85 
28 3.36 ± 0.67 2.17 ± 0.52a 3.07 ± 0.32 4.19 ± 0.66b 
35 5.11 ± 0.72a 3.13 ± 0.09b 4.03 ± 0.73 5.52 ± 0.43 
 
 
* Means on the same raw having different asterisk are significantly 
(P<0.05) different. 
  
 
Table 3.5.5 Changes in calcium level (mmol/l) following 
administration of three different doses of Doramectin injected 
intramuscularly in donkeys. 
 
 
Days 
Control  
Mean ± SD 
DRMTOX1 
Mean ± SD 
DRMTOX2 
Mean ± SD 
DRMTOX3 
Mean ± SD 
0 2.49 ± 0.04 2.45 ± 0.07 2.58 ± 0.05 2.55 ± 0.09 
1 2.49 ± 0.03 2.54 ± 0.07 2.57 ± 0.02 2.54 ± 0.06 
2 2.61 ± 0.05 2.60 ± 0.04 2.60 ± 0.04 2.70 ± 0.03 
3 2.61 ± 0.05 2.63 ± 0.05 2.59 ± 0.05 2.63 ± 0.04 
4 2.58 ± 0.02 2.61 ± 0.10 2.61 ± 0.03 2.67 ± 0.04 
5 2.50 ± 0.02 2.56 ± 0.08 2.57 ± 0.04 2.53 ± 0.05 
6 2.25 ± 0.08 2.31 ± 0.03 2.44 ± 0.08 2.35 ± 0.06 
7 2.20 ± 0.19 2.45 ± 0.08 2.28 ± 0.08 2.17 ± 0.08 
14 2.40 ± 0.21 2.39 ± 0.24 2.33 ± 0.06 2.33 ± 0.18 
21 2.34 ± 0.17 2.39 ± 0.09 2.08 ± 0.08 2.39 ± 0.15 
28 2.33 ± 0.17 2.23 ± 0.08 2.49 ± 0.23 2.29 ± 0.10 
35 2.34 ± 0.08 2.25 ± 0.06 2.46 ± 0.19 2.27 ± 0.08 
 
  
 
Table 3.5.6 Changes in inorganic phosphorus concentration (mmol/l) 
following administration of three different doses of Doramectin 
injected intramuscularly in donkeys. 
 
 
Days 
Control  
Mean ± SD 
DRMTOX1 
Mean ± SD 
DRMTOX2 
Mean ± SD 
DRMTOX3 
Mean ± SD 
0 0.96 ± 0.06 0.80 ± 0.13 1.16 ± 0.10 0.90 ± 0.07 
1 0.94 ± 0.07 0.95 ± 0.11 0.84 ± 0.05 0.94 ± 0.06 
2 1.29 ± 0.04 1.15 ± 0.12 0.98 ± 0.11 1.23 ± 0.25 
3 1.32 ± 0.18 1.10 ± 0.07 0.98 ± 0.12 1.05 ± 0.10 
4 1.36 ± 0.11a 0.81 ± 0.08b 1.05 ± 0.11c 1.01 ± 0.09c 
5 1.13 ± 0.13 1.00 ± 0.16 1.27 ± 0.09 1.01 ± 0.07 
6 1.03 ± 0.11 0.89 ± 0.10a 1.20 ± 0.04b 1.10 ± 0.10 
7 1.06 ± 0.14 1.09 ± 0.07 1.07 ± 0.09 1.21± 0.11 
14 1.16 ± 0.20 0.94 ± 0.05 0.89 ± 0.04 1.01 ± 0.08 
21 1.35 ± 0.06 1.23 ± 0.18 1.21 ± 0.08 1.22 ± 0.10 
28 1.34 ± 0.04 1.13 ± 0.14 1.16 ± 0.07 1.13 ± 0.06 
35 1.33 ± 0.04 1.13 ±  0.05 1.15 ± 0.08 1.12 ± 0.04 
 
* Means on the same raw having different asterisk are significantly 
(P<0.05) different. 
  
 
Table 3.5.7 Changes in triiodothyronine (T3) level (ng/ml) in donkeys 
following treatment with different doses of Doramectin for whole 
week. 
 
Days 
Control  
Mean ± SD  
DRMTOX1 
Mean ± SD 
DRMTOX2 
Mean ± SD  
DRMTOX3 
Mean ± SD  
0 0.88 ± 0.40 0.79 ± 0.24 1.21 ± 0.37 0.85 ± 0.17 
1 1.00 ± 0.33 1.01 ± 0.80 1.84 ± 0.53 1.37 ± 0.87 
2 0.88 ± 0.55 0.87 ± 0.44 1.03 ± 0.47 0.74 ± 0.48 
3 0.77 ± 0.37 0.92 ± 0.40 1.21 ± 0.22 0.86 ± 0.27 
4 1.16 ± 0.31 1.00 ± 0.70 0.74 ± 0.25 0.72 ± 0.61 
5 2.25 ± 0.49 1.96 ± 0.36 2.21 ± 0.42 2.31 ± 1.01 
6 2.01 ± 0.25 2.12 ± 0.11 1.82 ± 0.24 2.27 ± 0.99 
7 1.94 ± 0.48 1.64 ± 0.34 1.70 ± 0.24 1.86 ± 0.41 
14 2.13 ± 0.93 2.23 ± 0.41 2.77 ± 1.12 2.23 ± 0.35 
21 2.38 ± 0.76 1.88 ± 0.79 2.55 ± 0.57 2.04 ± 0.50 
28 2.57 ± 0.97 1.70 ± 0.43 1.87 ± 0.34 2.03 ± 0.45 
 
  
 
Table 3.5.8 Changes in thyroxine (T4) level (ng/ml) in donkeys 
following treatment with different doses of Doramectin for whole 
week. 
 
 
Days  
Control  
Mean ± SD  
DRMTOX1 
Mean ± SD 
DRMTOX2 
Mean ± SD  
DRMTOX3 
Mean ± SD  
0 10.47 ± 8.56 10.23 ± 5.49 12.12 ± 7.42 11.72 ± 3.41 
1 14.60 ± 10.86 7.86 ± 6.17 13.16 ± 9.48 9.66 ± 11.81 
2 4.21 ± 4.40 5.81 ± 3.89 10.00 ± 5.28 7.01 ± 4.34 
3 8.35 ± 7.48 5.42 ± 2.68 6.54 ± 1.14 3.60 ± 2.74 
4 11.61 ± 7.14 4.93 ± 1.25 11.08 ± 8.67 7.58 ± 3.77 
5 28.94 ± 5.87 36.53 ± 15.88 30.11 ± 10.08 31.03 ± 13.91 
6 26.55 ± 15.74 21.55 ± 5.64 36.39 ± 12.85 23.21 ± 5.26 
7 18.46 ± 6.87 21.76 ± 5.33 54.06 ± 34.48 30.73 ± 12.38 
14 16.47 ± 9.07 17.44 ± 4.38 14.70 ± 5.29 14.98 ± 4.02 
21 19.46 ± 3.64 21.98 ± 9.26 24.10 ± 9.50 22.33 ± 7.70 
28 32.86 ± 19.13 24.40 ± 7.69 24.39 ± 13.29 35.49 ± 4.70 
 
 
  
 
Table 3.5.9 Changes in thyroid stimulating hormone (TSH) level 
(mIU/ml) in donkeys following treatment with different doses of 
Doramectin for whole week. 
 
 
Days  
Control  
Mean ±SD  
DRMTOX1 
Mean ± SD 
DRMTOX2 
Mean ± SD  
DRMTOX3 
Mean ± SD  
0 0.70 ± 0 .30 0.55 ± 0.40 0.59 ± 0.47 0.58 ± 0.41 
1 0.72 ± 0.53 0.93 ± 0.53 0.77 ± 0.14 0.72 ± 0.15 
2 0.71 ± 0.49 0.64 ± 0.49 0.90 ± 0.21 0.47 ± 0.50 
3 0.95 ± 0.15 0.55 ± 0.42 1.05 ± 0.34 0.55 ± 0.37 
4 0.89 ± 0.33 0.57 ± 0.25 0.58 ± 0.50 0.68 ± 0.07 
5 1.05 ± 0.24 0.39 ± 0.28 0.78 ± 0.55 0.48 ± 0.37 
6 0.89 ± 0.79 0.75 ± 0.34 0.97 ± 0.29 0.69 ± 0.19 
7 0.57 ± 0.46 0.74 ± 0.55 0.96 ± 0.19 0.67 ± 0.51 
14 0.87 ± 0.13 0.87 ± 0.36 1.03 ± 0.12 0.72 ± 0.57 
21 1.24 ± 0.44 1.01 ± 0.10 0.91 ± 0.46 0.87 ± 0.27 
28 0.93 ± 0.22 1.36 ± 0.79 0.93 ± 0.55 1.07 ± 0.52 
 
  
Figure 3.5.1 Change in triiodothyronine (T3) level in donkeys following treatment 
with different doses of Doramectin for a whole week.
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Figure 3.5.2 Change in thyroxine (T4) level in donkeys following treatment with 
different doses of Doramectin for a whole week. 
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Figure 3.5.3 Change in thyroid stimulating hormone (TSH) level in donkeys following 
treatment with different doses of Doramectin for a whole week.
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 DISCUSSION  
 
In this study the overall prevalence of nematode infestation was 
70.1%. This parasitical infection is higher than that recorded by Kheir and 
Kheir (1981) who reported 56.2% at Nyala town and 24% in Bahr El Arab. 
This may be attributed to the large number of animals examined in this study 
(1200 donkeys) compared to the small number of animals examined in 
Nyala town (215) and Bahr El Arab (120). The seasonal prevalence of 
gastrointestinal nematodes revealed that gastrointestinal parasites were more 
prevalent in cold season (72.5%) than hot (69.3%), and rainy season 
(68.5%). Kheir and Kheir, (1981), stated that infection with helminth 
parasites was noticed to be higher at the beginning of the rainy season (July 
– August). The relationship between high nematode infestation and cold 
winter months may be attributed to suitable winter temperature (22-26ºC) 
and humidity (85-100%) thereby favouring survival and hatching of 
nematode eggs. 
It has been found that 58.6% of the examined animals harboured mild 
infection, while 21.9% and 19.5% of the animals harboured moderate and 
severe infection respectively. This lowered egg production was observed 
before by Kheir and Kheir (1981) in case of multiple infection with three 
nematode species, where the egg counts fell to 100, 200, and 300 eggs per 
gram of faeces as compared with the corresponding counts in case of single 
infection. Although most of egg counts recorded in this study were more 
than 300 eggs per gram of faeces for mixed infection, yet no clinical signs 
were noticed in these animals. Kheir and Kheir, (1981), attributed this to the 
age of animals under investigation (4-10 years), whereby they might have 
acquired old age resistance against helminth parasites. 
The infection with single nematode species was higher than with 
multiple infections which agree with the findings of Kheir and Kheir, 
(1981).  
The rainy season recorded higher EPG compared to cold and hot. 
Again these findings are in agreement with those of Kheir and Kheir, (1981). 
Helminths recorded for the first time with high prevalence are 
Dictyocaulus arnfieldi (70.5%), but in Moroco, Pandey (1980b) reported 
48% and in Ethiopia, Feseha et al., (1991) reported 83%. The reported 
prevalence of Strongylus spp. in this study (35.8%) is in agreement with the 
findings of Kheir and Kheir (1981) at Nyala town (41.3%), and at Bahr El 
Arab (31%), where in Chad, Graber (1970) reported 89%, and in Kenya, 
Mukhwana (1994) reported 57.6%, in Ethiopia, Feseha et al., (1991) 
reported 100% prevalence. In this study Cyathostomes recorded were 
36.7%. In Morocco, Abdelkarim (1991) reported 52%, in Chad, Graber 
(1970), reported 89% and in Kenya Mukhwana (1994) reported 15.4%, 
where in Ethiopia, Feseha et al., (1991) reported 100%. Parascaris equorum 
recorded here were 10.7%, while Kheir and Kheir (1981) reported 6.6% in 
Nyala and 6.8% at Bahr El Arab. In Kenya 20.7%, in Ethiopia, 33%, in 
Chad 72%, in Morocco 37% was reported by Mukhwana (1994), Feseha et 
al., (1991), Graber (1970) and Abdelkarim (1991) respectively. The 
prevalence of Trichostrongylus axei in this study was 12%, in Ethiopia 
100% Feseha et al., (1991), in Morocco 93.5% Pandey et al., (1992a). 
Strongyloides westeri (3.4%), while Kheir and Kheir (1981), reported (4.1%) 
at Nyala and (6.8%) at Bahr El Arab. In Morocco Abdelkarim (1991), 
reported 1% and in Chad Graber (1970) reported 6%. 
Although, in Sudan very little attention has thus far been paid to the 
parasites of donkeys, the presence of large numbers of several species of 
helminths in the same animal as revealed in this study; it is highly likely that 
these parasites might exert pathological effects on donkeys. The animals are 
further subjected to the stress of poor nutrition and hard work which aid in 
the precipitation of infestation. It may therefore be advisable to treat such 
animals with anthelmintics.  
Total white blood cells (WBC) count reported in this study is in 
accord with the previous reports of Zinkl et al. (1990), French and Patrick 
(1995), Folch et al. (1997), but is greater than that reported by Mori et al. 
(2004), and less than that reported by Nayeri (1978).  Female animals 
showed significant decrease in WBCs count in the hot season when 
compared with the rainy season which may be attributed to the increased 
level of infection in the rainy season with different pathogens and increased 
susceptibility to allergens. The packed cell volume values are close to those 
reported by Nayeri (1978) and French and Patrick (1995), though greatly 
different from that reported by Mori et al., (2004), Folch et al., (1997) and 
Zinkl et al., (1990). Seasonally, the packed cell volume values did not show 
any significant difference for the male donkeys, while in female donkeys 
there is significant (P<0.05) decrease in the values reported in the hot season 
when compared with the rainy season. For haemoglobin the values reported 
in this study are in relevance with those reported by Nayeri (1978) in Iranian 
donkeys, and French and Patrick (1995) in United Kingdom donkeys, but 
they are lower than those reported by Zinkl et al., (1990) in the American 
donkeys, and Mori et al., (2004) in the Brazilian donkeys. As reported for 
the (PCV) the (Hb) values showed significant decrease in the hot season 
when compared with the rainy season. The values of the mean corpuscular 
haemoglobin concentration (MCHC) reported in this study are in accordance 
with the results obtained previously by Nayeri (1978), Zinkl et al., (1990), 
French and Patrick (1995), Folch et al., (1997), and Mori et al., (2004). In 
this study we could observe generally that the haematological values 
reported in the hot season are less than those reported in the rainy or cold 
seasons, and this may be attributed generally to the availability of feed and 
pasture, also the increase in temperature results in decrease of appetite of the 
animals.  The difference in the values reported by researchers in America 
and other European countries may be attributed to whether the animals are 
working donkeys or not.   
Serum constituents obtained in this study are within normal and 
reference values reported by the previous studies (Nayeri, 1978; Zinkl et al., 
1990; Gupta et al., 1994; French and Patrick, 1995; Jordana et al., 1998; and 
Mori et al., 2003). In this study we attempted, for the first time the break 
down analysis of the phospho- and sphingolipids components using the high 
performance liquid chromatography technique (HPLC), thus we were unable 
to do comaparisons between our findings and those of others with the 
exception of the total phospholipids, which were obtained colorimetrically 
by Jordana et al., (1998). For the enzymes, the values obtained in this study 
for the AST and ALT (GOT and GPT) are much lower than the previous 
reports, but a report from Croatia (Milinkovic-Tur et al., 2005) agreed with 
our results, with respect to the observation that non-working donkeys 
normally show decreased values of enzymes. The application of the New SI 
units (Kaneko et al., 1997) being a must, may constitute difficulties when 
comparing the results with previous reports. 
Our results show that total protein concentration is significantly 
(P<0.05) low in the cold season when compared with the hot and rainy 
season, although it is within the normal range suggested by the other authors 
(French and Patrick, 1995, Kaneko et al., 1997). Temperature stress, either 
high or low, is associated with nitrogen loss, increased adrenal activity, and 
increased protein turnover, resulting in a decrease in total serum protein, a 
decrease in albumin, and often an increase in α2-globulin (Kaneko et al., 
1997). This might have accounted for our observations. 
Blood plasma contains three major protein fractions: albumin, globulin, 
and fibrinogen. In humans, sheep, goat, rabbits and rat there are mostly 
albumins, while in horse, pig and cattle the ratio of albumins and globulins is 
almost equal, or globulins prevail (Swenson, 1993). Here in this study the 
ratio of albumin and globulins is almost equal. 
 Serum albumin in these results is significantly low in the cold season 
than the hot or rainy season, which agrees with the justifications that 
temperature stress affect protein content of serum or plasma (Kaneko et al., 
1989). The results obtained in this study for albumin concentration is closely 
related to the findings of French and Patrick (1995) and Jordana et al., 
(1998), but is lower than those reported by Mori et al., (2003).                                           
The difference in total globulin values between the rainy, cold, and 
hot seasons may also be attributed to the effect of temperature. 
High levels of unconjugated bilirubin indicate that too much 
haemoglobin is being destroyed or that the liver is not actively treating the 
haemoglobin it is receiving. 
Male animals showed significant (P<0.05) difference between the hot 
and the cold season with respect to bilirubin concentration, while female 
showed no significant change. The results obtained in this study for bilirubin 
are in accordance with the findings of Zinkl et al., (1990), Gupta et al., 
(1994) and within the range suggested by French and Patrick (1995). 
In urea concentration, there is significant difference (P<0.05) in the 
level of blood urea between the seasons. The hot season was associated with 
higher concentrations when compared with rainy or cold seasons and this 
may be accounted for by haemconcentration due to water loss during the hot 
season. 
The results obtained in this study for urea concentration fall within the 
range suggested by Kaneko et al., (1997) and Jordana et al., (1998) for 
horses and donkeys, respectively, and agree with the findings of French and 
Patrick (1995), and Mori et al., (2003) in donkeys. 
The plasma level of creatinine is relatively independent of protein 
ingestion, water intake, rate of urine production and exercise. Since its rate 
of production is constant, elevation of plasma creatinine is indicative of 
under - excretion, suggesting kidney impairment. Depressed levels of plasma 
creatinine are rare and not clinically significant. Our results show significant 
increase (P<0.05) in the level of blood creatinine in the cold season when 
compared with the hot season in both male and female animals.  
Probably as a result of some interaction with renal function these 
results for creatinine are in accordance with the findings of Zinkl et al., 
(1990) and Jordana et al., (1998), and within the range suggested by French 
and Patrick (1995), but lower than those suggested by Gupta et al., (1994) 
and Mori et al., (2003). 
Blood uric acid levels reported in this study are significantly (P<0.05) 
low in the cold season when compared with the rainy and hot seasons in 
both male and female animals. This may be attributed to nutritional 
deficiency resulting from lack of appetite during the hot weather. 
The only report for uric acid concentration in equines was that of 
Kaneko et al., (1997) and although his values are higher than ours, this could 
be of comparative with the results obtained in this study. 
Serum glucose is significantly (P<0.05) higher in the cold season than 
the hot, which is also significantly (P<0.05) higher than the rainy. This may 
be attributed to hormonsl effects (T3, T4 and glucocorticoides). The 
difference between male and female animals may attributed to the effect of 
testerone and the increase in metabolism by about 10% and build of muscle 
mass and increased body protein. The results of Nayeri (1978), Gutpa et al., 
(1994) in Iranian and exotic (Poitu and Italian) donkeys, respectively are 
similar to our results for glucose concentration, though they are lower than 
the results obtained by Zinkl et al., (1990). The findings of Mori et al., 
(2003) that female donkeys showed low glucose concentration than the male 
donkeys are in accord with our results. 
Cholesterol assays are used for screening for atherosclerotic risk and 
in the diagnosis and treatment of disorders involving elevated cholesterol 
levels as well as lipid and lipoprotein metabolic disorders. Serum cholesterol 
concentration tends to be inversely related to thyroid hormone activity 
(Duncan et al., 1994).  
The values reported here for cholesterol concentration are in 
accordance with the findings of Gupta et al., (1994) using indigenous Indian 
donkeys, Italian donkeys and Poitu breed. The results of Jordana et al., 
(1998) are in agreement with the values of the male donkeys. Mori et al., 
(2003) on the other values similar to values obtained for female donkeys in 
this study. 
The values reported in this study for triglycerides are in agreement 
with the findings of French and Patrick (1995) and Jordana et al., (1998). 
 The method used in this study for phospholipids separation is able to 
separate PG, PE, PI, PC, and SM within 27 minutes, including the 
regeneration of the column. The SM resulted in two peaks, as described by 
others (Christie et al., 1989; Becart et al., 1990; Vaghela and Kilara, 1995). 
And this presumably may be due to the heterogeneity of SM fatty acid 
residues (Breton et al., 1989). The method was unable to separate 
phosphoatidylserine from phosphatidylinositol. Phosphatidylserine, which is 
only present in trace amounts in lecithin fractions, is often poorly separated 
from other phospholipids. Despite all this, the concentration of 
phospholipids obtained in this study is in close agreement with the findings 
of Jordana et al., (1998), though slightly lower. In the present study, 
phosphatidylcholine forms the major part of the phospholipids in donkeys 
serum followed by phosphatidylglycerol.   
Our findings here revealed low values for AST concentration as reported 
by Milinkovic-Tur et al., (2005), who attributed the low values of the 
enzyme activity to the state of the animal (working or not) and this also 
agrees with the definition of Duncan et al., (1994) that AST is not only a 
liver enzyme but is also related to muscle mass of the animal. In addition to 
species, breed and age, AST activity is influenced by muscle activity 
(Weigert et al., 1980). Working horses have an approximately 60% higher 
activity (112 IU/L) than horses which are at rest for several days (70 IU/L) 
(Weigert et al., 1980). The results of French and Patrick (1995) partly 
support our results. 
The results obtained in this study for ALT fall within the range suggested 
by Kaneko et al., (1997) and Zinkl et al., (1990) for horses and donkeys, 
respectively. ALT activity in the blood plasma also is influenced by age and 
muscle activity (Weigert et al., 1980).  
There is significant increase (P<0.05) in the inorganic phosphorus 
concentration in the hot season when compared with the rainy and cold 
seasons in both groups of animals studied here. The results obtained in this 
study for inorganic phosphorus are in accordance with the findings of Nayeri 
(1978), Kaneko et al., (1997), Gupta et al., (1994), and Mori et al., (2003), 
and fall within the range suggested by Jordana et al., (1998). 
The results obtained in this study for calcium concentration are in 
accordance with the findings of Mori et al., (2003) in Brazilian donkeys. The 
values reported by Nayeri (1978) and Zinkl et al., (1990) are however higher 
than our results. 
The results obtained in this study for zinc concentration are 
comparable to reference ranges for zinc in horses 600–1200 ug/L (Wichert et 
al., 2002), and are also in accordance with the mean value reported by Liu 
(2003) 0.75 ± 0.13 mg/L (11.48 ± 1.99 µmol/l). 
Although the results obtained in this study for copper show lower 
values than those obtained by results of Liu (2003) who reported mean 
values for copper in horses at 11.6 ± 2.5 mg/L, but they were within the 
reference range for copper in horses  500–1500 ug/L (Wichert et al., 2002).   
The values obtained in this study for sodium concentration in 
donkeys’ serum are in agreement with findings of Nayeri (1978) in Iranian 
donkeys and that of Mori et al., (2003) in Brazilian donkeys, and that of 
Gupta et al., (1994) in thoroughbred Indian horses. Sodium blood level 
showed significant increase (P<0.05) in the cold season when compared 
with the hot and the rainy seasons. Such hypernatraemia occurs with 
decreased extra cellular fluid (Duncan et al., 1994). 
The values obtained in this study for potassium concentration in 
donkeys’ serum are in agreement with findings of Nayeri (1978) in Iranian 
donkeys and that of Mori et al., (2003) in Brazilian donkeys, and similar to 
those obtained by Gupta et al., (1994) in thoroughbred Indian horses. 
The results obtained in this study for T3 values are in agreement with 
the findings of Duckett et al., (1989) who repoted a level of 54.06 ± 14.02 
ng/dl and a range of 13.30 to 97.40 ng/dl; Sojka et al., (1993) reported 
baseline values ranging from 0.21 to 0.80 ng of T3/ml. Chen and Riley 
(1981) reported a mean T3 192.9 µg/dl for neonatal foals and 98.96 µg/dl for 
mature horses.  
In this study female donkeys had lower T4 values as compared with 
the values in male donkeys. The range value for T4 in this study agrees with 
the findings of Sojka et al., (1993), the mean ± SD for T4 in all donkeys is 
lower than those reported by Thomas and Adams (1978).   
In this study the level of T3 is lower in male than in female donkeys 
and T4 is higher in male than female donkeys, while TSH did not show any 
difference between sexes. Thyroid hormone levels were found to be lower in 
mares than in stallions by one group of investigators using horses (Reap et 
al., 1978), but lower in stallions and geldings than mares by others (Motley 
1972; Irvine 1967). Other investigators have found no difference in thyroid 
hormones between sexes in horses (Kallfelz 1982) 
In this study, a 100% reduction in faecal egg count was shown at 
DRMT1 and IVMT groups after administration of Doramectin by 
intramuscular injection. This finding is in accordance with the findings of 
Davies and Schwalbach (2000) in horses in South Africa and Costa et al., 
(1998). These findings indicate that Doramectin and Ivermectin are both 
effective against adult Cyathostomes, Strongylus spp., Trichostrongylus axei 
and Parascaris equorum in donkeys. 
DiPietro et al., (1982), reported that Ivermectin given intramuscularly 
to horses produced >99% efficacy against Gastrophilus spp., 100% against 
stomach nematodes and adult large strongyles, and 98% to 99% against 
adult Cyathostomes. Ivermectin at 200 µg or 300µg was 86% to 97% 
effective against immature stages of cyathostomes. Activity of Ivermectin 
against arterial stages of S. vulgaris was incomplete.  
Nematode burden in the treated animals were much lower than those 
recovered from control animals. But the presence of some nematodes in the 
animals treated with Doramectin subcutaneously substantiates our finding 
that Doramectin injected subcutaneously was 99.24-99.80% effective. The 
presence of some Strongylus vulgaris larvae in the animals treated with 
Ivermectin and Doramectin supports a similar finding of Costa et al., (1998) 
who reported that Ivermectin had 67.8% efficacy against Strongylus vulgaris 
larvae found in the mesenteric artery aneurisms; which is in agreement with 
our results (69.23%). The faecal egg count reduction of 99.24% recorded in 
day 14 after administration of Doramectin subcutaneously confirms the 
results obtained from the slaughtered animals. Abbakar et al., (2003) 
reported the same observation in sheep treated subcutaneously with 
Doramectin. The fact that Doramectin may be administered by intramuscular 
injection ensures that no anthelmintic is wasted hence no under-dosing 
occurs, provided the animal weight is accurately determined. Under- dosing 
has been suggested as an important factor in hastening the development of 
resistance (Prichard, 1990) and this is often a risk associated with oral 
dosing, as spillage frequently occurs. No adverse reactions were observed 
such as irritation or swelling at the injection site in any of the treated 
donkeys.  
The minor alterations in blood constituents observed in this study 
appear to be biologically insignificant, although some are statistically 
significant. They are within the normal range suggested by different authors 
in donkeys’ worldwide (Nayeri, 1978; Zinkl et al., 1990; Gupta et al., 1994; 
French and Patrick, 1995; Jordana et al., 1998; Mori et al., 2003). These 
constituents are subject to variation with changes in feeding, handling and 
husbandry, and the alterations may not be drug related. Here in this study the 
significant increase in total protein concentration observed in the animals 
treated subcutaneously is within the normal range and does not exceed the 
values of the second group of animals treated intramuscularly. Similar 
results were obtained in camels injected subcutaneously with Ivermectin 
(Ibrahim et al., 1981 and Hisham, 1999) and in sheep after injection of 
Ivermectin at three times the recommended dose i.e. 600 µg/kg body weight 
(Shadad, 1997). The simultaneous increase in globulin level is also partially 
in agreement with the findings of Hisham (1999) and Ibrahim et al., (1981) 
in camels. In a similar fashion albumin levels are normal. Herd and Kociba 
(1985) reported similar non significant increase in total protein and albumin 
level in horses treated with Ivermectin intramuscularly. The significant 
increase in urea blood level observed in days 20 and 24 of the experiment 
was also observed by Herd and Kociba (1985) who showed significant 
increase in urea level 8 days later after Ivermectin injection. In this 
experiment, at day 28 the level returned below that of day zero. Shadad 
(1997) reported significant increase in urea levels in sheep treated with three 
times the recommended dose of Ivermectin. Sodium level in the two treated 
groups showed different results such that in animals treated subcutaneously 
the sodium level showed transient and significant decrease in day 16 when 
compared with pretreatment level, but in days 20, 24 and 28 there was no 
significant increase. In the other group where the animals were treated 
intramuscularly, there was significant increase in sodium level immediately 
after treatment till day 12 and then non significant increase. They also 
observed significant reduction in sodium level after 4 and 8 days. Herd and 
Kociba (1985) observed significant decrease in potassium after 4 days, but 
the level returned to the pretreatment level after that. In this study there is 
significant increase in potassium level till the end of the experiment. Herd 
and Kociba (1985) suggest that the fluctuations in these parameters are due 
to nutrition and management. We agree with this justification because all 
parameters reported here did not exceed normal ranges. We conclude that 
Doramectin Injectable formulation in parasitized animals does not seem to 
affect kidney or liver functions adversely. It may be safe to use this dosage 
level, but further studies need to be carried out before a final word can be 
cast. 
No significant difference between the three treatment groups and the 
control in total protein concentration has been observed during the whole 
period of the experiment. The fluctuation in total protein concentration in the 
control and treated groups did not exceed the normal range suggested by 
other researchers (Nayeri, 1978; Gupta et. al., 1994; French and Patrick, 
1995; Jordana et al., 1998; Mori et al., 2003). Herd and Kociba (1985) 
reported that non significant difference in total protein concentration was 
also observed in horses injected intramuscularly with Ivermectin. The 
albumin concentration showed significant difference (P<0.05) at day zero 
(before injection of the drug) between treatment groups 2 and 4 (DRMTOX1 
and DRMTOX3). At day 2 there was significant increase in albumin 
concentration in treatment groups DRMTOX1 and DRMTOX2 during the 
last three weeks of the experiment there was no significant difference 
between the treatment groups and the control. This result is in accordance 
with the findings of Herd and Kociba (1985).   
There was a significant decrease in total globulins concentration at 
day 7 in DRMTOX1 and DRMTOX2 groups, as well as on day 35 within 
DRMTOX2. When compared with the pre treatment level it was found that 
there was considerable increase in total globulins concentration which agrees 
with the findings of Hisham (1999) in camels, Herd and Kociba (1985) in 
horses. 
Urea concentration showed a significant increase on day 4 in 
treatment group (DRMTOX3) when compared with the control group. At 
day 35 treatment group (DRMTOX1) showed significant decrease when 
compared with control group. Herd and Kociba (1985) reported similar 
significant increases in urea level in horses treated intramuscularly with 
Ivermectin.  
The three treatment groups did not show any significant difference 
when compared with the control group in serum calcium level. Herd and 
Kociba (1985) reported significant decrease in calcium level 4 days after the 
treatment, but the level returned to the pretreatment level at day 8 post 
treatment. 
Inorganic phosphorus level showed significant (P<0.05) decrease at 
days 4 and 6 post treatment when compared with the control group. Herd 
and Kociba (1985) reported significant decrease in inorganic phosphorus 
level 4 days post treatment. In this study during the last three weeks there 
was no significant difference between the treatment groups and the control 
group with respect to phosphorus levels. 
Minor alterations in blood constituents observed in our study appear 
to be biologically insignificant, although statistically significant. The same 
alterations occurred in the control group to some extent, which means that 
they are subjected to variations in changes with feeding, handling and 
husbandry, and the alterations may not be drug related (Herd and Kociba, 
1985). Normal levels of calcium, phosphorus, sodium, creatinine, bilirubin 
and glucose were also observed in horses given up to 12 mg/kg bwt 
Ivermectin (Herd and Kociba, 1985). In this study the effect of treatment on 
thyroid hormones revealed non significant difference (P>0.05) between the 
treatment groups and the control which indicates that Doramectin Injectable 
at these dose levels did not have any effect on thyroid hormones. The 
increase in thyroid hormones concentration in the treated groups occurred at 
the same time in the control animals.  
Conclusion and recommendations 
 
5.1 Conclusion  
 This study revealed that there is a high percentage of infection 
(70.1%) with gastrointestinal nematodes among working donkeys in 
Khartoum state. The baseline data obtained in this study covered most of the 
parameters that might be utilized to improve the productive performance of 
the working donkeys. A single intramuscular injection of Doramectin or 
Ivermectin administered at a dose rate of 200 µg/kg body weight was highly 
efficient against naturally acquired infections of adult Cyathostomes, 
Strongylus spp., Trichostrongylus axei and Parascaris equorum; Oxyuris 
equi; Triodontophorus spp.; gastrointestinal nematodes in donkeys. 
According to results obtained in this study, we conclude that Doramectin 
Injectable formulation is safe for use in equines as an Injectable formulation 
at the recommended dose, as no untoward or harm effect was observed.  
5.2 Recommendations   
1. A strategic programme for helminths control for donkeys should be 
applied, especially in the working animals, so as to minimize the 
percentage of infection first and to increase the draught power of the 
animals. 
2. At least two treatments the first at summer (March –April) and second 
in late Autumn/early winter (October – December) would be required 
to keep the worm burden at a low level. An additional treatment in 
July might be useful. 
3. The use of avermectins is advised for their broad spectrum of activity 
and high safety margins. 
4. The application of new programmes for research concerning the 
impact of thyroid hormones on lipid metabolism is highly 
recommended. 
5. Research in equines must be encouraged and development plans 
should be undertaken to conserve and multiply the current small 
numbers of equines.  
References 
Abbakar, A. D.; Seri, H. I.; Ismail, A. A. (2003). The effect of anthelmintic 
treatment on internal parasites in communally grazed sheep as reflected 
in the faecal nematode egg count in the South Darfur State of Sudan. 7th 
Sci. Cong. Egyptian Society for Cattle Diseases, 7- 9 Dec. 2003, Assiut, 
Egypt. 148 - 152. 
Abdelkarim, M. (1991). Variation saisonnieres des populations 
vermineuses et gastrophiliennes chez les asines de la region de Settat 
(Chaouia). These Doctorat Veterinaire, Institue Agronomique et 
Veterinaire Hassan II, Rabat, Maroc. 
Abe, A.; Yamashita, S.; Noma, A. (1989). Sensitive, direct colorimetric 
assay for copper in serum. Clin. Chem.; 35(4):552-554.  
Allain, C. C.; Poon, L. S.; Chan, C. S.; Richmond, W.; Fu, P. C. (1974). 
Enzymatic determination of total serum cholesterol.  Clin Chem. 
20(4):470-5. 
Anonymous (1986). Manual of Veterinary Parasitological Techniques, 
Ministry of Agriculture, Fisheries and Food. Reference Book 418, (3rd 
Ed.). HMSO, London, p.160. 
Asquith, R. L.; Kulwich, R. (1981). Safety and therapeutic activity of 
Ivermectin as an equine anthelmintic. J. Equ. Vet. Sci. 1: 18-20. 
 Barham, D.; Trinder, P. (1972). An improved colour reagent for the 
determination of blood glucose by the oxidase system. 
Analyst. 97(151): 142-5. 
Barnett, R. N.; Skodon, S. B.; Goldberg, M. H. (1973). Performance of 
“kits” used for clinical chemical analysis of calcium in serum. Am. J. 
Clin. Pathol. 59 (6): 836-45. 
Bartels, H.; Bohmer, M.; Heierli, C. (1972). Serum creatinine determination 
without protein precipitation.  Clin. Chim. Acta; 37: 193 - 197. 
Bartholomew, R. J.; Delany, A. M. (1966). Blood albumin determination. 
Proceedings of Australian Association of Clinical Biochemists. 1-214. 
Bartlet, A. L. (1985). Pharmacology of ectoparasites for animal treatment. 
In: An introduction to Veterinary Pharmacology. Frank Alexander 
(Ed.). Church hill Livingstone Inc., New York USA. 381-382. 
Bauer, J. E. (1990). Normal blood chemistry. In: Koterba, A. M., 
Drummond, W. H. and Kosch, P. C. (Eds.): Equine Clinical 
neonatology. Philadelphia, Lea & Febiger, pp 602 - 614. 
Becart, J.; Chevalier, C.; Biesse, J. (1990). Quantitative analysis of 
phospholipids by HPLC with a light – scattering evaporating detector – 
application to raw materials for cosmetic use. J. High Resolut. 
Chromatogr. 13: 126 -129. 
Bligh, E. G.; Dyer, W. J. (1959). A rapid method of total lipid extraction and 
purification. Can. J. Biochem. Physiol.; 37(8): 911-7. 
Bradford, M. M. (1976). A rapid and sensitive method for the quantitation 
of microgram quantities of protein utilizing the principle of protein-dye 
binding. Anal. Biochem. 7; 72:  248-54. 
Breton, L.; Serkiz, L.; Volland, J. P.; Lepagnol, J. (1989). A new rapid 
method for phospholipids separation by high – performance liquid 
chromatography with light – scattering detection. J. Chromatogr. B. 
497: 243-249. 
Bucolo G.; David H. (1973). Quantitative determination of serum 
triglycerides by the use of enzymes. Clin. Chem.; 19(5):476-82. 
 Caboni, M. F.; Menotta, S.; Lercker, G. (1996). Separation and analysis of 
phospholipids in different foods with a light – scattering detector. J. 
AOCS. 73: 1561-1566. 
Camac, R. (1997). Introduction and origins of the donkey. In The 
professional hand book of the Donkey. Elisabeth D. Svendsen (Ed.). 3rd 
edition. Whittet Books. London. 9 - 18. 
Campbell, W. C.; Benz, G. W. (1984). Ivermectin: a review of efficacy and 
safety. J. Vet. Pharm. & Therap. 7: 1-16. 
Chen, C. L.; Riley, A. M. (1981). Serum thyroxine and triiodothyronine 
concentrations in neonatal foals and mature horses. Am. J. Vet. Res. 42, 
1415-1417. 
Christie, W. W.; Noble, R. C.; Davies, G.  (1989). Phospholipids in milk 
and dairy – products. J. Soc. Dairy Technol.  40: 10-12. 
 Conder, G. A.; Rooney, K. A.; Illyes, E. F.; Keller, D. S.; Meinert, T. R.; 
Logan, N. B. (1998). Field efficacy of Doramectin pour-on against 
naturally acquired, gastrointestinal nematodes of cattle in North 
America. Vet. Parasitol. 77(4): 259-265. 
Cooper, J. R. (1982). Amino acids. In Cooper JR, Bloom FR, Roth RH 
(Eds.). The Biochemical Basis of Neuropharmacology, 4th Ed., Oxford 
University Press. pp. 250. 
Costa, A. J.; Barbosa, O. F.; Moraes, F. R.; Acuna, A. H.; Rocha, U. F.; 
Soares, V. E.;  Paullilo, A. C.; Sanches, A. (1998). Comparative 
efficacy evaluation of moxidectin gel and Ivermectin paste against 
internal parasites of equines in Brazil. Vet.  Parasitol. 80(1):29-36. 
Couvillion, C. E.; Pote, L. M.; Seifker, C.; Logan, N. B. (1997). Efficacy of 
Doramectin for treatment of experimentally induced infection with 
gastrointestinal nematodes in calves. Am. J. Vet. Res. 58(3): 282-285. 
Davies, J. A.; Schwalbach, L. M. J. (2000). A study to evaluate the field 
efficacy of Ivermectin, fenbendazole, and pyrantel pamoate, with 
preliminary observations on the efficacy of Doramectin, as anthelmintic 
in horses. J. South. Afri. Vet. Assoc. 71(3): 144-147. 
De Martin, D. W. (1977). Study on the thyroid function of male and female 
Thoroughbred horses in different times after winning races at the 
Hippodrome Cidade Jardin, with the use of ‘‘in vitro’’ 125I – T3 and 125I 
– T3 tests. Rev. Fac. Med. Vet. Zootec. Univ. S. Paulo. 14, 199-203. 
Deroover, E.; Cobb, R.; Rock, D. W.; Guerino, F. (1997). Persistent 
efficacy: importance and impact of trial design. Vet. Parasitol. 73 (3-4): 
365-371. 
DiPietro, J. A.; Todd, K. S.; Lock, T. F.; McPherron, T. A. (1982). 
Anthelmintic efficacy of Ivermectin given intramuscularly in horses. 
Am. J. Vet. Res. 43: 145-148. 
Dorchies, P.; Ducos de Lahitte, J.; Flochlay, A.; Blond-Rio, F. (1998). 
Efficacy of moxidectin 2% equine gel against natural nematode 
infections in ponies. Vet. Parasitol. 74: 85-89. 
Doumas, B. T.; Watson, W. A.; Biggs, H. G. (1971). Albumin standards and 
the measurement of serum albumin with promocresol green. Clin. 
Chim. Acta; 31: 87-96. 
Duckett, W. M.; Manning, J. P.; Weston, P. G. (1989). Thyroid hormone 
periodicity in healthy adult geldings. Equine Vet. J. 21(2), 123-125.  
Duncan, J. L. (1983). Anthelmintics for use in equine practice. In: 
Pharmacological basis of large animal medicine. J. A. Bogan; P. Lees; 
A. T. Yoxall (Eds.). Blackwell Scientific Publications, USA, 565 pp. 
 Duncan, J. R.; Prasse, K. W.; Mahaffey, E. A. (1994). Veterinary 
laboratory medicine medicine, clinical pathology. 3rd edition. Iowa state 
university press (AMES). 
Eckhardt, E. R. M.; Wang, D. Q. H.; Donovan, J. M.; and Carey, M. C. 
(2002). Dietary sphingomyelin suppresses intestinal cholesterol 
absorption by decreasing thermodynamic activity of cholesterol 
monomers. Gastroenterology. 122: 948-956. 
Eggestein, M.; Kreutz, F. H. (1966). A new determination of the neutral fats 
in blood serum and tissue. I. Principles, procedure, and discussion of 
the method. Klin. Wochenschr.; 44(5):262-7. 
Eisa, A. M.; ElBadawi, E. S.; Saad, M. B. A.; Ibrahim, A. M.; ElGezuli, A. 
Y. (1979). Check list and first records of helminth parasites of domestic 
and wild animals reported in the Sudan during the period 1902-1975. 
Sud. J. Vet. Res. (1): 55-63. 
Fadia, Y. Ali (2000). Studies on equine onchocerciasis in Southern Darfur 
State. M. Sc. thesis, post graduate College, University of Khartoum. 
Fawcett, J. K.; Scott, J. E. (1960). A rapid and precise method for the 
determination of urea. J Clin Pathol. 13: 156-9. 
Feseha, G. A.; Mohammed, A., and Yilma, J. M. (1991). Vermicular 
endoparasitism in donkeys of Debre Zeit and Menagescha, Ethiopia. 
Strategic treatment with Ivermectin and fenbendazole in donkeys, 
mules and horses in tropical agricultural development, Proceedings of a 
colloquium on donkeys, mules and horses (Eds. Fielding D. and 
Pearson R. A.), University of Edinburgh, Centre for Tropical Veterinary 
Medicine, UK, 156-166. 
Fisher, M.; Mrozik, H. (1989). Chemistry. In: Ivermectin and Abmectin. 
Campbell, W.C. (Ed.). Springer Verlag, New York, USA. p. 1-23. 
Folch, P.; Jordana, J.; Cuenca, R. (1997). Reference ranges and the 
influence of age and sex on haematological values of the endangered 
Catalonian donkey. The Veterinary Journal. 154: 163-168.  
Fossati, P.; Prencipe, L.; Berti, G. (1980). Use of 3, 5-dichloro-2-
hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system 
in direct enzymic assay of uric acid in serum and urine. Clin Chem.; 
26(2):227-31. 
French, J. M.; Patrick, V. H. (1995). Reference values for physiological and 
biochemical parameters in domestic donkey (Equus asinus). Equine 
Vet. Edu. 7(1) 33-35. 
Fritz, L. C.; Wang, C. C.; Gorio, A. (1979). Avermectin B1a irreversibly 
blocks pre synaptic potentials at the lobster neuromuscular by reducing 
muscle membrane resistance. Proc. Natl. Acad. Sci. USA. 76: 2062-
2066. 
Geary, G. T.; Sims, S. M.; Thomas, E. M.; Vanover, L.; Davis, J. P.; 
Winterrowd, C. A.; Klein, R. D.; Ho, N. F. H.; Thompson, D. P. (1993). 
Haemonchus contortus: Ivermectin induced paralysis of the pharynx. 
Experimental Parasitology. 77: 88-96. 
Gokbulut, C.; Boyacioglu, M..; Karademir, U. (2005). Plasma 
pharmacokinetics and faecal excretion of Ivermectin (Eqvalan® paste) 
and Doramectin (Dectomax®, 1%) following oral administration in 
donkeys. Res. Vet. Sc. 79: 233 – 238. 
Gokbulut, C.; Nolan, A.M.; Mckellar, Q.A. (2001). Plasma 
pharmacokinetics and faecal excretion of Ivermectin, Doramectin and 
moxidectin following oral administration in horses. Equ. Vet. J. 33(5): 
494-498. 
Goldenburg, H.; Fernandez, A. (1966). Simplified method for the 
estimation of inorganic phosphorus in body fluids. Clin. Chem. 12 (12): 
871-82. 
Goudie, A. C.; Evans, N. A.; Gration, K. A.; Bishop, B. F.; Gibson, S. P.; 
Holdom, K. S.; Kaye, B.; Wicks, S. R.; Lewis, D.; Weatherley, A. J.; 
Bruce, C.; Herbert, A.; Seymour, D. (1993). Doramectin - a potent 
novel endectocide. Vet. Parasitol. 49(1): 5-15. 
Graber, M. (1970). Helminths et helminthiases des equides (anes et 
chevaux) de la Republique du Tchad. Rev. Elev. Med. Vet. Pay. Trop., 
23: 207-222. 
Gupta, A. K.; Varshney, J. P.; Uppal, P. K. (1994). Comparative studies on 
biochemical indices in different breeds of equines. Indian Vet. J. 71: 
26-30. 
Hamid, M. E.; Fadia, Y. A.; Abakar, A. D. (2001). Haematological and 
blood chemical changes in donkeys naturally infected with Onchocerca 
cervicalis and Strongylus spp. in Sudan. Sud J. Vet. Sc. Anim. Husb. 
39(1&2): 111-115. 
Harvey, J. W. (1990). Normal haematologic values. In: Koterba, A. M., 
Drummond, W. H. and Kosch, P. C. (Eds.): Equine Clinical 
neonatology. Philadelphia, Lea & Febiger, p. 561-570. 
Heinemann G.; Vogt, W. (1988). The determination of bilirubin with a new 
enzymatic method (Dri-STAT bilirubin) using the Hitachi 704 selective 
analyzer. J. Clin. Chem. Clin. Biochem. 26(6):391-7. 
Herd, R. P.; Kociba, G. J. (1985). Effect of Ivermectin on equine blood 
constituents. Equ. Vet. J. 17: 142-144. 
Herrera, L. (1958). The precision of percentiles in establishing normal 
limits in medicine. J. Lab. Clin. Med. 52: 34-42. 
Hightower, D.; Miller, L.; Kyzar, J. R.; (1971). Comparison of serum and 
plasma thyroxine determinations in horses. JAVMA; 159: 449-450. 
Hilali, M.; Derhali, F. S.; Baraka, A. (1987). Incidence and monthly 
prevalence of Gastrophilus spp. Larvae (diptera: Gastrophilidae) in the 
stomach of donkeys (Equus asinus) in Egypt. Vet. Parasitol. 23: 297-
305. 
Hisham, I. S. F. (1999). Some pharmacotoxic aspects of Ivermectin in 
camels (Camelus dromedaries). M. V. Sc. Thesis, faculty of 
Postgraduate Studies, University of Khartoum, Sudan.86 pp. 
Ho, N. F. H.; Sims, S. M.; Vidmar, T. J.; Day, J. S.; Barsuhan, C. L.; 
Thomas, E. M.; Geary, T. G.; Thompson, D. P. (1994). Theoretical 
perspectives on anthelmintic drug discovery: Interplay of transport 
kinetics, physiochemical properties, and in vitro activity of anthelmintic 
drugs. J. Pharmaceutical Sci. 83: 1052-1059. 
Homsher, R.; Zak, B. (1985). Spectrophotometric investigation of sensitive 
complexing agents for the determination of zinc in serum. 
Clin. Chem.; 31(8): 1310-3. 
Ibrahim, M. S.; Mohamed, A. R.; El-balkemy, F. A.; Omran, H.; El-
Mekkauri, M. F. (1981). Studies on the relation between the effect of 
ivomec® as a parasitic control and the general health condition of 
camels. Res. Bull. No. 375 Oct. 1981 Zagazig university Egypt. 
Irvine, C. H. G. (1967). Thyroxine secretion rate in the horse in various 
physiological states. J. Endocr. 39, 313-320. 
Irvine, C. H. G.; Evans, M. J. (1975). Post - natal changes in total and free 
thyroxine and triiodothyronine in foal serum. J. Reprod. Fertil. (suppl), 
23: 709-715. 
Irvine, C. H. G.; Evans, M. J. (1977). Hypothyroidism in foals. N. Z. Vet. J. 
25: 354. 
Jain, N. C. (1986). Schalm’s Veterinary Haematology. Lea and Febiger, 
Philadelphia, USA. 1221pp. 
Jordana, J.; Folch, P.; Cuenca, R. (1998). Clinical biochemical parameters 
of the endangered Catalonian donkey breed: normal values and the 
influence of sex, age, and management practices effect. Res. Vet. S. 64, 
7-10. 
Joseph, P. Arena; Ken, K. Liu; Phillip, S. Paress; Easter, G. Frazier; Doris, 
F. Cully; Helmut Morzik; James, M. Schaeffer (1995). The mechanism 
of action of avermectins in Caenorhabditis elegans: correlation 
between activation of glutamate sensitive chloride current, membrane 
binding, and biological activity. J. Parasitology. 81(2): 286-294. 
Kallfelz, F. A. (1982). The thyroid. In: Equine Medicine and Surgery. 3rd 
edition. Eds: R. A. Mansmann, E. S. McAllister and P. W. Pratt. Am. 
Vet. Publ., Santa Barbara, California. p. 891-895. 
Kallfelz, F. A.; Erali, R. P. (1973). Thyroid function tests in domesticated 
animals: free thyroxine index. Am. J. Vet. Res. 34: 1449-1451. 
Kaneko et al.,, J. J.; Harvey, J. W.; Bruss, M. L. (1997). Clinical 
Biochemistry of Domestic Animals, 5th ed., Academic Press. San 
Diego, London, Boston, New York, Sydney, Tokyo, Toronto.  
Katovich, M.; Evans, J. W.; Sanchez, O. (1974). Effects of season, 
pregnancy and lactation on thyroxine turnover in the mare. J. Anim. 
Sci. 38: 811-818. 
Kelley, S. T.; Oheme, F. W.; Brandt, G. W. (1974). Measurement of thyroid 
gland functions during the estrous cycle of nine mares. Am. J. Vet. Res. 
35: 657-660. 
Kelly, W. R. (1984). Veterinary Clinical Diganosis. Bailliere Tindall, 
London. 3rd edition. 440 pp. 
Kheir, S. M.; Kheir, H. S. M. (1981). Gastrointestinal nematodes of equines 
in the Southern Darfur region of the Sudan. Sud. J. Vet. Res. (3): 53-57. 
King, E. S.; Wooton, J. G. P. (1956). Microanalysis in: Medical 
Biochemistry. 3rd edition. Church hill, J. A. 57-60. 
Lankas, G. R.; Gordon, L. R. (1989). Toxicology. In Ivermectin and 
Abmectin. Edited by W.C. Campbell. Springer Verlag. New York Inc. 
p. 89-112. 
Lichtenfels, J. R. (1975). Helminths of domestic equids. Proceedings of 
helmointhological Society of Washington, special issue, 42, p. 92. 
Liu, Z. P. (2003). Lead poisoning combined with cadmium in sheep and 
horses in the vicinity of non-ferrous metal smelters The Science of the 
Total Environment 309: 117–126 
Lyons, E. T.; Drudge, J. H.; Tolliver, S. C. (1985). Ivermectin: treating for 
naturally occurring infections of lungworms and stomach worms in 
equids. Vet. Med. 58-64. 
Malan,  F. S.; Reinecke, R. K. (1981). Anthelmintic efficacy of 
fenbendazole paste in equines. J. South Afri. Vet. Assoc. 52 (2): 127 – 
130 
Malan, F. S.; Reinecke, R. K. (1979). Anthelmintic efficiency of 
fenbendazole in equines. J. South Afri. Vet. Assoc. 50 (4): 255-258. 
Manger, B. R. (1991). Helminths of horses. In: Veterinary applied 
pharmacology and therapeutics. G. C. Brander, D. M. Pugh, R. J. 
Bywater, W. l. Jenkins (Eds.). 517-518 
Mardell, R. (1978). A strategy for in vitro tests of thyroid function. 
Amersham, The radio-chemical centre, 21. 
Marshall, W. J. (Ed.) (1989). Illustrated textbook of clinical chemistry. 3rd 
edition. London: Gower Medical Publishing, 207-218. 
Martin, R. J. (1985). Chemotherapy of helminth infections: Nematocides, 
Fasciolicide. In: An introduction to veterinary pharmacology, edited by 
Frank Alexander. Church hill Livingstone Inc. New York USA. p. 362. 
 Mason, I. L. (1996). A World Dictionary of Livestock Breeds, Types and 
Varieties. 4th Edition. C. A. B International. 273 pp. 
Matthee, S. (2003). Anthelmintic treatment in horses: the extra-label use of 
products and the danger of under-dosing. J. S. Afr. Vet. Assoc.; 74(2): 
53 - 56. 
Mckellar, Q.; Benchaoui, H. (1996). Avermectins and milbemycins. J. Vet. 
Pharmacol. Ther. 19, 331-351. 
McMurray, C. H.; Logan, E. F.; McParland, P. J.; McRoy, F. J.; O’Neill, D. 
G. (1978). Sequential changes in some blood components in the normal 
neonatal calf. Br. Vet. J. 134: 590-597. 
 Medani, M. A. (2003). Animal Resources and Animal Production in 
the Sudan (2nd Edition).University of Khartoum Printing Press. (In 
Arabic). 
Milinkovic-Tur, S.; V. Peric; Z. Stojevic; M. Zdelar-Tuk; J. Pirsljin (2005). 
Concentrations of total proteins and albumins, and AST, ALT and GGT 
activities in the blood plasma of mares during pregnancy and early 
lactation. Vet. arhiv 75, 195-202. 
Mohamed, E. Hamid; Fadia, Y. Ali; Abdulla, A. Fadlallah; Adam, D. 
Abakar (1998). Record of clinical cases presented to Nyala veterinary 
Teaching Hospital. Sud. J. Vet. Sci. Anim. Husb. 37(1&2): 114-120. 
 Mori, E.; Fernandes, W. R.; Mirandola, R. M. S.; Kubo, G.; Ferreira, R. R.; 
Oliveira, J. V.; Gacek, F.; (2003). Reference values on serum 
biochemical parameters of Brazilian donkey (Equus asinus) breed. J. 
Equ. Vet. S. 23(8): 358-264. 
Mori, E.; Mirandola, R. M. S.; Ferreira, R. R.; Oliveira, J. V.; Gacek, F.; 
Fernandes, W. R. (2004). Reference values on haematologic parameters 
of the Brazilian donkey (Equus asinus) breed. J. Equ. Vet. S. 24(7): 
271-276. 
Morris, D. D.; Garcia, M. (1983). Thyroid-stimulating hormone: response 
test in healthy horses, and effect of phenylbutazone on equine thyroid 
hormones. Am. J. Vet. Res. 44, 503-507. 
Motley, J. S. (1972). Use of radioactive triiodothyronine in the study of 
thyroid function in normal horses. Vet. Med. Small Anim. Clin. 67, 
1225-1228. 
Mukhwana, E. J. (1994). Helminth parasites of donkeys (Equus asinus), 
Burchell’s zebras (Equus burchelli) and camels (Camelus dromedaries) 
in a selected area of northern Kenya. In proceedings of a 2nd 
Colloquium on working equines (Eds. Bakkoury M. and Prentis R. A.), 
Institute Agronomique et veterinaire Hassan II, Rebat, Morocco. 45 - 
50. 
Nayeri, G. D. (1978). Blood characteristics of the adult donkey. Zbl. Vet. 
Med. A, 25, 541-547. 
Panadero, R.; Lopez, C.; Mezo, M.; Morrondo, P.; Diez-Banos, P. (1997). 
Effect of early treatment with Ivermectin and Doramectin on the 
dynamics of antibody response in cattle naturally infested by 
Hypoderma lineatum and H. bovis. Vet. Parasitol. 73(3-4): 325-334. 
Pandey, V. S. (1980a). Seasonal prevalence of Strongylus vulgaris in the 
anterior mesenteric artery of the donkey in Morocco. Vet. Parasitol. 7: 
357-362. 
Pandey, V. S. (1980b). Epidemiological observations on lungworm, 
Dictyocaulus arnfieldi, in donkeys from Morocco, J. Helminth. 54: 275-
279. 
Pandey, V. S. and Eysker, M. (1988). Parasites of the stomach in donkeys of 
the highveld of Zimbabwe. The veterinary Quarterly. 10(4) 246-248. 
Pandey, V. S. and Eysker, M. (1989). Strongylus vulgaris in donkeys 
(Equus asinus) from the Highveld of Zimbabwe. Vet. Parasitol. 32: 
173-179. 
Pandey, V. S. and Eysker, M. (1990). Internal parasites of donkeys from the 
highveld of Zimbabwe. Zimbabwe Vet. J. 21: 27-32. 
Pandey, V. S.; Ouhelli, H.; verhulst, A. (1992a). Epidemiological 
observations on stomach worms of donkeys in Morocco. Vet. Res. 
Communi. 16: 273-279.  
Pandey, V. S.; Ouhelli, H.; verhulst, A. (1992b). Epidemiological 
observations on Gastrophilus intestinalis and G. nasalis in donkeys 
from Morocco. Vet. Parasitol. 41: 285-292. 
Payne, J. M.; Dew, S. M.; Manston, M. I. (1970). The use of a metabolic 
profile test in dairy herd. Vet. Rec. 87: 150-158. 
Payne, J. M.; Rowland, G. J.; Manston, R.; Dew, S. M. (1973). A statistical 
appraisal of the results of metabolic profile test on 75 dairy herds. Br. 
Vet. J. 129: 370. 
Pepeu, G.; Pepeu, I. M.; Amaducci, L. (1996). A review of 
phosphatidylserine pharmacological and clinical effects. Is 
phosphatidylserine a drug for aging brain? Pharmacol. Res. 33: 73-80. 
Perez, R.; Cabezas, I.; Godoy, C.; Rubilar, L.; Munoz, L.; Arboix, M.; 
Castells, G.; Alvinerie, M. (2002). Pharmacokinetics of Doramectin and 
Ivermectin after oral administration in horses. Vet. J. 163: 161-167. 
Phillips, F. E.; Logan, N. B.; Jones, R. M. (1996). Field evaluation of 
Doramectin for treatment of gastrointestinal nematode infections and 
louse infestations of cattle. Am. J. Vet. Res. 57(10): 1468-1471. 
Prichard, R. K. (1990). Anthelmintic resistance in nematodes: extent, recent 
understanding and future directions for control and research. Int. J. 
Parasiotol. 20: 515-523.   
Reap, M.; Cass, C.; Hightower, D. (1978). Thyroxine and triiodothyronine 
levels in ten species of animals. Southwest Vet. 31, 31-34. 
Reed, A. H.; Henry, R. J.; Mason, W. B. (1971). Influence of statistical 
method used on the resulting estimate of normal range. Clin. Chem. 17: 
275-284.  
Reinecke, R. K; Le Roux, D. J.(1972). Anthelmintic activity of 
mebendazole in equines. Journal of the South African Veterinary 
Medical Association 43: 287-294.  
Reitman, S.; Frankel, S. (1957). A colorimetric method for the 
determination of serum glutamic oxalacetic and glutamic pyruvic 
transaminases.  Amer. J. Clin. Path. 28: 56 -63. 
Rowland, G. J.; Pecock, R. M. (1971). A use of the computer as an aid in 
diagnosis of metabolic problems of dairy herds. J. Dairy Res. 38: 353-
362. 
Saito, H.; and Ishihara, K. (1997). Antioxidant activity and active sites of 
phospholipids as antioxidants. J. AOCS. 74: 1531-1536. 
Sarkar, B.  C.; Chauhan, U. P. (1967). A new method for determining micro 
quantities of calcium in biological materials. Anal. Biochem. 20 (1): 
155-66. 
SBAR (2000). Statistical Bulletin for Animal Resources. Ministry of Animal 
Resources.  10: 14. 
Schlotthauer, C. F. (1931). The incidence and types of disease of the 
thyroid gland of adult horses. J. Am. Vet. Med. Ass. 78: 211-218. 
Schneider, T.; Heidemann, R.; Epe, C.; Stoye, M. (1994). Investigations 
into the efficacy of Doramectin on reactivated somatic larvae of 
Ancylostoma caninum Ercolani 1895 (Ancylostomatidae) in pregnant 
bitches. Zentralbl Veterinarmed [B] 41(9): 603-607. 
Sedmark,  J. J.; Grossberg, S. E. (1977). A rapid, sensitive, and versatile 
assay for protein using Coomassie brilliant blue G250. Anal. Biochem. ; 
79(1-2): 544-52. 
Shadad, S. A. I. (1997). Pharmacological studies on Ivermectin in ewes. Ph. 
D. thesis, faculty of Pharmacy, University of Khartoum. 
Shoop, W. L.; Ostlind, D. A.; Rohrer, S. P.; Mickle, G.; Haines, H. W.; 
Michael, B. F.; Mrozik, H.; and Fisher, M. H. (1995). Avermectins and 
milbemycins against Fasciola hepatica: in vivo drug efficacy and in 
vitro receptor binding. Int. J. Parasitol. 25, 923-927 
Smith, E. O.; Campbell, W. C. (1996). Effect of Ivermectin on 
Caenorhabditis elegans larvae previously exposed to alcoholic 
immobilization. J. Parasitol. 82(1): 187-188. 
Sojka, J. E.; Johnson, M. A.; Bottoms, G. D. (1993). Serum 
triiodothyronine, total thyroxine, and free thyroxine concentrations in 
horses. Am. J. Vet. Res. 54 (1): 52-55. 
Soulsby, E. J. L. (1982). Helminth, Arthropods and protozoa of 
domesticated animals. 7th edition, Bailliere Tindal, London. 
Soulsby, E. J. L. (1997). Foreword. In: The professional handbook of the 
donkey. Elisabeth D. Svendsen (ed.) 3rd edition. Whitet Books Limited 
London. 5-6. 
Spector, T. (1978). Refinement of the Coomassie blue method of protein 
quantitation. A simple and linear spectrophotometric assay for less than 
or equal to 0.5 to 50 microgram of protein. Anal Biochem. ; 86 (1): 
142-6. 
Sprong, R. C.; Hulstein, M. F.; and van der Meer, R. (2002). Bovine milk 
fat components inhibit food borne pathogens. Int. Dairy. J. 12: 209-215. 
Stein, E. A.; and Myers, G. L. (1995). National cholesterol education 
program recommendations for triglycerides measurement: executive 
summary. Clin. Chem.; 41: 1421-1426. 
Svendsen, E. D. (1994). Workshop summary: donkey parasitology. Vet. 
Parasitol. 54: 287-290. 
Swenson, M. J. (1993). Dukes’ Physiology of Domestic Animals, 11th ed., 
Cornell Univ. Press. Itaca and London. pp. 41-43.  
Takagi, S.; Ito, K.; shibata, H. (1974). Effects of training on plasma 
fibrinogen concentration and thyroid hormone level in young race 
horses. Exp. Rep. Equine Hlth. Lab. 11, 94-105.  
Takiguchi, Y.; Mishna, H.; Okuda, M.; and Terada, M. (1980). 
Milbemycins, a new family of macrolide antibiotics: fermentation, 
isolation and physico – chemical properties. J. Antibiot. 33, 1120-1127.   
Taussky, H. H.; Shorr, E. (1953). A microcolorimetric method for the 
determination of inorganic phosphorus. J. Biol. Chem. 202 (2): 675-85. 
Taylor, S.; Craig, T. M. (1993). Lungworms in donkeys: evaluation of 
anthelmintic under field conditions. J. Equ. Vet. Sc.13 (3): 150-152. 
Thienpont, D.; Rochette, F.; Vanparijs, O. F. J. (1979). Diagnosing 
helminthiasis by coprological examination. Janssen Research 
Foundation. Beerse, Belgium, p.187. 
Thomas C. L. Jr.; Adams J. C. (1978). Radioimmunoassay of equine serum 
for thyroxine: reference values. Am J Vet Res.; 39 (7): 1239. 
Tietz N. W. (1995). Clinical guide to laboratory tests, 3rd ed. Philadelphia, 
Pa: WB Saunders Company, 130-131. 
Trawford, A. (1997). Parasites in UK donkeys. In: The Professional Hand 
Book of the Donkey. E. D. Svendsen (Ed.) 3rd edition. Whittet Books 
Limited. London. 56-69. 
Turner, M. J.; Schaeffer, J. M. (1989). Mode of action of Ivermectin. In: 
Ivermectin and Abmectin. W. C. Campbell (Ed.). Springer Verlag. New 
York Inc. p. 73-86. 
Urquhart, G. M.; Armour, J.; Duncan, J. L.; Dun, A. M.; Jennings, F. W. 
(1988). Veterinary Parasitology. Longman group U.K. Ltd., Longman 
house, Burnt Mill, Harlow, Essex CM 202 JE. England. p. 263. 
Vaghela, M. N.; and Kilara, A.  (1995). Quantitative analysis of 
phospholipids from whey – protein concentrates by high – performance 
liquid chromatography with a narrow – bore column and an evaporative 
light – scattering detector. J. AOCS. 72: 729-733. 
Vesper, H.; Schmelz, E. M.; Nikolova-Karakashian, M. N.; Dillehay, D. L.; 
Lynch, D. V.; and Merrill, A. H. (1999). Sphingolipids in food and the 
emerging importance of sphingolipids to nutrition. J. Nutr. 129: 1239-
1250. 
Wahlefeld, A. W.; and Bergmeyer, H. U. (1974). Methods of enzymatic 
analysis. 2nd English edition. New York, NY; Academic Press Inc. 
1831. 
Weigert, P.; Scheck, K.; Lemmer, B.; Noreisch, W. (1980). 
Labordiagnostische Haflinger Pferden und Maultieren (Tragtiere der 
Bundeswehr). Enzymaktivitäten im Serum. Tierärztl. Praxis 8, 387. 
Wichert, B.; T. Frank and E. Kienzle (2002). Zinc, Copper and Selenium 
Intake and Status of Horses in Bavaria1. Presented as part of the 
Waltham International Symposium: Pet Nutrition Coming of Age held 
in Vancouver, Canada, August 6–7, 2001. J. Nutr. 132: 1776-1777. 
Williams, G. Z., Young, D. S., Stein, M. R., Cotlove, E. (1970). Biological 
and analytic components of variation in long-term studies of serum 
constituents in normal subjects. I. Objectives, subject selection, 
laboratory procedures, and estimation of analytic deviation. Clin Chem. 
16(12):1016-21. 
Wilson, R. T. (1978). Studies on the Livestock of   Southern Dar Fur. IV. 
Notes on Equines. Trop. Anim. Hlth. Prod. 10 183-189.  
Wilson, R. T. (1990). An Introduction to Animal Husbandry in the Tropics. 
W. J. A. Payne (Ed.). 4th edition. Longman Group. Longman House 
Burnt Mill, Harlow, Essex CM202 JE, England. 581- 603. 
Wintrobe, M. M. (1976). Clinical Haematology. Lea and Febiger, 
Philadelphia, USA. 2021pp.  
Wootton, T. D. P. (1974). Plasma sodium and potassium microanalysis: In 
medical biochemistry. p. 62-65. 5th edition, Churchill. 
Xiao, L.; Herd, R. P.; Majewski, G. A. (1994). Comparative efficacy of 
moxidectin and Ivermectin against hypobiotic and encysted 
cyathostomes and other equine parasites. Vet. Parasitol. 53: 83-90. 
Zinkl, J. G.; Mae, D.; Merida, P. G.; Farver, T. B.; Humble, J. A. (1990). 
Reference ranges and the influence of age and sex on hematologic and 
serum biochemical values in donkeys (Equus asinus). Am. J. Vet. Res. 
51(3): 408-413. 
Table 1.1 Estimates of equine population by states. 
States Horses Donkeys 
North Kordofan 69000 10.6 % 635000 10.0 % 
South Kordofan 13000 2.0 % 273050 4.3 % 
West Kordofan 43000 6.6 % 571500 9.0 % 
North Darfur 16000 2.5 % 673100 10.6 % 
South Darfur 225000 34.6 % 514350 8.1% 
West Darfur 169000 26.0 % 774700 12.2% 
Elgedarif 10000 1.5 % 476250 7.5 % 
Kassala 8000 1.2 % 273050 4.3 % 
Red Sea 10000 1.5 % 196850 3.1 % 
Blue Nile 13000 2.0 % 228600 3.6 % 
Sennar 10000 1.5 % 247650 3.9 % 
Elgezira 22000 3.4 % 768350 12.1 % 
White Nile 28000 4.3 % 393700 6.2% 
Northern 1000 0.2 % 146050 2.3 % 
River Nile 2000 0.3 % 158750 2.5 % 
Khartoum 8000 1.2 % 6350 0.1 % 
North upper Nile 500 0.1 % 6350 0.1 % 
Unity 2000 0.3 % 0 0.0 % 
Gongoli 0 0.0 % 0 0.0 % 
North bahr Elgazal 500 0.1 % 6350 0.1 % 
Albohairat 0 0.0 % 0 0.0 % 
Warab 0 0.0 % 0 0.0 % 
Bahr Elgabal 0 0.0 % 0 0.0 % 
 East Eqquatoria 0 0.0% 0 0.0 % 
West Eqquatoria 0 0.0% 0 0.0 % 
Total 650000 100.0 % 6350000 100.0 % 
  
Table 1.2 some biochemical blood constituents of the adult horses.* 
 
 
Parameter Median ± SD 
ALT (GPT)  14 ± 11 (3 – 23) UI 
AST (GOT) 296 ± 70 (226 – 366) UI 
Bilirubin (Total bilirubin) 
17.2 (7.1 – 34.2) mmol 
1.0 (1 – 2.0) mg/dl 
Calcium  
3.1 ± 0.14 (2.8-3.4) mmol/l 
12.4 ± 0.58 (11.2-13.6) mg/dl 
Cholesterol (Total) 
2.88 ± 0.47 (1.94-3.89) mmol/l 
111 ± 18 (75-150) mg/dl 
Inorganic Phosphorus 
1.00 – 1.81 mmol/l 
3.1 – 5.6 mg/dl 
Potassium (K) 3.51 ± 0.57 (2.4 – 4.7) mmol/l 
Total protein 63.5 ± 5.9 (52-79) g/l 
Albumin 30.9 ± 2.8 (26-37) g/l 
Total globulins  33.3 ± 7.1 (26.2-40.4) g/l 
Sodium (Na) 139 ± 3.5 (132-146) mmol/l 
Uric acid 
53.5 – 65.4 mmol/l 
0.9 – 1.1 mg/dl 
Urea  3.57 – 8.57 mmol/l 
 
 
 
 * Source: Kaneko et al., (1997).  
 
Table 1.3 some haematological and biochemical parameters of the 
Iranian donkeys.* 
 
Parameter Male Female 
RBC X 106/C.mm. 8.295 ± 1.511 7.833 ± 1.711 
Hb (g/dl) 11.92 ± 1.36 13.19 ± 1.92 
PCV (%) 33.65 ± 3.59 35.67 ± 4.94 
MCV (cu. u) 41.91 ± 8.17 47.24 ± 10.15 
MCH (u. ug) 14.88 ± 3.07 17.56 ± 4.31 
MCHC (%) 35.57 ± 3.64 36.62 ± 5.48 
WBC X103/C.mm. 13.384 ± 3.092 13.703 ± 2.682 
Lymphocyte %  51.33 ± 8.18 54.08 ± 8.10 
Esinophil  % 9.23 ± 3.29 7.78 ± 3.91 
Monocyte  % 0.38 ± 0.67 0.56 ± 0.85 
Neutrophil  % 38.71 ± 6.89 37.75 ±7.90 
Basophil  % 0.084 ± 0.21 0.02 ± 0.09 
Ca (mg/dl) 10.81 ± 1.20 10.07 ± 0.72 
Cholesterol (mg/dl) 187.4 ± 28.45 202.8 ± 43.5 
Glucose (mg/dl) 60.06 ± 14.95 59.72 ± 12.99 
Inorganic phosphate (mg/dl) 3.29 ± 0.99 3.63 ± 1.19 
Na (mmol/L) 103.9 ± 26.75 92.1 ± 34.16 
K (mmol/L) 2.78 ± 0.69 2.30 ± 0.82 
 
  
 
*Source: Nayeri (1978). 
 
 
Table 1.4 some hematological parameters of the American donkeys.* 
 
 
 
 
Parameter Mean ± SD Reference range 
RBC X 106/ul. 6.65 ± 1.05 4.56 – 8.74 
Hb (g/dl) 13.1 ± 1.7 9.7 – 16.5 
PCV (%) 38 ± 5 29 – 48 
MCV (fl) 57.9 ± 5.5 46.9 – 69.0 
MCH (u. ug) 19.9 ± 1.9 16.0 – 23.8 
MCHC (%) 34.3 ± 1.1 32.1 – 36.5 
WBC X103/c. mm. 10.3 ± 2.5 5.2 – 15.4 
Lymphocyte %  42.9 ± 11.8 19.4 – 66.4 
Esinophil  % 5.4 ± 4.4 0.0 – 14.1 
Monocyte  % 5.1 ± 2.9 0.0 – 10.7 
Neutrophil  % 45.5 ± 11.5 23.1 – 69.5 
Basophil  % 0.4 ± 0.5 0.0 – 1.4 
 
* Reference range: Mean ± 2SD 
  
 
 
 
 
*Source: Zinkl et al., (1990). 
 
Table 1.5 some biochemical parameters of the American donkeys.* 
 
Parameter Mean ± SD Reference range  
Serum protein (g/dl) 7.2 ± 0.7 5.9 – 8.6 
Albumin (g/dl) 3.3 ± 0.3 2.6 – 4 
Globulin (g/dl) 3.9 ± 0.7 2.5 – 5.3 
Total bilirubin (mg/dl) 0.1 ± 0.2 0 – 0.4 
BUN (mg/dl) 18 ± 5 12 – 24 
Creatinine (mg/dl) 1.1 ± 0.3 0.6 – 1.6 
CK (U/L) 64 ± 43 0 – 150 
AST (U/L) 487 ± 119 248 – 725 
ALT (U/L) 18 ± 32 0 – 83 
ID (U/L) 3 ± 1 0.2 – 5.0 
ALP (U/L) 236 ± 75 86 – 395 
GGT (U/L) 69 ± 29 10 – 128 
LD (U/L) 427 ± 161 105 – 749 
Ca (mg/dl) 11.8 ± 0.8 10.2 – 13.3 
Cholesterol (mg/dl) 108 ± 30 48 – 168 
Glucose (mg/dl) 84 ± 22 40 – 128 
Inorganic phosphate (mg/dl) 4.3 ± 1.3 1.8 – 6.8 
Na (mEq/L) 141 ± 4 132 – 149 
K (mEq/L) 4.2 ± 0.6 3.0 – 5.4 
Mg (mg/dl) 2.6 ± 0.4 1.8 – 3.3 
Cl (mEq/L) 102 ± 3 95 - 109 
* Reference range: Mean ± 2SD 
 
*Source: Zinkl et al., (1990). 
Table 1.6 Comparative values (Mean ± S.E.) of various enzyme 
activities, metabolites and ion contents in different breeds of equines in 
India.* 
 
 
Exotic donkeys 
Parameters  
Indigenous 
donkeys Poitu  Italian  
SGOT IU/L 311.01 ± 1.751 331.98 ± 1.637 314.82 ± 1.9 
SGPT IU/L 11.98 ± 0.894 14-30 ± 0.525 11.85 ± 0.5 
AP IU/L 251.91 ± 1.554 236.52 ± 1.671 277.69 ± 1.9 
TSP g/dl 7.80 ± 0.250 8.31 ± 0.227 8.63 ± 0.3 
Albumin g/dl 3.62 ± 0.124 3.70 ±0.125 4.01 ± 0.1 
Cholesterol  mg/dl 56.85 ± 0.751 55.04 ± 0.714 64.91 ± 0.7 
Glucose mg/dl 67.55 ± 1.016 49.13 ± 0.747 54.94 ± 0.7 
BUN mg/dl 11.70 ± 0.34 10.09 ± 0.38 14.77 ± 0.6 
Creatinine mg/dl 1.24 ± 0.132 1.48 ± 0.118 1.75 ± 0.1 
Total Bilirubin  mg/dl 0.322 ± 0.077 0.334 ± 0.076 0.324 ± 0.0 
Direct Bilirubin  mg/dl 0.075 ± 0.040 0.080 ± 0.035 0.072 ± 0.0 
Calcium mg/dl 10.20 ± 0.074 10.20 ± 0.268 10.01 ± 0.31 
Phosphorus mg/dl 2.98 ± 0.181 2.95 ± 0.213 3.12 ± 0.2 
Sodium mEq/L 128.60 ± 0.834 129.61 ± 0.609 121.00 ± 0.95 
Potassium mEq/L 4.65 ± 0.173 4.55 ± 0.281 4.49 ± 0.221 
Chloride mEq/L 115.60 ± 0.685 120.94 ± 1.019 132.40 ± 1.0 
 
 
 
 *Source: Gupta et al., (1994). 
  
 
Table1.7 Comparative biochemical values (Mean ± S.E.) of adult mares 
of two different breeds in India.* 
 
 
 
parameters Kathiawari Thoroughbred 
SGOT IU/L 312.34 ± 1.309 351.48 ± 1.294 
SGPT IU/L 10.10 ± 0.471 15.91 ± 0.238 
AP IU/L 165.06 ± 2.109 211.60 ± 1.211 
TSP g/dl 7.59 ± 0.292 9.13 ± 0.215 
Albumin g/dl 3.48 ± 0.148 2.91 ± 0.124 
Cholesterol  mg/dl 97.83 ± 0.904 105.09 ± 0.784 
Glucose mg/dl 71.81 ± 0.851 76.85 ± 0.844 
Calcium mg/dl 10.57 ± 0.288 9.48 ± 0.163 
Sodium mEq/L 129.8 ± 1.276 109.43 ± 0.719 
Potassium mEq/L 4.96 ± 0.302 2.87 ± 0.140 
 
 
 
 
 
 
 
 
 *Source:  Gupta et al., (1994). 
 
 
Table 1.8 Haematological parameters of the adult donkey in  
United Kingdom.* 
 
 
 
Parameter Median 5 % 95 % 
White blood cells count 109/l 10.2 6.1 16.1 
Neutrophils % 50.5 28 78 
Lymphocytes% 43 17 65 
Eosinophils % 4 1 10 
Basophils% 0 0 0.08 
Monocytes% 1 0 5 
Total Red blood cells count 1012/l 5.5 4 7.3 
Packed cell volume L/L 0.33 0.25 0.38 
Haemoglobin g/dl 11.6 9 15.3 
Mean corpuscular volume femtolitre 64 57 79 
MCH picograms 21.9 18.9 28.6 
MCHC g/dl 34.8 31.4 39.1 
 
  
  
 
  
*Source: French and Patrick (1995). 
  
 
Table 1.9 some biochemical blood constituents of the adult donkey in 
United Kingdom.* 
 
 
 
Parameter Median 5 % 95 % 
Creatinine (umol/l) 75 53 141 
Creatinine phosphokinase (IU/L) 40 15 149 
Total bilirubin (umol/l) 2.7 1.4 7.7 
Urea (mmol/l) 3.9 1.9 7.6 
Triglycerides (mmol/l) 1 0.2 4.3 
Total protein (g/l) 70 58 82 
Albumin (g/l) 28 20 34 
Total globulins (g/l) 40 29 53 
ϒ - Glutamate transferase (IU/L) 17 8 49 
Glutamate dehydrogenase (IU/L) 1.6 0.4 8 
Aspartate aminotransferase (IU/L) 109 59 199 
Alkaline phoshatase (IU/L) 265 150 563 
 
 
 
 
 
 * Source: French and Patrick (1995). 
 
 
 
Table 1.10 Some haematological parameters of the Catalonian donkey.* 
 
 
Parameter All donkeys 
Mean ± SD 
Young 
Mean ± SD 
Adult  donkeys 
Mean ± SD 
RBC X 1012 l-1. 6.87 ± 1.22 7.14± 1.34  6.77 ± 1.17 
Hb (gl-1) 122.8 ± 22.7 118.4 ± 14.1 124.5 ± 25.1 
PCV (ll-1) 0.36 ± 0.05 0.34 ± 0.03 0.36 ± 0.05 
MCV (fl) 52.6 ± 7.5 48.6 ± 5.7 54.1 ± 7.6 
MCH (pg) 18.4 ± 2.2 16.9 ± 1.9 19.1 ± 2.1 
MCHC (gl-1) 347.0 ± 12.8 347.1 ± 11.2 346.9 ± 13.4 
WBC (109l-1) 10.7 ± 2.9 13.9 ± 3.0 9.6 ± 1.8 
Lymphocyte (109l-1) 5.3 ± 2.4 8.0 ± 2.7 4.2 ± 1.2 
Esinophil  (109l-1) 0.68 ± 0.54 0.81 ± 0.71 0.63 ± 0.46 
Monocyte  (109l-1) 0.22 ± 0.19 0.27 ± 0.26 0.21 ± 0.16 
Neutrophil  (109l-1) 4.5 ± 1.2 5.0 ± 1.3 4.3 ± 1.2 
Basophil  (109l-1) 0.02 ± 0.06 0.02 ± 0.05 0.02 ± 0.06 
 
 
 
 
  
*Source: Folch et al., (1997).  
 
 
 
Table 1.11 Serum clinical biochemical parameters of the Catalonian 
donkey breed.* 
 
 
 
Analyte  Mean ± SD Range   
Urea (mg/dl) 36 ± 7.7 16.0 – 56.8 
Cholesterol (mg/dl) 71.1 ± 26.3 40.7 – 249.3 
Triglycerides (mg/dl) 74.8 ± 32.5 11.1 – 182.4 
AST (IU/L) 254 ± 57 165 – 491 
Inorganic phosphorus (mg/dl) 3.80 ± 0.86 2.21 – 5.90 
LDH (IU/L) 315 ± 139 94 – 869 
GGT (IU/L) 48 ± 22 20 – 112 
Creatinine kinase ((IU/L) 195 ± 104 75 – 645 
Creatinine (mg/dl) 1.06 ± 0.22 0.49 – 1.56 
Phospholipids (mmole/l) 1.71 ± 0.42 0.01 – 3.34 
Total bilirubin (mg/dl) 0.05 ± 0.03 0.00 – 0.17 
Albumin (g/dl) 2.68 ±0.36 1.75 – 3.61 
 
 
 
  
 
 
*Source: Jordana et al., (1998). 
 Table 1.12 Serum biochemical values of female and male of the 
Brazilian donkey breed.* 
 
Analyte  Female donkey 
Mean ± SD 
Male donkey 
Mean ± SD 
Total 
Mean ± SD  
Glucose (mg/dl) 55.15 ± 5.76  76.33 ± 12.96 58.35 ± 10.40 
Cholesterol (mg/dl) 87.80 ± 10.06 92.39 ± 9.29 88.41 ± 9.86 
Serum protein (g/dl) 6.75 ± 0.36 7.25 ± 0.33 6.82 ± 0.40 
Albumin (g/dl) 3.08 ± 0.17 3.42 ± 0.20 3.13 ± 0.21 
Creatinine (mg/dl) 1.82 ± 0.13 1.66 ± 0.10 1.80 ± 0.14 
Urea (mg/dl) 24.30 ± 5.55 23.99 ± 4.68 24.25 ± 5.37 
Lactate (mg/dl) 20.59 ± 4.51 17.30 ± 4.24 20.10 ± 4.58 
AST (IU/L) 299.94 ± 64.20 272.40 ± 52.73 295.81 ± 62.79 
CK (IU/L) 151.85 ± 72.83 192.89 ± 97.18 158.00 ± 76.94 
GGT (IU/L) 44.22 ± 13.52 54.89 ± 8.05 45.82 ± 13.34 
LDH (IU/L) 584.57 ± 153.88 527.61 ± 176.06 576.02 ± 156.32 
AP (IU/L) 353.75 ± 62.40 297.82 ± 70.60 345.36 ± 56.90 
Ca (mg/dl) 8.56 ± 0.17 8.40 ± 0.18 8.54 ± 0.18 
P (mg/dl) 2.73 ± 0.35 2.91 ± 0.59 2.76 ± 0.38 
Cl (mEq/L) 106.18 ± 3.42 105.33 ± 1.51 106.05 ± 3.20 
Na (mEq/L) 121.59 ± 4.29 121.00 ± 3.52 121.50 ± 4.14 
K (mEq/L) 3.80 ± 0.36 3.13 ± 0.31 3.70 ± 0.42 
 
 
 
 *Source: Mori et al., (2003). 
 
 
 
Table 1.13 haematological values of female and male of the Brazilian 
donkey breed.* 
 
 
 
Analyte  Male donkey 
Mean ± SD 
Female donkey 
Mean ± SD 
Total 
Mean ± SD 
RBC (x 106/ul) 7.29 ± 0.50 6.73 ± 0.67 6.82 ± 0.67 
PCV (%) 38.00 ± 1.79 37.56 ± 2.93 37.63 ± 2.76 
Hb (g/dl) 13.22 ± 0.73 12.80 ± 1.01 12.87 ± 0.98 
MCV (fl) 52.20 ± 2.37 56.06 ± 4.05 55.45 ± 4.06 
MCH (pg) 18.17 ± 0.40 19.10 ± 1.18 18.85 ± 1.14 
MCHC (g/dl) 34.77 ± 1.12 34.09 ± 1.24 34.20 ± 1.24 
WBC (x103/ul) 9.10 ± 1.23 8.06 ± 1.50 8.22 ± 1.49 
Neutrophil (x103/ul) 4.09 ± 0.70 3.26 ± 0.77 3.39 ± 0.81 
Lymphocytes (x103/ul) 4.27 ± 0.90 4.12 ± 0.85 4.15 ± 0.84 
Monocytes (x103/ul) 0.13 ± 0.11 0.13 ± 0.11 0.13 ± 0.11 
Eosinophils (x103/ul) 0.32 ± 0.22 0.39 ± 0.20 0.38 ± 0.20 
Basophils  (x103/ul) 0.03 ± 0.04 0.03 ± 0.04 0.03 ± 0.04 
 
 
  
 
Source: Mori et al., (2004). 
 
Table 1.14 New SI units 
 
 
Parameter Conventional unit X factor New SI units 
Albumin  g/dl  10.0 g/l 
Bilirubin  mg/dl  17.10 µmol/l 
Calcium  mg/dl  0.2495 mmol/l 
Cholesterol  mg/dl  0.02586 mmol/l 
Chloride  mEq/l 1.0 mmol/l 
Copper µg/dl 0.1574 µmol/l 
Creatinine  mg/dl  88.40 µmol/l 
Glucose mg/dl 0.05551 mmol/l 
Haemoglobin g/dl 10.0 g/l 
Iodine µg/dl 78.8 nmol/l 
Insulin µU/ml 7.175 pmol/l 
Iron µg/dl 0.1791 µmol/l 
Lactate mg/dl 0.1110 mmol/l 
Lead µg/dl 0.64826 µmol/l 
Magnesium mg/dl 0.4114 mmol/l 
Manganese µg/dl 0.1820 µmol/l 
Phosphorus  mg/dl  0.3229 mmol/l 
Potassium  mEq/l 1 mmol/ 
Protein  mg/dl  10 g/l 
Selenium  µg/dl 0.1266 µmol/l 
Sodium  mEq/l  1 mmol/l 
Thyroxine  µg/dl 12.87 nmol/l 
Triiodothyronine  ng/dl 0.01536 nmol/l 
Urates (Uric acid)  mg/dl   59.48 µmol/l 
Urea mg/dl  X 0.1665 mmol/l 
Urea nitrogen mg/dl 0.7140 mmol/l 
Urea nitrogen  mg/dl 0.3570 mmol urea/l 
Zinc µg/dl 0.1530 µmol/l 
Enzymes UI  X 16.67 nkat/l 
 
 
 
 * Source: Kaneko et al., (1997). 
 
 
 
Table 1.15 Class of drug, dosage, and method of administration of 
equine anthelmintics 
 
 
 
Drug class Anthelmintic  Dosage 
(mg/kg) 
Method 
Simple heterocyclic Piperazine 88 - 110 S 
Benzimidazole Thiabendazole 44 - 88 S, F, O 
Benzimidazole Mebendazole 8.8 S, F, O 
Benzimidazole Fenbendazole 5 - 10 S, F, O 
Benzimidazole Oxfenbendazole 10 S, F, O 
Benzimidazole Oxibendazole 10 - 15 S, O 
Imidothiazole – simple 
heterocyclic 
Levamisole –  
Piperazine 
8/88 S 
Tetrahydropyrimidine Pyrantel pamoate 6.6 S, F, O 
Organophosphate Trichlorofon 40 S, O 
Organophosphate Dichlorvos  35 F 
Probenzimidazole Febantel 6 S, F, O 
Avermectin Ivermectin 0.2 S, O 
 
S = stomach tube, F = feed, O = orally as paste or drench  
 
 
 
